{"title":"Diagnostic Imaging Radiology","description":"","products":[{"product_id":"digestive-disease-week-2024","title":"Digestive Disease Week 2024","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 418 videos, size: 421 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: gastroenterology, hepatology, endoscopy, and gastrointestinal surgery physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDigestive Disease Week® (DDW)\u003c\/p\u003e\n\u003cp\u003eDigestive Disease Week® (DDW) is the most prestigious meeting in the world for GI professionals. It provides an unparalleled opportunity to delve into exciting new developments with leaders in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.\u003c\/p\u003e\n\u003ch3\u003eHere are some details about the recent and upcoming events:\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGuidelines \u0026amp; Best of\u003c\/p\u003e\n\u003cp\u003e2024 AGA Guideline Highlights\u003c\/p\u003e\n\u003cp\u003eBest of DDW\u003c\/p\u003e\n\u003cp\u003eAGA Best of UEG Week 2023 at DDW\u003c\/p\u003e\n\u003cp\u003eGuidelines in Action: Case-Based ASGE Updates\u003c\/p\u003e\n\u003cp\u003eTimely Topics in Colorectal Cancer Screening\u003c\/p\u003e\n\u003cp\u003eOptimizing CRC Screening \u0026amp; Surveillance (High-Risk, IBD, Hereditary)\u003c\/p\u003e\n\u003cp\u003eReducing CRC Incidence: Screening \u0026amp; Surveillance Strategies\u003c\/p\u003e\n\u003cp\u003ePractice Guidelines (AASLD)\u003c\/p\u003e\n\u003cp\u003ePlenaries, Debates \u0026amp; Keynotes\u003c\/p\u003e\n\u003cp\u003eAASLD Presidential Plenary\u003c\/p\u003e\n\u003cp\u003eAGA Presidential Plenary; Presidential Address\u003c\/p\u003e\n\u003cp\u003eClinical \u0026amp; Basic Science Plenaries (AGA, DDW Late-Breaking)\u003c\/p\u003e\n\u003cp\u003eETI \/ EGD \/ GI Oncology \/ Liver \u0026amp; Biliary Section Plenaries\u003c\/p\u003e\n\u003cp\u003eCellular \u0026amp; Molecular \/ Microbiome (MMT) \/ NGM \/ PGDB Distinguished Plenaries\u003c\/p\u003e\n\u003cp\u003eAcademic Debates: Alcohol-Associated LT, Portal Hypertension, MASLD\u003c\/p\u003e\n\u003cp\u003eFireside \/ Shark Tank \/ World Cup of Endoscopy\u003c\/p\u003e\n\u003cp\u003eAI \u0026amp; Digital Health\u003c\/p\u003e\n\u003cp\u003eAI in Gastroenterology: Current \u0026amp; Future Applications\u003c\/p\u003e\n\u003cp\u003eAI in Endoscopy: New Tech \u0026amp; RCT Evidence (2024)\u003c\/p\u003e\n\u003cp\u003eGenerative AI \u0026amp; NLP in GI\u003c\/p\u003e\n\u003cp\u003eAI for Cancer Screening\u003c\/p\u003e\n\u003cp\u003eDigital Tools for GI Disorders\u003c\/p\u003e\n\u003cp\u003eChanging Practice in the Era of AI\u003c\/p\u003e\n\u003cp\u003eEsophagus \u0026amp; Foregut\u003c\/p\u003e\n\u003cp\u003eBarrett’s Esophagus: Advances, Updates \u0026amp; Chemoprevention\u003c\/p\u003e\n\u003cp\u003eEsophageal Pathophysiology \u0026amp; GERD: Controversies \u0026amp; Current Status\u003c\/p\u003e\n\u003cp\u003eManometry \u0026amp; EndoFLIP: A Practical Primer\u003c\/p\u003e\n\u003cp\u003eEsophageal Leaks \u0026amp; Fistulae: Stent, Clip, VAC—How to Choose\u003c\/p\u003e\n\u003cp\u003eFrontiers in Esophageal Endoscopy (ESD, Strictures, Stents, Patches)\u003c\/p\u003e\n\u003cp\u003eDGBI: Myths \u0026amp; Realities of Food Sensitivity \u0026amp; Microbiota Testing\u003c\/p\u003e\n\u003cp\u003eFunctional Dyspepsia; Nausea \u0026amp; Vomiting\u003c\/p\u003e\n\u003cp\u003ePadova Classification \u0026amp; HRM in Foregut Surgery\u003c\/p\u003e\n\u003cp\u003eFood as Medicine for Foregut Outcomes (Yamada Lecture)\u003c\/p\u003e\n\u003cp\u003eStomach, Obesity \u0026amp; Bariatrics\u003c\/p\u003e\n\u003cp\u003eEndobariatric Techniques \u0026amp; 2024 Updates\u003c\/p\u003e\n\u003cp\u003eMechanisms of Endoscopic \u0026amp; Metabolic Bariatric Therapies\u003c\/p\u003e\n\u003cp\u003eCurrent Insights in Bariatric Endoscopy\u003c\/p\u003e\n\u003cp\u003eObesity Management for Gastroenterologists\u003c\/p\u003e\n\u003cp\u003ePharmacologic Management of Obesity\u003c\/p\u003e\n\u003cp\u003eNutrition After Bariatric Procedures\u003c\/p\u003e\n\u003cp\u003eStomach\/Bariatric–Metabolic Diseases (I–II)\u003c\/p\u003e\n\u003cp\u003eSmall Bowel \u0026amp; Celiac\u003c\/p\u003e\n\u003cp\u003eSince Sliced Bread: Best in Celiac 2024\u003c\/p\u003e\n\u003cp\u003eMicrobially-Based Therapies for Celiac \u0026amp; Food Sensitivities\u003c\/p\u003e\n\u003cp\u003eDifficult \u0026amp; Obscure: Exploring the Small Bowel (2024)\u003c\/p\u003e\n\u003cp\u003eUpper GI Assortment\u003c\/p\u003e\n\u003cp\u003eColon \u0026amp; Quality\u003c\/p\u003e\n\u003cp\u003eAll Things Endoscopy: Esophagus to Colon\u003c\/p\u003e\n\u003cp\u003eFrontiers in Colonoscopy; Strategies to Improve Performance\u003c\/p\u003e\n\u003cp\u003eNovel Tools for Detection\/Resection of Colonic Lesions\u003c\/p\u003e\n\u003cp\u003eColonic ESD 2024: What’s New\u003c\/p\u003e\n\u003cp\u003eTwists \u0026amp; Turns: New Tools for Colonoscopy\u003c\/p\u003e\n\u003cp\u003eQuality Matters: Preps, Meds \u0026amp; Polyps\u003c\/p\u003e\n\u003cp\u003ePurging the Problem Polyp\u003c\/p\u003e\n\u003cp\u003eChallenges in Acute Care Colonoscopy (Case-Based)\u003c\/p\u003e\n\u003cp\u003eIBD\u003c\/p\u003e\n\u003cp\u003eAdvances in Pain, Sleep \u0026amp; Fatigue Management in IBD\u003c\/p\u003e\n\u003cp\u003eDietary Management; Precision Nutrition for IBD\u003c\/p\u003e\n\u003cp\u003eIBD Diagnosis, Monitoring \u0026amp; Complication Prediction\u003c\/p\u003e\n\u003cp\u003eControlled Trials (I–II); Late Breakers \u0026amp; Innovations\u003c\/p\u003e\n\u003cp\u003eRole of Environment; Innate\/Adaptive Immunity; Host Mechanisms\u003c\/p\u003e\n\u003cp\u003eSingle-Cell \u0026amp; Multi-Omics Insights in IBD Biology\u003c\/p\u003e\n\u003cp\u003eCrosstalk: Cellular \/ Epithelial Function \/ Barrier \/ Inflammation\u003c\/p\u003e\n\u003cp\u003eCoordinating IBD \u0026amp; PSC Management\u003c\/p\u003e\n\u003cp\u003eAdverse Events with Small Molecules\u003c\/p\u003e\n\u003cp\u003eUncontrolled Therapeutic Observations in IBD\u003c\/p\u003e\n\u003cp\u003eKey Challenges \u0026amp; Expert Strategies (Brotman, Powell, Funderburg Lectures)\u003c\/p\u003e\n\u003cp\u003eThe Best of the Basic Sciences in IBD\u003c\/p\u003e\n\u003cp\u003eMicrobiome, Nutrition \u0026amp; Gut–Brain Axis\u003c\/p\u003e\n\u003cp\u003eGut Microbiome: Ally or Foe for ICIs\u003c\/p\u003e\n\u003cp\u003eMicrobiome in IBD: Mechanism to Translation\u003c\/p\u003e\n\u003cp\u003eMicrobiome Modulation Across the Lifespan\u003c\/p\u003e\n\u003cp\u003eMicrobiome Therapeutics: Path to Clinical Success\u003c\/p\u003e\n\u003cp\u003eNavigating the Microbial Landscape for Precision Nutrition\u003c\/p\u003e\n\u003cp\u003eDietary\/Microbial Bioactives \u0026amp; Mucosal Health\u003c\/p\u003e\n\u003cp\u003eGut–Brain Axis: GRG Symposium \u0026amp; “Gut Instincts”\u003c\/p\u003e\n\u003cp\u003eTiny Ecosystems: Early-Life Microbiome\u003c\/p\u003e\n\u003cp\u003eWe Live in a Microbial World\u003c\/p\u003e\n\u003cp\u003eHepatology \u0026amp; Transplant\u003c\/p\u003e\n\u003cp\u003eAcute on Chronic Liver Failure: What GI Needs to Know\u003c\/p\u003e\n\u003cp\u003ePortal Hypertension \u0026amp; Complications of Cirrhosis; New Imaging\/IR\u003c\/p\u003e\n\u003cp\u003ePre-Surgery \/ Pre-Procedure Assessment in Cirrhosis\u003c\/p\u003e\n\u003cp\u003eNon-Invasive Assessment \u0026amp; Disparities in Liver Disease\u003c\/p\u003e\n\u003cp\u003ePredictors of Liver Disease Outcomes\u003c\/p\u003e\n\u003cp\u003eMASLD\/MASH: Beyond the Biopsy; Therapeutic Pipeline\u003c\/p\u003e\n\u003cp\u003ePharmacotherapies for Alcohol-Associated Liver Disease\u003c\/p\u003e\n\u003cp\u003eIt’s Not Over: Viral Hepatitis in the Modern Era; HCV Elimination\u003c\/p\u003e\n\u003cp\u003eImproving Access in Liver Transplantation\u003c\/p\u003e\n\u003cp\u003eInterventional Radiology for Portal Hypertension\u003c\/p\u003e\n\u003cp\u003ePancreas \u0026amp; Biliary\u003c\/p\u003e\n\u003cp\u003eClinical Acute \u0026amp; Chronic Pancreatitis; Preventing Mortality\u003c\/p\u003e\n\u003cp\u003ePainful Chronic Pancreatitis: Are Outcomes Improving?\u003c\/p\u003e\n\u003cp\u003eDiagnosing Exocrine Pancreatic Insufficiency\u003c\/p\u003e\n\u003cp\u003eInnovations in Early Detection of Pancreatic Cancer\u003c\/p\u003e\n\u003cp\u003ePancreatic EUS: Genomic Frontiers; AI \u0026amp; Imaging Advances\u003c\/p\u003e\n\u003cp\u003ePreclinical Models of Pancreatic Disease: Opportunities \u0026amp; Limits\u003c\/p\u003e\n\u003cp\u003eDifficult ERCP: Video Challenges; Minimizing Adverse Events\u003c\/p\u003e\n\u003cp\u003eRunning the Gauntlet: Novel Approaches to Biliary Stones \u0026amp; Strictures\u003c\/p\u003e\n\u003cp\u003eThinking Outside the Box: Multifaceted Biliary Challenges\u003c\/p\u003e\n\u003cp\u003eEndoscopic\/Operative Approaches to Obstructions \u0026amp; Collections\u003c\/p\u003e\n\u003cp\u003eMotility \u0026amp; Neurogastroenterology\u003c\/p\u003e\n\u003cp\u003eOropharyngeal \u0026amp; Esophageal Motility Disorders\u003c\/p\u003e\n\u003cp\u003eConstipation: Bench to Bedside; Clinical Practice Updates\u003c\/p\u003e\n\u003cp\u003eIBS: Pathophysiology \u0026amp; Clinical; IBS in IBD\u003c\/p\u003e\n\u003cp\u003eEnteric Neuromuscular Biology; Sensation in Health \u0026amp; Disease\u003c\/p\u003e\n\u003cp\u003eVagal Neuromodulation: Clinical \u0026amp; Basic Cross-Talk\u003c\/p\u003e\n\u003cp\u003eThe Gut as a Sensory Organ—To the Brain and Back\u003c\/p\u003e\n\u003cp\u003eEmesis, Pandemic \u0026amp; Motility—Moving Right Along\u003c\/p\u003e\n\u003cp\u003eOncology \u0026amp; Early Detection\u003c\/p\u003e\n\u003cp\u003eBiomarkers for Early GI Cancer Detection \u0026amp; Prognosis\u003c\/p\u003e\n\u003cp\u003eHarnessing Multi-Omics in GI Cancers\u003c\/p\u003e\n\u003cp\u003eGenetic Susceptibility: Risk Stratification \u0026amp; Surveillance\u003c\/p\u003e\n\u003cp\u003eFinding Fountains of Youth: Aging Mechanisms \u0026amp; GI Cancers\u003c\/p\u003e\n\u003cp\u003eEpidemiology \u0026amp; Screening of Barrett’s \u0026amp; Gastric Cancer\u003c\/p\u003e\n\u003cp\u003eH. pylori \u0026amp; Gastric Cancer: Pathogenesis \u0026amp; Diagnosis\u003c\/p\u003e\n\u003cp\u003eGI Cancer Progression \u0026amp; Therapeutic Implications\u003c\/p\u003e\n\u003cp\u003eNew Approaches to Hepatobiliary Neoplasia\u003c\/p\u003e\n\u003cp\u003eLiver \u0026amp; Biliary Carcinoma\u003c\/p\u003e\n\u003cp\u003eEndoscopic Innovation \u0026amp; Safety\u003c\/p\u003e\n\u003cp\u003eInnovations in Endoscopic Technology; Commercialization\u003c\/p\u003e\n\u003cp\u003eThird-Space Endoscopy: How I Do It; Quo Vadis\u003c\/p\u003e\n\u003cp\u003eAdoption of Advanced Tissue Resection in the U.S.\u003c\/p\u003e\n\u003cp\u003eUpdates in Endoscopic Resection \u0026amp; Defect Closure\u003c\/p\u003e\n\u003cp\u003eMinimizing Adverse Events in Endoscopy\u003c\/p\u003e\n\u003cp\u003eLooking for Closure: Repairing (Almost) Any Defect\u003c\/p\u003e\n\u003cp\u003ePre- and Post-Procedure Preparation\u003c\/p\u003e\n\u003cp\u003eUnderstanding \u0026amp; Minimizing ERCP-Related Adverse Events (2024)\u003c\/p\u003e\n\u003cp\u003ePediatrics\u003c\/p\u003e\n\u003cp\u003ePediatric Endoscopy: Insights \u0026amp; Innovation; Moving Forward\u003c\/p\u003e\n\u003cp\u003ePediatric Functional \u0026amp; Motility Disorders\u003c\/p\u003e\n\u003cp\u003eIntersections of Microbiome \u0026amp; Pediatrics\u003c\/p\u003e\n\u003cp\u003ePediatric IBD: Trends \u0026amp; Therapies (2024)\u003c\/p\u003e\n\u003cp\u003eMASLD \/ Metabolism \/ OMN\u003c\/p\u003e\n\u003cp\u003eClinical Advances in Steatotic Liver Disease \u0026amp; MASH\u003c\/p\u003e\n\u003cp\u003eMASLD for the Non-Hepatologist\u003c\/p\u003e\n\u003cp\u003eMASLD: Mechanisms \u0026amp; Therapeutic Targets\u003c\/p\u003e\n\u003cp\u003eWeight-Inclusive Care \u0026amp; Obesity Management (Multidisciplinary)\u003c\/p\u003e\n\u003cp\u003eMulti-Disciplinary MASLD + Obesity Management\u003c\/p\u003e\n\u003cp\u003eWeight Loss Therapies for MASLD\u003c\/p\u003e\n\u003cp\u003eMetabolism, Obesity, Diet \u0026amp; Nutrition in GI Cancer\u003c\/p\u003e\n\u003cp\u003eMesenteric Adipose Tissue in Obesity, MASLD \u0026amp; IBD\u003c\/p\u003e\n\u003cp\u003eNavigating the Microbial Landscape for Precision Nutrition\u003c\/p\u003e\n\u003cp\u003eEducation, Career \u0026amp; Wellness\u003c\/p\u003e\n\u003cp\u003eAGA Academy of Educators Plenary\u003c\/p\u003e\n\u003cp\u003eAcquiring New Skills After Fellowship\u003c\/p\u003e\n\u003cp\u003eToolkit for the Well-Equipped Gastroenterologist\u003c\/p\u003e\n\u003cp\u003eTraining in Ergonomic Endoscopy\u003c\/p\u003e\n\u003cp\u003eGI Fellow-Directed QI Projects; Residents \u0026amp; Fellows Research\u003c\/p\u003e\n\u003cp\u003eMeet the Editors: How to Get Published\u003c\/p\u003e\n\u003cp\u003eBranding \u0026amp; Leadership: Build Reputation Early\u003c\/p\u003e\n\u003cp\u003eEffecting Culture Change in Everyday Practice\u003c\/p\u003e\n\u003cp\u003eClinician Distress \u0026amp; Organizational Wellbeing\u003c\/p\u003e\n\u003cp\u003eAPP Career Planning; GI APP Roles\u003c\/p\u003e\n\u003cp\u003eA Day in the Life of a Liver Consultant (Floor-Based Consults)\u003c\/p\u003e\n\u003cp\u003eEquity, Advocacy \u0026amp; Global\u003c\/p\u003e\n\u003cp\u003eEquity \u0026amp; Inclusion in GI: We Can Do Better\u003c\/p\u003e\n\u003cp\u003eGender Equity Project (AGA)\u003c\/p\u003e\n\u003cp\u003eWe’re Now at the Table: Next Frontiers in GI Advocacy\u003c\/p\u003e\n\u003cp\u003eGlobal Outreach: Achalasia Management; Training Around the World\u003c\/p\u003e\n\u003cp\u003eEndoscopic Training in Underserved Areas (WEO Symposium)\u003c\/p\u003e\n\u003cp\u003eGreener Endoscopy: Environmental Impact \u0026amp; New Tech\u003c\/p\u003e\n\u003cp\u003eASGE International Collaborations (FAAED, GESA, JGES, KSGE, TAGE, SIED, AMEG, POHER, Pan-Arab, SOBED)\u003c\/p\u003e\n\u003cp\u003eMiscellaneous \u0026amp; Cross-Cutting Science\u003c\/p\u003e\n\u003cp\u003eConnecting the Exposome \u0026amp; Microbiome\u003c\/p\u003e\n\u003cp\u003eHost–Microbe Interactions in IBD\u003c\/p\u003e\n\u003cp\u003eCell Atlases; Organoids \u0026amp; Engineered Systems\u003c\/p\u003e\n\u003cp\u003eEpithelial Junctions, Barrier \u0026amp; Signaling\u003c\/p\u003e\n\u003cp\u003eInflammatory Tuning of Epithelial Proliferation\u003c\/p\u003e\n\u003cp\u003eHuman \u0026amp; Experimental Cholestasis \u0026amp; Autoimmunity\u003c\/p\u003e\n\u003cp\u003eMucosal Healing \u0026amp; Repair; Tissue Regeneration\u003c\/p\u003e\n\u003cp\u003ePIEZO2 \u0026amp; Mechanosensation\u003c\/p\u003e\n\u003cp\u003ePhage \u0026amp; Fungal Tools to Tame Inflammation\u003c\/p\u003e\n\u003cp\u003eEnvironmental Drivers of IBD (Giannella Lecture)\u003c\/p\u003e\n\u003cp\u003eThe Dawn of New Gut–Microbe Concepts\u003c\/p\u003e\n\u003cp\u003eThe Interplay of Fibrotic TME, Immunity \u0026amp; Metabolism in HBP Neoplasia\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716115652,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Digestive-Disease-Week-2024.png?v=1784215286"},{"product_id":"cme-science-advanced-breast-imaging-2024","title":"CME Science Advanced Breast Imaging 2024","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 21 videos, size: 4.23 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e• Release date: November 27th, 2023\u003c\/p\u003e\n\u003cp\u003e• Expiration date: November 27th, 2025\u003c\/p\u003e\n\u003cp\u003e• Estimated time to complete activity: 15 hours\u003c\/p\u003e\n\u003cp\u003e• Jointly provided by Partners for Advancing Clinical Education (PACE) and CME Science\u003c\/p\u003e\n\u003cp\u003eEducational Objectives\u003c\/p\u003e\n\u003cp\u003eMeet all of your MQSA CME requirements, as well as Breast MR CME requirements for ACR accreditation. We will cover digital mammography, breast MRI, breast ultrasound, tomosynthesis, interventional practices, breast cancer, lymph nodes, high risk lesions, BIRADS, implants, screening, risk management and more\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, participants should better be able to:\u003c\/h3\u003e\n\u003cp\u003e• Optimize imaging methods to reduce the number of false-positive mammography interpretations.\u003c\/p\u003e\n\u003cp\u003e• Describe recent advances and techniques in breast imaging.\u003c\/p\u003e\n\u003cp\u003e• Integrate information presented in this course into efforts to improve the imaging skills in practice.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Curriculum Advanced Breast Imaging 2024\u003c\/p\u003e\n\u003cp\u003eTomosynthesis Update 2023: What Have We Learned? What’s Next? – Tanya Moseley, MD\u003c\/p\u003e\n\u003cp\u003eIs Contrast Enhanced Mammography a Better Mammogram – Tanya Moseley, MD\u003c\/p\u003e\n\u003cp\u003eBreast Anatomy and Benign Breast Entities with mammogram and Ultrasound Correlation – Sarah Pittman, MD\u003c\/p\u003e\n\u003cp\u003eCalcifications – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eBI-RADS 3 Dilemmas on Digital Mammography \u0026amp; Ultrasound – Sunita Pal, MD\u003c\/p\u003e\n\u003cp\u003eChallenging Calcification Cases on Digital Mammography – Sunita Pal, MD\u003c\/p\u003e\n\u003cp\u003eBI-RADS 3: Probably Benign – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eTips on Improving Cancer Detection on Digital Mammo \u0026amp; Ultrasound Part 1 – Sunita Pal, MD\u003c\/p\u003e\n\u003cp\u003eImaging After Breast Conservation Therapy – Sarah Pittman, MD\u003c\/p\u003e\n\u003cp\u003eTips on Improving Cancer Detection on Digital Mammo \u0026amp; Ultrasound Part 2 – Sunita Pal, MD\u003c\/p\u003e\n\u003cp\u003eMultimodality Radiology-Pathology Correlation Elevated Risk Pathology – Sunita Pal, MD\u003c\/p\u003e\n\u003cp\u003eSimplifying Biopsies with Breast Ultrasound – Tanya Moseley, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer Staging with Ultrasound – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eTargeted Axillary Dissection: History and Updates – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eBreast Cancer Localization – No More Wires – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eBreast MRI Approaches and Cases – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eAbbreviated Breast MRI and Novel Breast Imaging Modalities – Tanya Moseley, MD\u003c\/p\u003e\n\u003cp\u003eMR Guided Breast Biopsies: The Moseley Method – Tanya Moseley, MD\u003c\/p\u003e\n\u003cp\u003eRisk Management – Alfred Watson, MD\u003c\/p\u003e\n\u003cp\u003eBiomarkers and Neoadjuvant Imaging – Cody Mayo, MD\u003c\/p\u003e\n\u003cp\u003eArtificial Intelligence in Breast Imaging – Cody Mayo, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716279492,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/CME-Science-Advanced-Breast-Imaging-2024.jpg?v=1784215288"},{"product_id":"american-society-for-gastrointestinal-endoscopy-annual-postgraduate-course-leveraging-new-advances-to-improve-patient-outcomes-may-2024","title":"American Society for Gastrointestinal Endoscopy Annual Postgraduate Course Leveraging New Advances to Improve Patient Outcomes May 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: gastroenterologists, surgical endoscopists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis course contains recordings from the live course that took place at DDW in Washington D.C. in May of 2024.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal endoscopists across the globe look to future trends, such as the conversion of GI endoscopy data into 3D images, and how this and other technologies may advance endoscopic practice that improves patient care.\u003c\/p\u003e\n\u003cp\u003eYet, how can endoscopists integrate all these technologies when the cost of procedures continues to challenge early practice adoption? How do endoscopic practices address managing larger geriatric patient populations who present with increasing co-morbidities? Also, how does one manage the ever-changing patient lifestyle where unhealthy nutritional habits continue to grow, increasing other GI disease states? ASGE’s 2024 Postgraduate Course: Leveraging New Advances to Improve Patient Outcomes is guaranteed to provide essential endoscopic resources, current research highlights and forward practice trends.\u003c\/p\u003e\n\u003ch3\u003eDuring the course, you’ll identify practice resources you can use with sessions that cover topics such as:\u003c\/h3\u003e\n\u003cp\u003ePancreatobiliary disease states\u003c\/p\u003e\n\u003cp\u003eEsophageal disorders\u003c\/p\u003e\n\u003cp\u003eEmerging trends in high-quality colonoscopy techniques\u003c\/p\u003e\n\u003cp\u003eManagement of endoscopic varices\u003c\/p\u003e\n\u003cp\u003eAnd more!\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eAppraise evidence-based practice recommendations in the management of colon polyps and high-quality colonoscopy\u003c\/p\u003e\n\u003cp\u003eDiscuss critical updates in endohepatology and endobariatrics\u003c\/p\u003e\n\u003cp\u003eRecognize endoscopic complications and management techniques\u003c\/p\u003e\n\u003cp\u003eIdentify management of pancreatitis and associated complications\u003c\/p\u003e\n\u003cp\u003eList key indications, contraindications and set-up of endoscopic procedures in pregnant and other high-risk patients\u003c\/p\u003e\n\u003cp\u003eCompare and contrast practical approaches to gastrointestinal health in LGBTQIA+ patients\u003c\/p\u003e\n\u003cp\u003eDiscuss advancing endoscopy training throughout post-gastroenterology fellowship years\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEndoscopic Treatment of Chronic Pancreatitis: When to Intervene\u003c\/p\u003e\n\u003cp\u003eProving Cancer in Indeterminate Biliary Strictures (ERCP Pathways)\u003c\/p\u003e\n\u003cp\u003eRefractory GERD: Moving Beyond Medical Therapy\u003c\/p\u003e\n\u003cp\u003eEosinophilic Esophagitis (EoE): Optimal Treatment \u0026amp; Monitoring\u003c\/p\u003e\n\u003cp\u003ePreventing the Post-Polypectomy Bleed: Techniques \u0026amp; Tips\u003c\/p\u003e\n\u003cp\u003eEntrepreneurship in GI: Hirschowitz Endowed Lecture\u003c\/p\u003e\n\u003cp\u003eHigh-Quality Colonoscopy: Top 10 Must-Do Practices\u003c\/p\u003e\n\u003cp\u003eImmediate Post-Endoscopic Management of Colonic Perforation\u003c\/p\u003e\n\u003cp\u003eDuodenal Adenomas: Risks \u0026amp; Endoscopic Therapy Strategy\u003c\/p\u003e\n\u003cp\u003eLGBTQIA+ Digestive Health: Key Considerations for Clinicians\u003c\/p\u003e\n\u003cp\u003eBetter Billing in Gastroenterology \u0026amp; Endoscopy (Overholt Endowed Lecture)\u003c\/p\u003e\n\u003cp\u003eEMR Reality Check: The Good, the Bad \u0026amp; the Ugly (if you need, keep or omit)\u003c\/p\u003e\n\u003cp\u003eManagement of Early Pancreatic Fluid Collections\u003c\/p\u003e\n\u003cp\u003eERCP Pancreatitis Complications: How to Avoid \u0026amp; Manage (Video Tip)\u003c\/p\u003e\n\u003cp\u003eEsophageal Leaks \u0026amp; Fistulae: Stent vs Clip vs VAC—Choosing the Intervention\u003c\/p\u003e\n\u003cp\u003eEndoscopic Management of Gastric Varices + Coil \u0026amp; Glue (Video Tip)\u003c\/p\u003e\n\u003cp\u003eTop Ten Do’s \u0026amp; Don’ts for LGBTQ+ Patient Interactions\u003c\/p\u003e\n\u003cp\u003eEndoscopy in Pregnancy: Safety \u0026amp; Best Practices\u003c\/p\u003e\n\u003cp\u003eVideo Quiz \u0026amp; Case-Based Learning\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A Sessions (Pancreatobiliary, Esophagus, Colon, Stomach\/Small Bowel)\u003c\/p\u003e\n\u003cp\u003eCourse Welcome, Overview \u0026amp; Wrap-Up\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405716508868,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-for-Gastrointestinal-Endoscopy-Annual-Postgraduate-Course-Leveraging-New-Advances-to-Improve-Patient-Outcomes-May-2024.jpg?v=1784215293"},{"product_id":"outpatient-endovascular-and-interventional-society-10th-annual-national-scientific-meeting-2023","title":"Outpatient Endovascular and Interventional Society 10th Annual National Scientific Meeting 2023","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: vascular surgeons, interventional radiologists, cardiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 10th Annual National Scientific Meeting of the Outpatient Endovascular and Interventional Society (OEIS) is a dynamic three-day event dedicated to advancing safe, high-quality outpatient endovascular and interventional care. This meeting brings together multidisciplinary experts and professionals to explore innovations, regulatory topics, and practice models in office-based and outpatient procedural medicine.\u003c\/p\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eCutting-edge techniques in outpatient embolization and cardiac interventions\u003c\/p\u003e\n\u003cp\u003eLegal, compliance, and reimbursement frameworks impacting outpatient interventional practices\u003c\/p\u003e\n\u003cp\u003eTechnological solutions and troubleshooting strategies via hands-on forums\u003c\/p\u003e\n\u003cp\u003eBest practices in patient selection, safety, and practice management tailored to outpatient workflows\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eLocation: Disney’s Coronado Springs Resort, Lake Buena Vista, Florida\u003c\/p\u003e\n\u003cp\u003eFormat: In-person event featuring symposia, panel discussions, hands-on technology sessions, and networking receptions\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003ch3\u003eThis meeting is designed for:\u003c\/h3\u003e\n\u003cp\u003eVascular surgeons, interventional radiologists, cardiologists, and outpatient interventionalists\u003c\/p\u003e\n\u003cp\u003ePractice leaders, researchers, healthcare administrators, and allied health professionals involved in outpatient procedural care\u003c\/p\u003e\n\u003cp\u003eAnyone looking to shape and elevate the standards of outpatient interventional practice\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eStay ahead of the curve with practical, evidence-based updates in outpatient interventional medicine\u003c\/p\u003e\n\u003cp\u003eEngage in interactive sessions that blend clinical learning, legal insight, and hands-on technology exposure\u003c\/p\u003e\n\u003cp\u003eBuild valuable connections with peers, industry leaders, and innovators in the field\u003c\/p\u003e\n\u003cp\u003eGain actionable strategies to improve safety, efficiency, and patient experience in your practice\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSymposium- New Frontiers in Out-Patient Embolization.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405717917892,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Outpatient-Endovascular-and-Interventional-Society-10th-Annual-National-Scientific-Meeting-2023.jpg?v=1784215309"},{"product_id":"harvard-neurological-emergencies-2024","title":"Harvard Neurological Emergencies 2024","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: emergency physicians, neurologists, hospitalists, intensivists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eImaging and lab algorithms that accelerate decisions while minimizing overuse\u003c\/p\u003e\n\u003cp\u003eWhen to escalate: thrombolysis, thrombectomy, airway\/ventilation, transfer triggers\u003c\/p\u003e\n\u003cp\u003ePractical medication sequencing and dosing for time-sensitive therapies\u003c\/p\u003e\n\u003cp\u003eCommunication that sticks: risk discussion, documentation, and handoffs\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eFormat: Live lectures, case discussions, panel Q\u0026amp;A, and concise take-home checklists\u003c\/p\u003e\n\u003cp\u003eStructure: Thematic blocks designed for next-day implementation in ED\/ICU\/inpatient workflows\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eEmergency physicians, neurologists, hospitalists, intensivists, advanced practice providers, nurses, pharmacists, and trainees caring for patients with acute neurologic illness.\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eReplace uncertainty with clear, step-by-step action plans\u003c\/p\u003e\n\u003cp\u003eImprove time-to-treatment and reduce preventable morbidity\u003c\/p\u003e\n\u003cp\u003eBring back ready-to-use algorithms, order prompts, and counseling scripts\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWednesday, October 23, 2024\u003c\/p\u003e\n\u003cp\u003e7:50am to 8:00am Welcome and Introduction Jonathan A. Edlow, MD, FACEP and Joshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e8:00am to 9:00am Keynote Presentation: Cerebral Aneurysms: 2024 Update Christopher S. Ogilvy, MD\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15am to 10:00am Neuroimaging 101 William Copen, MD\u003c\/p\u003e\n\u003cp\u003e10:00am to 10:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:45am Back Pain 2024: Red Flags and Beyond Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:00am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:00am to 11:15am Break\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:45am Neuroimaging of the Spine: What to Order and How to Read William Copen, MD\u003c\/p\u003e\n\u003cp\u003e11:45am to 12:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:30pm Updates in Urgent Management of Spinal Cord and Cauda Equina Disorders Ganesh Shankar, MD\u003c\/p\u003e\n\u003cp\u003e12:30pm to 12:45pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:45pm to 1:45pm Break\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm Neuroimaging in Stroke William Copen, MD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:15pm Subdural Hematoma: Medical and Surgical Management Christopher Stapleton, MD\u003c\/p\u003e\n\u003cp\u003e3:15pm to 4:00pm Intracerebral HemorrhageJoshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e1:45pm to 2:30pm Altered Mental Status and Delirium Maura Kennedy, MD and Eyal Kimchi, MD, PhD\u003c\/p\u003e\n\u003cp\u003e2:30pm to 3:15pm Gait Disturbance and Falls Shan Liu, MD, SD\u003c\/p\u003e\n\u003cp\u003e3:15pm to 4:00pm Exacerbations of Chronic Neurologic Diseases: Parkinson’s, ALS, and Others Doreen Ho, MD\u003c\/p\u003e\n\u003cp\u003e4:00pm to 4:15pm Break\u003c\/p\u003e\n\u003cp\u003e4:15pm to 4:45pm Functional Neurological Disorders: How to Diagnose and How to Treat Sara Finkelstein, MD, MSc\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eThursday, October 24, 2024\u003c\/p\u003e\n\u003cp\u003e8:00am to 8:45am Keynote Presentation: State of the Art in Endovascular Therapy Thanh Nguyen, MD\u003c\/p\u003e\n\u003cp\u003e8:45am to 9:00am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:30am Acute Stroke 2024: IV Thrombolytics Joshua N. Goldstein, MD, PhD\u003c\/p\u003e\n\u003cp\u003e9:30am to 9:45am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:45am to 10:15am TIA in 2024: What to Do and When to Do It Matthew S. Siket, MD\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:30am to 10:45am Break\u003c\/p\u003e\n\u003cp\u003e10:45am to 11:15am Diagnosing Subarachnoid Hemorrhage: Whom to Image? Whom to LP? Nicole Dubosh, MD\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:30am to 12:00pm SAH Management Nicole Dubosh, MD\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:15pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:15pm Break\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Seizures and Epilepsy: Updates in Treatment Evie Marcolini, MD, FACEP, FCCM\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm CNS Infections Evie Marcolini, MD, FACEP, FCCM\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Stroke Management: Beyond Revascularization Sandeep Kumar, MD\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Carotid Stenosis: When to Intervene and How Sandeep Kumar, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Managing Difficult Headaches Rebecca Burch, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:45pm Break\u003c\/p\u003e\n\u003cp\u003e3:45pm to 4:45pm Headache Causes You Cannot Miss: Red Flags and How to Use Them Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003eFriday, October 25, 2024\u003c\/p\u003e\n\u003cp\u003e8:00am to 9:00am Keynote Presentation: Coma and Brain Death David Greer, MD\u003c\/p\u003e\n\u003cp\u003e9:00am to 9:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:15am to 10:00am Dizziness 2024: The Evidence-Based Approach—with Video Evaluations of Real Patients Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e10:00am to 10:15am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:15am to 10:30am Break\u003c\/p\u003e\n\u003cp\u003e10:30am to 11:15am Diagnosing and Treating BPPV: Have More Fun in Your Practice! Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e11:15am to 11:30am Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:30am to 12:00pm Posterior Circulation Strokes: Dizziness “Plus” Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e12:00pm to 12:15pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:15pm to 1:15pm Break\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Acute Generalized Weakness Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm POCUS on the Brain: Point-of-Care Ultrasound for Neurologic Evaluation Onyinyechi Eke, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Traumatic Brain Injury Brian Edlow, MD\u003c\/p\u003e\n\u003cp\u003e1:15pm to 2:00pm Arterial Dissections MingMing Ning, MD, MMSc\u003c\/p\u003e\n\u003cp\u003e2:00pm to 2:45pm Cerebral Venous Thrombosis: Updates and New 2024 Guidelines Aneesh Singhal, MD\u003c\/p\u003e\n\u003cp\u003e2:45pm to 3:30pm Reversible Cerebral Vasoconstriction Syndrome: How to Diagnose and Treat this Underdiagnosed Cause of Acute Severe Headache Aneesh Singhal, MD\u003c\/p\u003e\n\u003cp\u003e3:30pm to 3:45pm Break\u003c\/p\u003e\n\u003cp\u003e3:45pm to 4:30pm The Psychology of Diagnostic Errors: A Clinician’s Perspective Jonathan A. Edlow, MD, FACEP\u003c\/p\u003e\n\u003cp\u003e4:30pm to 4:45pm Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e4:45pm to 5:00pm Course Wrap-Up, Q\u0026amp;A Jonathan A. Edlow, MD, FACEP and Joshua N. Goldstein, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405719621828,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Neurological-Emergencies-2024.jpg?v=1784215318"},{"product_id":"meetings-by-mail-penn-radiology-breast-imaging-immersion-2026","title":"Meetings By Mail Penn Radiology Breast Imaging Immersion 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: radiologists and breast imaging specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: 4\/15\/26\u003c\/p\u003e\n\u003cp\u003eTopics include: BI-RADS updates, screening, asymmetries, calcifications, architectural distortion, ultrasound, breast MR, tomosynthesis, core needle biopsy, concordance, practice development, high risk lesions, male, young, pregnant and much more!\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eOptimize the interpretation and clinical application of digital breast tomosynthesis (DBT) and breast ultrasound.\u003c\/p\u003e\n\u003cp\u003eEvaluate complex breast MRI cases and implement advanced MRI techniques for breast cancer screening and staging.\u003c\/p\u003e\n\u003cp\u003eApply current BI-RADS criteria across all modalities to accurately categorize breast lesions and guide patient management.\u003c\/p\u003e\n\u003cp\u003eEnhance precision in performing image-guided interventional breast procedures, including biopsies and localizations.\u003c\/p\u003e\n\u003cp\u003eIdentify and navigate challenging or ambiguous findings in multi-modality breast imaging to reduce false positives and avoid diagnostic pitfalls.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eBest for radiologists and breast imaging specialists who want advanced training in tomosynthesis, breast MRI, ultrasound, and interventions.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSession 1: BI-RADS and Screening\u003c\/p\u003e\n\u003cp\u003eBI-RADS Manual v2025 Changes\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eGetting to Know the National Mammography Database\u003c\/p\u003e\n\u003cp\u003eCindy Lee, MD, CMQ\u003c\/p\u003e\n\u003cp\u003eScreening and Diagnostic Ultrasound: Nuts and Bolts\u003c\/p\u003e\n\u003cp\u003eCindy Lee, MD, CMQ\u003c\/p\u003e\n\u003cp\u003eHow to Talk to Skeptics About Screening\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers\u003c\/p\u003e\n\u003cp\u003eMultiple Faculty\u003c\/p\u003e\n\u003cp\u003eSession 2: Asymmetries, Calcifications and Architectual Distortion\u003c\/p\u003e\n\u003cp\u003eAsymmetries Made Easy\u003c\/p\u003e\n\u003cp\u003eSophia O’Brien, MD, MSEd\u003c\/p\u003e\n\u003cp\u003eSophia O’Brien, MD, MSEd\u003c\/p\u003e\n\u003cp\u003eArchitectural Distortion\u003c\/p\u003e\n\u003cp\u003eSophia O’Brien, MD, MSEd\u003c\/p\u003e\n\u003cp\u003eIs Probably Benign Really Just Benign?\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eCystic Masses in the Breast\u003c\/p\u003e\n\u003cp\u003eSophia O’Brien, MD, MSEd\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers\u003c\/p\u003e\n\u003cp\u003eMultiple Faculty\u003c\/p\u003e\n\u003cp\u003eSession 3: Multi Modality Challenges and Biopsy Breakthroughs\u003c\/p\u003e\n\u003cp\u003eCracking the Case: the Right Tool for the Right Job\u003c\/p\u003e\n\u003cp\u003eM. Zuley, MD, FACR, FSBI\u003c\/p\u003e\n\u003cp\u003ePractical Approach to Breast MRI Interpretation\u003c\/p\u003e\n\u003cp\u003eHabib Rahbar, MD\u003c\/p\u003e\n\u003cp\u003eMulti-Modality Breast Implant Evaluation\u003c\/p\u003e\n\u003cp\u003eC. Lee, MD, FSBI, FACMQ, CMQ\u003c\/p\u003e\n\u003cp\u003eUltrasound Guided Core Nipple Biopsy\u003c\/p\u003e\n\u003cp\u003eSophia O’Brien, MD, MSEd\u003c\/p\u003e\n\u003cp\u003eBreast Radiology Concordance Cases\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eSession 4: Postive Developments and False Negatives\u003c\/p\u003e\n\u003cp\u003eRadiologist Recruitment and Retention: Mission Possible!\u003c\/p\u003e\n\u003cp\u003eCindy Lee, MD, CMQ\u003c\/p\u003e\n\u003cp\u003eCase Series: False Negatives – Where Did We Go Wrong??\u003c\/p\u003e\n\u003cp\u003eEmily Conant, MD\u003c\/p\u003e\n\u003cp\u003eAchieving Financial Independence: Buying Happiness?\u003c\/p\u003e\n\u003cp\u003eCindy Lee, MD, CMQ\u003c\/p\u003e\n\u003cp\u003eDiagnostic Remote Work: Is it Really Possible?\u003c\/p\u003e\n\u003cp\u003eMargarita L. Zuley, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers\u003c\/p\u003e\n\u003cp\u003eMultiple Faculty\u003c\/p\u003e\n\u003cp\u003eSession 5: High Risk and Lower Percentage Populations\u003c\/p\u003e\n\u003cp\u003eHigh Risk Lesions (and High Stakes!)\u003c\/p\u003e\n\u003cp\u003eEmily Conant, MD\u003c\/p\u003e\n\u003cp\u003eThe Male Breast\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eManagement of the Young and Pregnant\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eTaking the Risk Out of High Risk\u003c\/p\u003e\n\u003cp\u003ePeter R. Eby, MD\u003c\/p\u003e\n\u003cp\u003eQuestions and Answers\u003c\/p\u003e\n\u003cp\u003eMultiple Faculty\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405719851204,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Penn-Radiology-Breast-Imaging-Immersion-2026.jpg?v=1784215322"},{"product_id":"foundation-for-advanced-cardiovascular-education-and-training-9th-annual-eras-symposium-2026","title":"Foundation for Advanced Cardiovascular Education and Training 9th Annual ERAS Symposium 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: anesthesiologists, surgeons, and ERAS coordinators\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Foundation for Advanced Cardiovascular Education and Training 9th Annual ERAS Symposium 2026 focuses on the multidisciplinary implementation, optimization, and future directions of Enhanced Recovery After Surgery (ERAS) protocols. The program covers specialized ERAS applications across diverse surgical fields—including cardiac, orthopedic, gynecologic, and emergency surgery—while addressing financial considerations, quality verification, and the integration of emerging technologies like AI.\u003c\/p\u003e\n\u003cp\u003eSuccessful implementation of an Enhanced Recovery After Surgery (ERAS) program requires a multidisciplinary team effort and active participation of the patient in the recovery program. The ERAS program is an opportunity to collaborate with leading experts in the field with a goal to hasten functional recovery and improve postoperative outcomes.\u003c\/p\u003e\n\u003ch3\u003ePresentations may focus on any topic related to Enhanced Recovery at your facility. These include, but are not limited to:\u003c\/h3\u003e\n\u003cp\u003eAvoidance of post op complications\u003c\/p\u003e\n\u003cp\u003eCommunication and teamwork\u003c\/p\u003e\n\u003cp\u003eReduction in opioid usage\u003c\/p\u003e\n\u003cp\u003ePreoperative optimization\u003c\/p\u003e\n\u003cp\u003eFinancial impact of ERAS\u003c\/p\u003e\n\u003cp\u003ePatient reported outcomes\u003c\/p\u003e\n\u003cp\u003ePatient or staff education\u003c\/p\u003e\n\u003cp\u003eData collection and auditing\u003c\/p\u003e\n\u003cp\u003eAI and Technology Advancements\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eImplement and customize ERAS protocols across various surgical specialties, including ambulatory, cardiac, vascular, and orthopedic trauma surgery.\u003c\/p\u003e\n\u003cp\u003eEvaluate the role of interactive design and the Delphi Method in developing and optimizing effective ERAS programs within hospital systems.\u003c\/p\u003e\n\u003cp\u003eAnalyze the financial impact of ERAS implementation, including budget management, return on investment (ROI), and the role of compliance audits.\u003c\/p\u003e\n\u003cp\u003eAssess the clinical benefits of prehabilitation, specific medication management (e.g., SGLT-2i), and postoperative complication mitigation strategies like treating GI tract dysfunction.\u003c\/p\u003e\n\u003cp\u003eIntegrate emerging technologies, such as Artificial Intelligence, for real-time decision support to enhance surgical outcomes and align with ACS Quality Verification Programs.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for anesthesiologists, surgeons, and ERAS coordinators who want updates on multidisciplinary perioperative pathways and prehabilitation.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e1 ERAS – Kevin Elias, MD Where Did We Come From. Where Will We Go\u003c\/p\u003e\n\u003cp\u003e2 ERAS Sharifa Himidan, MD When Developing A New Program What To Ask, How To Ask For Input\u003c\/p\u003e\n\u003cp\u003e3 Delphi Method – What To Ask Whom – Gregg Nelson, MD\u003c\/p\u003e\n\u003cp\u003e4 Panel Discussion\u003c\/p\u003e\n\u003cp\u003e5 Transforming Care Through Interactive Design – Jessica Ardoin, MSN\u003c\/p\u003e\n\u003cp\u003e6 Importance Of An ERAS Coordinator – Charlette Hart, MSN\u003c\/p\u003e\n\u003cp\u003e7 Panel Discussion\u003c\/p\u003e\n\u003cp\u003e8 Fievos Christofi, PhD Postoperative Ileus and GI Tract Dysfunction- Mechanisms and Novel Treatment Strategies Beyond ERAS\u003c\/p\u003e\n\u003cp\u003e9 ERAS Before and Beyond the Hospital Walls – Kenneth Cummings, MD\u003c\/p\u003e\n\u003cp\u003e10 ERAS In Ambulatory Surgery – Jarrett Heard, MD\u003c\/p\u003e\n\u003cp\u003e11 Mending the Mountains- Implementing ERAS Protocols For Optimal Fragility Fracture Care In West Virgina – Katherine Shumate, MSN\u003c\/p\u003e\n\u003cp\u003e12 Bringing the Team Along “Recovering Recovery” – Donald Taylor, MHA\u003c\/p\u003e\n\u003cp\u003e13 ERAS In Emergency Surgery – Ready for Prime Time – Nicole Bedros, MD\u003c\/p\u003e\n\u003cp\u003e14 Updates In ERAS Gynecologic Surgery – Gabriella Smith, MD\u003c\/p\u003e\n\u003cp\u003e15 Cardiac Surgery ERAS 2025 – Robert Smith, MD\u003c\/p\u003e\n\u003cp\u003e16 ERAS Ortho-Trauma – Antonia Chen, MD\u003c\/p\u003e\n\u003cp\u003e17 Vascular Sugery – ERAS Updates – Emily Spangler, MD\u003c\/p\u003e\n\u003cp\u003e18 Interactive Audience Survey – Elizabeth Papaila, MD\u003c\/p\u003e\n\u003cp\u003e19 Debate – Is Prehab Ready For Prime Time. – Kevin Elias, MD\u003c\/p\u003e\n\u003cp\u003e20 Debate – From My Perspective, the Secret Of ERAS Is…\u003c\/p\u003e\n\u003cp\u003e21 Debate – Do Compliance Audits Drive Results or Resentment\u003c\/p\u003e\n\u003cp\u003e22 Perioperative Medicine – Opportunities To Magnify The Impact Of ERAS Principles – Richard Urman, MD\u003c\/p\u003e\n\u003cp\u003e23 Finance Presentation to ERAS – Justin Meier, SVP\u003c\/p\u003e\n\u003cp\u003e24 ERAS Budget – From The OSU Persepective – Michele Humeidan, MD\u003c\/p\u003e\n\u003cp\u003e25 Panel Discussion\u003c\/p\u003e\n\u003cp\u003e26 ROI Of Artificial Intelligence In Surgery- Description, Prediction, \u0026amp; Real-Tim Decision Support To Improve Surgical\u003c\/p\u003e\n\u003cp\u003e27 Ticket To Success – Samantha McCollum, BSN \u0026amp; Teresa Glandory, MSN\u003c\/p\u003e\n\u003cp\u003e28 Pedal Movement -Mallory Royall, DNP\u003c\/p\u003e\n\u003cp\u003e29 Impact Of Prehabilitation On Early Postoperative Opioid Use Following Radical Cystectomy Within An Enhanced Recovery Pathway\u003c\/p\u003e\n\u003cp\u003eAbstracts Panel\u003c\/p\u003e\n\u003cp\u003e32 How ERAS Aligns With The ACS Quality Verification Programs – Clifford Ko, MD\u003c\/p\u003e\n\u003cp\u003e33 Pediatric ERAS – Mary Brindle, MD\u003c\/p\u003e\n\u003cp\u003e34 ERAS And The Older Patient – Courtney Collins, MD\u003c\/p\u003e\n\u003cp\u003e35 Bespoke ERAS Pathways – Cedar Fowler, MD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720015044,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Foundation-for-Advanced-Cardiovascular-Education-and-Training-9th-Annual-ERAS-Symposium-2026.png?v=1784215325"},{"product_id":"harvard-emergency-medicine-updates-current-practices-2026","title":"Harvard Emergency Medicine Updates \u0026 Current Practices 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eGain practical, immediately applicable strategies across critical care, trauma, pediatrics, geriatrics, health equity, and innovation through interactive lectures, case-based discussions, and recorded sessions for flexible learning.\u003c\/p\u003e\n\u003ch3\u003eJoin us for a dynamic one-week live-stream virtual postgraduate course hosted by the Massachusetts General Hospital (MGH) Department of Emergency Medicine. Designed for emergency physicians, specialty physicians, primary care doctors, physician assistants, nurse practitioners, nurses, and EMTs, this live-streaming course offers a unique opportunity to learn from leading experts in the field. This five-day course will cover a vast array of topics that may include:\u003c\/h3\u003e\n\u003cp\u003eAcute Compartment Syndrome\u003c\/p\u003e\n\u003cp\u003eAcute Ischemic Stroke Updates\u003c\/p\u003e\n\u003cp\u003eAirway Advances\u003c\/p\u003e\n\u003cp\u003eARDS\u003c\/p\u003e\n\u003cp\u003eApproach to the Critically Ill Trauma Patient\u003c\/p\u003e\n\u003cp\u003eAtypical Presentations of Disease in Older Adults\u003c\/p\u003e\n\u003cp\u003eBurns\u003c\/p\u003e\n\u003cp\u003eCardiac Arrest\u003c\/p\u003e\n\u003cp\u003eClinical Informatics in Emergency Medicine\u003c\/p\u003e\n\u003cp\u003eCurrent Practice in Newborn Fever\u003c\/p\u003e\n\u003cp\u003eCritical Care Double Feature: Push-Dose Pressors and Phenobarbital for Severe Alcohol Withdrawal\u003c\/p\u003e\n\u003cp\u003eED Care of the Psychiatric Patient\u003c\/p\u003e\n\u003cp\u003eEMTALA, Medical Screening Exams, and Challenging Patients: Considerations for Your Next Shift\u003c\/p\u003e\n\u003cp\u003eEnvironmental Impacts of Healthcare and What Emergency Physicians Can Do\u003c\/p\u003e\n\u003cp\u003eEKG’s\u003c\/p\u003e\n\u003cp\u003eFrailty\u003c\/p\u003e\n\u003cp\u003eGeriatric Falls\u003c\/p\u003e\n\u003cp\u003eImproving ED Patient Experience\u003c\/p\u003e\n\u003cp\u003eInnovating in Emergency Medicine: Challenges and Opportunities\u003c\/p\u003e\n\u003cp\u003eMedical Jargon\u003c\/p\u003e\n\u003cp\u003eMild Head Trauma\u003c\/p\u003e\n\u003cp\u003eOperationalizing Health Equity in the ED\u003c\/p\u003e\n\u003cp\u003ePediatrics – Bronchiolitis: What’s Known and What’s New\u003c\/p\u003e\n\u003cp\u003ePersonalized Management in Septic Shock\u003c\/p\u003e\n\u003cp\u003ePOCUS – (Cardiac, Lung, eFAST, Pediatrics, and Procedures)\u003c\/p\u003e\n\u003cp\u003ePostpartum Hemorrhage\u003c\/p\u003e\n\u003cp\u003ePredictive Model Evaluation\u003c\/p\u003e\n\u003cp\u003ePulmonary Embolism\u003c\/p\u003e\n\u003cp\u003eScrotal Pain\u003c\/p\u003e\n\u003cp\u003eSepsis Updates\u003c\/p\u003e\n\u003cp\u003eSocial Determinants of Health: Why Health Equity is the Business of Emergency Medicine\u003c\/p\u003e\n\u003cp\u003eSTI’s\u003c\/p\u003e\n\u003cp\u003eSupporting Humanitarian Disasters with Digital Health\u003c\/p\u003e\n\u003cp\u003eUpdate on Ventricular Fibrillation Cardiac Arrest\u003c\/p\u003e\n\u003cp\u003eVasopressors and Shock Pearls\u003c\/p\u003e\n\u003cp\u003eWhat’s New in PEM Literature\u003c\/p\u003e\n\u003cp\u003eWilderness Medicine \/ High Altitude Illness\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eIdentify underlying tachydysrhythmias.\u003c\/p\u003e\n\u003cp\u003eIdentify most up-to-date therapeutics for cardiac arrest.\u003c\/p\u003e\n\u003cp\u003eIntegrate the latest evidence-based practice strategies in treating patients with acute hemorrhagic stroke.\u003c\/p\u003e\n\u003cp\u003eUtilize latest evidence based algorithms and strategies in management of PE and DVT.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for emergency medicine physicians, nurse practitioners, and physician assistants who want updates on critical care, POCUS, and ED innovations.\u003c\/p\u003e\n\u003cp\u003eWho Should Participate\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine Physicians, Specialty Physicians, Physician Assistants, Nurse Practitioners, Nurses, EMT\/Paramedics, and Others.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e01 Echo in Pulmonary Embolism\u003c\/p\u003e\n\u003cp\u003e02 Emergency Management of Burns\u003c\/p\u003e\n\u003cp\u003e03 AI in the ED\u003c\/p\u003e\n\u003cp\u003e04 Clinical Informatics in the ED\u003c\/p\u003e\n\u003cp\u003e05 Geriatric Falls\u003c\/p\u003e\n\u003cp\u003e06 Impact of Boarding on Geriatric Patients\u003c\/p\u003e\n\u003cp\u003e07 Scrotal Pain in the ED\u003c\/p\u003e\n\u003cp\u003e08 ARDS\u003c\/p\u003e\n\u003cp\u003e09 Professionalism what does it really mean… and why do we care\u003c\/p\u003e\n\u003cp\u003e10 Mild Head Trauma\u003c\/p\u003e\n\u003cp\u003e11 Cardiac Arrest\u003c\/p\u003e\n\u003cp\u003e12 Improving Emergency Department Patient Experience Principles and Practice\u003c\/p\u003e\n\u003cp\u003e13 Innovation in Emergency Medicine Challenges and Opportunities\u003c\/p\u003e\n\u003cp\u003e14 Tele-Disaster Medicine – From COVID to Ukraine\u003c\/p\u003e\n\u003cp\u003e15 Current Practice in Newborn Fever\u003c\/p\u003e\n\u003cp\u003e16 Airway Advances\u003c\/p\u003e\n\u003cp\u003e17 POCUS Cardiac and Lung\u003c\/p\u003e\n\u003cp\u003e18 POCUS E-FAST\u003c\/p\u003e\n\u003cp\u003e19 POCUS – Procedures (IV, LP)\u003c\/p\u003e\n\u003cp\u003e20 POCUS – Pediatric Cases\u003c\/p\u003e\n\u003cp\u003e21 How to read ischemia on ECGs\u003c\/p\u003e\n\u003cp\u003e22 Practice Updates in Acute PE\u003c\/p\u003e\n\u003cp\u003e23 Critical Care Double Feature Push Dose Pressors in the ED and Severe Alcohol Withdrawal 1\u003c\/p\u003e\n\u003cp\u003e23 Critical Care Double Feature Push Dose Pressors in the ED and Severe Alcohol Withdrawal 2\u003c\/p\u003e\n\u003cp\u003e24 10 Things You Never Imagined About Monitoring Blood Pressure\u003c\/p\u003e\n\u003cp\u003e25 Beyond “Medical Clearance” ED Evaluation of the Patient Presenting with Acute Psychiatric Complaints\u003c\/p\u003e\n\u003cp\u003e26 Update on the treatment of ventricular fibrillation cardiac arrest\u003c\/p\u003e\n\u003cp\u003e28 Cranial Nerve Deficits\u003c\/p\u003e\n\u003cp\u003e30 Recent Cardiologic Advances in EM\u003c\/p\u003e\n\u003cp\u003e31 Vasopressors and Shock Pearls\u003c\/p\u003e\n\u003cp\u003e32 On-field management of medical emergencies in the elite athlete take home lessons for your next shift\u003c\/p\u003e\n\u003cp\u003e33 Hand Injuries How would You treat them; Case-Based Updates\u003c\/p\u003e\n\u003cp\u003e34 STI\u003c\/p\u003e\n\u003cp\u003e35 Wilderness Medicine High Altitude Equity is the Business of Emergency Medicine\u003c\/p\u003e\n\u003cp\u003e36 Frostbite Management in the ED\u003c\/p\u003e\n\u003cp\u003e37 Practical Sustainability Reducing Harm from Environmental Impacts of Healthcare\u003c\/p\u003e\n\u003cp\u003e38 Management of Postpartum Hemorrhage\u003c\/p\u003e\n\u003cp\u003e39 Current concepts in the management of septic shock\u003c\/p\u003e\n\u003cp\u003e40 Ocular Emergencies\u003c\/p\u003e\n\u003cp\u003eApril 27 Afternoon Session\u003c\/p\u003e\n\u003cp\u003eApril 27 Morning Session\u003c\/p\u003e\n\u003cp\u003eApril 28 Afternoon Session\u003c\/p\u003e\n\u003cp\u003eApril 28 Morning Session\u003c\/p\u003e\n\u003cp\u003eApril 29 Afternoon Session\u003c\/p\u003e\n\u003cp\u003eApril 29 Morning Session\u003c\/p\u003e\n\u003cp\u003eApril 30 Afternoon Session\u003c\/p\u003e\n\u003cp\u003eApril 30 Morning Session\u003c\/p\u003e\n\u003cp\u003eMay 01 Afternoon Session\u003c\/p\u003e\n\u003cp\u003eMay 01 Morning Session\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720178884,"sku":null,"price":182.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Emergency-Medicine-Updates-Current-Practices-2026.jpg?v=1784215328"},{"product_id":"docmeded-2026-current-challenges-in-gynecologic-and-obstetric-pathology","title":"DocmedED 2026 Current Challenges in Gynecologic and Obstetric Pathology","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists, gynecologic and obstetric physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis activity is primarily aimed at pathologists who encounter gynecologic and obstetric cases in their practice, as well as pathologists training in the field of gynecologic pathology.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize clinically relevant placental conditions that carry a clinical risk for complications, recurrence in future gestations, or require immediate management.\u003c\/p\u003e\n\u003cp\u003eUnderstand the major changes in female genital tract neoplasia classification introduced by the 2025 World Health Classification.\u003c\/p\u003e\n\u003cp\u003eAppraise the current recommendations on molecular and immunohistochemical testing of gynecologic cancers for classification, prognostic and therapeutic purposes.\u003c\/p\u003e\n\u003cp\u003eRecognize the morphologic spectrum of high-grade endometrial and ovarian carcinoma and the importance of each recognized type in light of pathogenesis, prognosis, and management.\u003c\/p\u003e\n\u003cp\u003eIdentify types of uterine mesenchymal neoplasia with malignant potential, distinguishing them from benign lesions and impacting patient care.\u003c\/p\u003e\n\u003cp\u003eDevelop a practical approach to the evaluation of vulvo-vaginal and cervical squamous neoplasia, endocervical glandular lesions and miscellaneous (melanocytic, mesenchymal) diseases in the lower female genital tract.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Placental Pathology A Sailing Guide\u003c\/p\u003e\n\u003cp\u003e02 How Molecular Classification Informs Endometrial Cancer Diagnosis and Management\u003c\/p\u003e\n\u003cp\u003e03 High Grade Endometrial Carcinoma Difficult but Relevant\u003c\/p\u003e\n\u003cp\u003e04 Mastering Your Fleet of Biomarker Tests in Gynecologic Cancer\u003c\/p\u003e\n\u003cp\u003e05 Ovarian Epithelial Neoplasia Made Easy\u003c\/p\u003e\n\u003cp\u003e06 Warming Up to Frozen Section Diagnosis of Ovarian Masses\u003c\/p\u003e\n\u003cp\u003e07 Smooth Sailing to Uterine Mesenchymal Neoplasia Diagnosis\u003c\/p\u003e\n\u003cp\u003e08 Non-Smooth Sailing to Uterine Mesenchymal Neoplasia Diagnosis\u003c\/p\u003e\n\u003cp\u003e09 Your Compass to Lower Genital Tract Pathology Navigation Squamous Lesions\u003c\/p\u003e\n\u003cp\u003e10 Your Compass to Lower Genital Tract Pathology Navigation Warts, Plaques and Rashes\u003c\/p\u003e\n\u003cp\u003e11 Your Compass to Lower Genital Tract Pathology Navigation Endocervical Lesions\u003c\/p\u003e\n\u003cp\u003e12 Your Compass to Lower Genital Tract Pathology Navigation Non-epithelial Lesions\u003c\/p\u003e\n\u003cp\u003ePATHGC26_ESyllabus\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720637636,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2026-Current-Challenges-in-Gynecologic-and-Obstetric-Pathology.webp?v=1784215334"},{"product_id":"american-medical-seminars-family-internal-medicine-a-practical-approach-to-common-primary-care-problems-2024","title":"American Medical Seminars Family \u0026 Internal Medicine A Practical Approach to Common Primary Care Problems 2024","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: Family Medicine Physicians, Internal Medicine Physicians, Emergency Medicine and Urgent Care Physicians, Hospitalists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe 2025 Family \u0026amp; Internal Medicine: A Practical Approach to Common Primary Care Problems is a comprehensive, multi-day seminar hosted by American Medical Seminars. This program is specifically designed to provide a practical, evidence-based approach to diagnosing, treating, and managing a wide array of common medical issues frequently encountered in primary care and internal medicine settings. Across the four days, the curriculum bridges multiple disciplines, equipping frontline healthcare providers with the most up-to-date clinical guidelines and therapeutic strategies to enhance patient outcomes, improve care transitions, and manage both medical and psychiatric comorbidities effectively.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this comprehensive 4-day educational activity, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eCardiovascular \u0026amp; Neurological Management: Develop strategies to assess, risk-stratify, and manage stroke, transient ischemic attacks (TIA), hypertension, hyperlipidemia, and congestive heart failure utilizing current clinical guidelines.\u003c\/p\u003e\n\u003cp\u003ePerioperative \u0026amp; Transitional Care: Implement consistent cardiovascular risk stratification for non-cardiac surgery and develop effective transition-of-care strategies to reduce preventable hospital readmissions.\u003c\/p\u003e\n\u003cp\u003eChronic Disease Management: Accurately evaluate, stage, and formulate treatment plans for complex and chronic conditions such as COPD, obesity, diabetes, anemia, thyroid disease, and dementia.\u003c\/p\u003e\n\u003cp\u003ePsychiatric \u0026amp; Behavioral Health: Screen for and manage psychiatric comorbidities, including substance use disorders, anxiety, depression, and effectively interact with difficult patients, while also recognizing provider burnout.\u003c\/p\u003e\n\u003cp\u003eAcute \u0026amp; Office Emergencies: Evaluate and manage common office emergencies (e.g., shortness of breath, abdominal pain, syncope, seizures) and accurately identify clinical signs indicating the urgent need for emergency department transfer.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003ch3\u003eThis practical, clinical program is designed for healthcare professionals who provide primary, comprehensive, and urgent care, including:\u003c\/h3\u003e\n\u003cp\u003eFamily Medicine Physicians\u003c\/p\u003e\n\u003cp\u003eInternal Medicine Physicians\u003c\/p\u003e\n\u003cp\u003eGeneral Practitioners\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine and Urgent Care Physicians\u003c\/p\u003e\n\u003cp\u003eHospitalists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners (NPs)\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants (PAs)\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003ch3\u003eThe curriculum covers a highly detailed and robust selection of primary care topics across the 4 days. The detailed topics include:\u003c\/h3\u003e\n\u003ch3\u003eCardiovascular \u0026amp; Pulmonary Issues:\u003c\/h3\u003e\n\u003cp\u003eEvaluation and Treatment of Hypertensive Patients: Identifying new blood pressure categories, employing non-pharmacologic and pharmacologic treatments for compelling indications, and formulating therapeutic goals for different patient populations.\u003c\/p\u003e\n\u003cp\u003eApproach to the Management of Chest Pain: Evaluating history, physical exams, and EKG findings. Strategizing the use of cardiac biomarkers for Acute Coronary Syndrome (ACS) and applying recent research guidelines.\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Management of Heart Failure: Evaluating symptoms, detecting causes of systolic heart failure, employing standard-of-care therapies, and applying the ACCF\/AHA Guidelines (including determining when to refer for device therapy).\u003c\/p\u003e\n\u003cp\u003eCardiac Issues in Peri-Operative Risk Assessment: Maximizing cardiovascular outcomes and managing comorbidities (valvular heart disease, tobacco use, hyperlipidemia) for patients undergoing non-cardiac surgery.\u003c\/p\u003e\n\u003cp\u003eChronic Obstructive Pulmonary Disease (COPD): Evaluating diagnostic criteria, analyzing the role of smoking, staging COPD, formulating treatment plans, and monitoring therapeutic efficacy.\u003c\/p\u003e\n\u003ch3\u003eNeurology \u0026amp; Endocrinology:\u003c\/h3\u003e\n\u003cp\u003eApproach to the Management of Stroke: Assessing common presentations of stroke\/TIA, utilizing initial treatment strategies, risk stratification, and developing secondary prevention plans.\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Treatment of Recurrent Headaches: Differentiating symptoms of migraine, tension, and cluster headaches. Comparing initial therapies, prophylactic regimens, supportive lifestyle changes, and pharmacologic options for acute pain.\u003c\/p\u003e\n\u003cp\u003ePractical Approach to Thyroid Disease: Assessing the role of screening TSH, managing hypothyroidism\/elevated TSH, and utilizing a cost-effective approach to diagnosing thyroid nodules.\u003c\/p\u003e\n\u003ch3\u003eGeneral Internal Medicine \u0026amp; Geriatrics:\u003c\/h3\u003e\n\u003cp\u003eAnemia – A Finding, Not Yet a Diagnosis: Distinguishing etiologies for common anemias, constructing diagnostic evaluations, developing therapeutic options, and formulating follow-up assessments.\u003c\/p\u003e\n\u003cp\u003ePractical Approach to the Outpatient with Dementia: Screening for dementia, managing polypharmacy and drug-drug interactions, and developing long-term, cost-effective follow-up and referral processes.\u003c\/p\u003e\n\u003cp\u003eStrategies to Address Preventable Hospital Readmissions: Identifying risk factors, utilizing evidence-based stratification tools, and developing proactive transition-of-care strategies.\u003c\/p\u003e\n\u003cp\u003eCommon Office Emergencies: Evaluating and treating shortness of breath, abdominal pain, syncope, seizures, endocrine crises, and trauma in the primary care office.\u003c\/p\u003e\n\u003ch3\u003ePsychiatry \u0026amp; Behavioral Health:\u003c\/h3\u003e\n\u003cp\u003eDealing with Difficult Patients: Recognizing why patients and family members may be difficult, implementing response techniques, and evaluating how medical\/psychiatric illnesses affect behavior.\u003c\/p\u003e\n\u003cp\u003eProvider Wellness: Identifying and defining stress, differentiating and treating PTSD vs. Burnout, and addressing the ongoing effects of COVID-19 on physician well-being.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405720932548,"sku":null,"price":99.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Medical-Seminars-Family-Internal-Medicine-A-Practical-Approach-to-Common-Primary-Care-Problems-2024.jpg?v=1784215339"},{"product_id":"american-society-of-echocardiography-advanced-echo-2026","title":"American Society of Echocardiography Advanced Echo 2026","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + file sub vtt +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: echocardiography physicians, cardiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: April 29, 2026\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this program, participants will be better able to:\u003c\/h3\u003e\n\u003cp\u003eApply recent clinical guidelines to accurately assess right heart chamber quantification, complex diastolic dysfunction, and heart failure with preserved ejection fraction (HFpEF).\u003c\/p\u003e\n\u003cp\u003eEvaluate complex valvular and structural heart diseases, utilizing procedural echocardiography to confidently guide interventions such as TAVR, Mitral TEER, and Left Atrial Appendage (LAA) occlusion.\u003c\/p\u003e\n\u003cp\u003eIdentify and differentiate specific cardiomyopathies and infiltrative diseases, leveraging modern echo clues to diagnose conditions like amyloidosis in the era of targeted therapy.\u003c\/p\u003e\n\u003cp\u003eCharacterize specialized and congenital cardiac conditions, including uncorrected adult congenital defects, ventricular septal defects, and bicuspid valve aortopathy.\u003c\/p\u003e\n\u003cp\u003eIntegrate cutting-edge echocardiography technologies into daily clinical practice to enhance coronary and structural assessments.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eASE Guideline Right Heart Chamber Quantification\u003c\/p\u003e\n\u003cp\u003eRV PA Coupling \u0026amp; LV PA Coupling\u003c\/p\u003e\n\u003cp\u003eRV PA Coupling A Window into Right Heart Performance\u003c\/p\u003e\n\u003cp\u003eVentricular Diastolic Function- Normal Physiology \u0026amp; the Stages of Dysfunction\u003c\/p\u003e\n\u003cp\u003e5 Rapid-Fire Cases- Application of the Diastology Guidelines\u003c\/p\u003e\n\u003cp\u003e2025 ASE Guideline Approach to Diagnose HFpEF\u003c\/p\u003e\n\u003cp\u003eEvaluation of Dilated CM- Ischemic, Postpartum, Infiltrative, Who Recovers..\u003c\/p\u003e\n\u003cp\u003eDefining AS Severity- When to be Confident, When to be Cautious\u003c\/p\u003e\n\u003cp\u003eLifetime Management of AS AVR- A Data-Driven Decision..\u003c\/p\u003e\n\u003cp\u003eImaging Following TAVR- What Does Best Practice Look Like..\u003c\/p\u003e\n\u003cp\u003eREDO TAVR- What the Future Holds\u003c\/p\u003e\n\u003cp\u003eContemporary Mitral Stenosis- When Calcium Attacks!\u003c\/p\u003e\n\u003cp\u003eHow Far to Push- Procedural Imaging for Mitral TEER Outside of A2 P2 \u0026amp; Beyond\u003c\/p\u003e\n\u003cp\u003eTricuspid Valve Interventions- Then \u0026amp; Now\u003c\/p\u003e\n\u003cp\u003eProsthetic Valve Function \u0026amp; Dysfunction- Doppler Defined\u003c\/p\u003e\n\u003cp\u003eDifficult Doppler Decisions in VHD- The Role of Stress Echo \u0026amp; CMR\u003c\/p\u003e\n\u003cp\u003eDeep Dive into Amyloid- Role of Echo \u0026amp; Imaging AL or ATTR..\u003c\/p\u003e\n\u003cp\u003eAmyloidosis \u0026amp; Infiltrative Disease- Echo Clues in the Era of Targeted Therapy\u003c\/p\u003e\n\u003cp\u003eWhat to Look for During Surgical Myectomy\u003c\/p\u003e\n\u003cp\u003eIdentifying \u0026amp; Describing Uncorrected Adult Congenital Defects\u003c\/p\u003e\n\u003cp\u003eVentricular Septal Defects- From Diagnosis to Device Closure\u003c\/p\u003e\n\u003cp\u003eBicuspid Valves and Aortopathy- A Guideline Approach to Imaging \u0026amp; Action\u003c\/p\u003e\n\u003cp\u003eGuiding LAA Occlusion- The Interventional Echocardiographer’s Perspective\u003c\/p\u003e\n\u003cp\u003eHow to Assess the Quantity \u0026amp; Clinical Importance of Pericardial Effusion\u003c\/p\u003e\n\u003cp\u003eWhat Do I Need to Know About Artificial Intelligence..\u003c\/p\u003e\n\u003cp\u003eEchoes of Intelligence- How AI is Transforming Cardiac Imaging \u0026amp; Clinical Decision-Making\u003c\/p\u003e\n\u003cp\u003eHow to Incorporate 3D LV EF into Your Echo Lab\u003c\/p\u003e\n\u003cp\u003eStress, Strain, \u0026amp; Ischemia- Modern Echo Tools for Coronary Assessment\u003c\/p\u003e\n\u003cp\u003eAtrial Strain- When \u0026amp; Where Does It Help..\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721227460,"sku":null,"price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Echocardiography-Advanced-Echo-2026.png?v=1784215343"},{"product_id":"oakstone-ucsf-interventional-radiology-review-2025","title":"Oakstone UCSF Interventional Radiology Review 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: radiologist, surgeons\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eArterial, venous, and non-vascular interventions\u003c\/p\u003e\n\u003cp\u003eLiver tumor panel discussion\u003c\/p\u003e\n\u003cp\u003eSpine and musculoskeletal procedures\u003c\/p\u003e\n\u003cp\u003eGeniculate, prostate artery, and uterine artery embolization\u003c\/p\u003e\n\u003cp\u003ePelvic venous disease treatment\u003c\/p\u003e\n\u003cp\u003eLiquid embolics\u003c\/p\u003e\n\u003cp\u003eAnd more…\u003c\/p\u003e\n\u003cp\u003eDate of Original Release: January 1, 2025\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the conclusion of this activity, the participant will be able to:\u003c\/h3\u003e\n\u003cp\u003eImprove technique in arterial and venous interventions\u003c\/p\u003e\n\u003cp\u003eUnderstand the scope of interventional oncology procedures\u003c\/p\u003e\n\u003cp\u003eDescribe indications and recommend techniques for gastrointestinal and genitourinary tract interventions\u003c\/p\u003e\n\u003cp\u003eKnow the benefits and limitations in selecting IR devices (balloons, stents, catheters, etc.)\u003c\/p\u003e\n\u003cp\u003eCorrectly interpret CT, MR, US, and angiographic vascular images\u003c\/p\u003e\n\u003cp\u003eUnderstand the scope of neurointerventional and musculoskeletal interventions\u003c\/p\u003e\n\u003cp\u003eIdentify potential pitfalls and safety issues associated with IR procedures in order to minimize complications\u003c\/p\u003e\n\u003cp\u003ePracticing interventional radiologists\u003c\/p\u003e\n\u003cp\u003eInterventionalists preparing for the IR Certifying Oral Exam\u003c\/p\u003e\n\u003cp\u003eRadiologists\u003c\/p\u003e\n\u003cp\u003eSurgeons\u003c\/p\u003e\n\u003cp\u003ePhysicians\u003c\/p\u003e\n\u003cp\u003eHealthcare professionals interested in the latest advancements in interventional radiology\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721358532,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Oakstone-UCSF-Interventional-Radiology-Review-2025.jpg?v=1784215344"},{"product_id":"docmeded-2025-uc-san-diego-presents-radiology-review-course","title":"DocmedED 2025 UC San Diego Presents Radiology Review Course","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 72 videos, size: 18.5 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists as well as radiologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAbout This CME Teaching Activity ▼\u003c\/p\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDiscuss the differential diagnosis of the imaging appearance of common disease processes with appropriate imaging and clinical follow-up recommendations.\u003c\/p\u003e\n\u003cp\u003eDescribe the role of new imaging techniques in diagnostic radiology.\u003c\/p\u003e\n\u003cp\u003eDiscuss basic vascular and non-vascular interventional procedures.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdrenals.mp4\u003c\/p\u003e\n\u003cp\u003eAppendicular Skeletal Trauma.mp4\u003c\/p\u003e\n\u003cp\u003eApproach to Adult Heart Disease.mp4\u003c\/p\u003e\n\u003cp\u003eArterial Interventions.mp4\u003c\/p\u003e\n\u003cp\u003eAxial Skeletal Trauma.mp4\u003c\/p\u003e\n\u003cp\u003eBenign and Malignant Breast Disease.mp4\u003c\/p\u003e\n\u003cp\u003eBI-RADSr Update.mp4\u003c\/p\u003e\n\u003cp\u003eBiliary.mp4\u003c\/p\u003e\n\u003cp\u003eBrain Infections and White Matter Disease.mp4\u003c\/p\u003e\n\u003cp\u003eBrain Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eBreast MRI and Biopsy.mp4\u003c\/p\u003e\n\u003cp\u003eBreast Unknown Cases.mp4\u003c\/p\u003e\n\u003cp\u003eCardiovascular Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eCerebral Vascular Disease.mp4\u003c\/p\u003e\n\u003cp\u003eCNS Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Cardiac.mp4\u003c\/p\u003e\n\u003cp\u003eDevelopmental Abnormalities of the Brain and Spine.mp4\u003c\/p\u003e\n\u003cp\u003eDiagnostic Angiography.mp4\u003c\/p\u003e\n\u003cp\u003eDiffuse Lung Disease and HRCT.mp4\u003c\/p\u003e\n\u003cp\u003eDuplex Doppler The Essentials.mp4\u003c\/p\u003e\n\u003cp\u003eEndocrine Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eEsophagus and Stomach.mp4\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eGenitourinary Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eHead Trauma.mp4\u003c\/p\u003e\n\u003cp\u003eImaging in Gynecology.mp4\u003c\/p\u003e\n\u003cp\u003eInterventional Oncology.mp4\u003c\/p\u003e\n\u003cp\u003eLarge Joint MRI.mp4\u003c\/p\u003e\n\u003cp\u003eLiver.mp4\u003c\/p\u003e\n\u003cp\u003eMediastinum and Hila.mp4\u003c\/p\u003e\n\u003cp\u003eMedicolegal – Issues in Medical Malpractice.mp4\u003c\/p\u003e\n\u003cp\u003eMedicolegal – Licensing, Contracts, and Negotiations.mp4\u003c\/p\u003e\n\u003cp\u003eMetabolic and Endocrine Diseases of the Musculoskeletal System.mp4\u003c\/p\u003e\n\u003cp\u003eMiscellaneous GU Procedures HSGs, RUGs, \u0026amp; Stones.mp4\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal Infection.mp4\u003c\/p\u003e\n\u003cp\u003eNon-Interpretive Skills Cognitive Errors.mp4\u003c\/p\u003e\n\u003cp\u003eNon-Tumorous Spinal Cord and Intradural Disease.mp4\u003c\/p\u003e\n\u003cp\u003eNon-Vascular Interventional Radiology.mp4\u003c\/p\u003e\n\u003cp\u003eObstetrical Sonography.mp4\u003c\/p\u003e\n\u003cp\u003eOrbit and Temporal Bone.mp4\u003c\/p\u003e\n\u003cp\u003ePancreas.mp4\u003c\/p\u003e\n\u003cp\u003ePediatric Chest Radiology.mp4\u003c\/p\u003e\n\u003cp\u003ePediatric Gastrointestinal Radiology.mp4\u003c\/p\u003e\n\u003cp\u003ePediatric Osteoradiology.mp4\u003c\/p\u003e\n\u003cp\u003ePET – Tumor and Whole Body Imaging.mp4\u003c\/p\u003e\n\u003cp\u003ePharynx, Larynx, and Deep Spaces of Neck.mp4\u003c\/p\u003e\n\u003cp\u003ePulmonary Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eQuality Control In Nuclear Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eRadiology of the Neonate.mp4\u003c\/p\u003e\n\u003cp\u003eRenal Cystic and Neoplastic Disease \u0026amp; Ureters.mp4\u003c\/p\u003e\n\u003cp\u003eRenal Infection-Inflammation \u0026amp; Bladder.mp4\u003c\/p\u003e\n\u003cp\u003eSigns in Chest Radiology.mp4\u003c\/p\u003e\n\u003cp\u003eSkeletal Radionuclide Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eSmall Bowel and Colon.mp4\u003c\/p\u003e\n\u003cp\u003eSmall Joint MRI.mp4\u003c\/p\u003e\n\u003cp\u003eSmall Parts Ultrasound.mp4\u003c\/p\u003e\n\u003cp\u003eSpinal Cord Tumors and Degenerative Spine Disease.mp4\u003c\/p\u003e\n\u003cp\u003eTargeted Approach to Arthritis.mp4\u003c\/p\u003e\n\u003cp\u003eThoracic Infection.mp4\u003c\/p\u003e\n\u003cp\u003eThoracic Neoplasms.mp4\u003c\/p\u003e\n\u003cp\u003eTumorous Conditions of Bone.mp4\u003c\/p\u003e\n\u003cp\u003eVenous Interventions.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721489604,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-UC-San-Diego-Presents-Radiology-Review-Course.jpg?v=1784215346"},{"product_id":"uscap-gynecologic-pathology-practical-strategies-for-modern-practice-2025","title":"USCAP Gynecologic Pathology Practical Strategies for Modern Practice 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: January 10, 2025\u003c\/p\u003e\n\u003cp\u003eSurgical pathologists practicing gynecologic pathology work in vastly different practice settings throughout the world. Consistent terminology and criteria for the diagnosis of entities is critical to ensure clear and effective communication, facilitating optimal prognostication and treatment. In recent years, advances in multiple areas of gynecologic pathology have changed our collective understanding of a variety of diseases. Many of these changes were reflected in the recent 2020 WHO Classification of Tumors of the Gynecologic Tract, which included changes in both terminology and diagnostic criteria. In addition, the evolution of targeted therapy has led to increasing requests for tumor biomarker testing, which differs by tumor location and histotype. This multimodal course will provide attendees with a comprehensive update in the practice of gynecologic pathology.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe recent updates in diagnostic terminology and criteria based on the 2020 WHO Classification of Tumors of the Gynecologic Tract\u003c\/p\u003e\n\u003cp\u003eDiscuss common diagnostic pitfalls and problems in differential diagnosis including practical tips\u003c\/p\u003e\n\u003cp\u003eExplain use and interpretation of widely available ancillary studies to aid in proper diagnosis\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEndometrial Biopsies – Joseph T. Rabban, MD, MPH.mp4\u003c\/p\u003e\n\u003cp\u003eEndometrial Biopsies – Joseph T. Rabban, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eEndometrial Carcinoma – Jennifer A. Bennett, MD.mp4\u003c\/p\u003e\n\u003cp\u003eEndometrial Carcinoma – Jennifer A. Bennett, MD.pdf\u003c\/p\u003e\n\u003cp\u003eEndometrial Carcinoma Case Discussion.pdf\u003c\/p\u003e\n\u003cp\u003eGlandular and Squamous Neoplasia of the Lower Female Genital Tract – Kyle Devins, MD.mp4\u003c\/p\u003e\n\u003cp\u003eGlandular and Squamous Neoplasia of the Lower Female Genital Tract – Kyle Devins, MD.pdf\u003c\/p\u003e\n\u003cp\u003eLecture Endometrial Biopsies Epithelial, Mesenchymal, and Gestation-Related Pathology – Joseph T. Rabban, MD, MPH.mp4\u003c\/p\u003e\n\u003cp\u003eLecture Endometrial Biopsies Epithelial, Mesenchymal, and Gestation-Related Pathology – Joseph T. Rabban, MD, MPH.pdf\u003c\/p\u003e\n\u003cp\u003eLecture Glandular and Squamous Neoplasia of the Lower Female Genital Tract – Kyle Devins, MD.mp4\u003c\/p\u003e\n\u003cp\u003eLecture Glandular and Squamous Neoplasia of the Lower Female Genital Tract – Kyle Devins, MD.pdf\u003c\/p\u003e\n\u003cp\u003eLecture Mesenchymal Tumors of the Female Genital Tract – Sarah Chiang, MD.mp4\u003c\/p\u003e\n\u003cp\u003eLecture Mesenchymal Tumors of the Female Genital Tract – Sarah Chiang, MD.pdf\u003c\/p\u003e\n\u003cp\u003eLecture Nuances of Sex Cord Stromal and Germ Cell Tumors of the Ovary – Esther Oliva, MD.mp4\u003c\/p\u003e\n\u003cp\u003eLecture Nuances of Sex Cord Stromal and Germ Cell Tumors of the Ovary – Esther Oliva, MD.pdf\u003c\/p\u003e\n\u003cp\u003eLecture The Spectrum of Epithelial Ovarian Tumors – Andre Pinto, MD.mp4\u003c\/p\u003e\n\u003cp\u003eLecture The Spectrum of Epithelial Ovarian Tumors – Andre Pinto, MD.pdf\u003c\/p\u003e\n\u003cp\u003eLecture Updates in Endometrial Carcinoma Biomarkers, Molecular Classification, and Reporting – Jennifer A. Bennett, MD.mp4\u003c\/p\u003e\n\u003cp\u003eLecture Updates in Endometrial Carcinoma Biomarkers, Molecular Classification, and Reporting – Jennifer A. Bennett, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMesenchymal Tumors of the Female Genital Tract – Sarah Chiang, MD.mp4\u003c\/p\u003e\n\u003cp\u003eMesenchymal Tumors of the Female Genital Tract – Sarah Chiang, MD.pdf\u003c\/p\u003e\n\u003cp\u003eMesenchymal Tumors of the Female Genital Tract Case Discussion.pdf\u003c\/p\u003e\n\u003cp\u003eNuances of Sex Cord Stromal and Germ Cell Tumors of the Ovary – Esther Oliva, MD.mp4\u003c\/p\u003e\n\u003cp\u003eNuances of Sex Cord Stromal and Germ Cell Tumors of the Ovary – Esther Oliva, MD.pdf\u003c\/p\u003e\n\u003cp\u003ePanel Discussion – Day 1.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion – Day 2.mp4\u003c\/p\u003e\n\u003cp\u003ePanel Discussion – Day 3.mp4\u003c\/p\u003e\n\u003cp\u003eThe Spectrum of Epithelial Ovarian Tumors – Andre Pinto, MD.mp4\u003c\/p\u003e\n\u003cp\u003eThe Spectrum of Epithelial Ovarian Tumors – Andre Pinto, MD.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721587908,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Gynecologic-Pathology-Practical-Strategies-for-Modern-Practice-2025.png?v=1784215347"},{"product_id":"docmeded-2025-classic-lectures-in-pathology-what-you-need-to-know-soft-tissue-pathology","title":"DocmedED 2025 Classic Lectures in Pathology What You Need to Know Soft Tissue Pathology","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis activity is intended and designed to educate pathologists.\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDevelop an approach to common morphologic patterns seen in soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eDiscuss the ancillary diagnostic approach to difficult soft tissue tumors including immunohistochemistry, molecular, and genetic diagnostic tests.\u003c\/p\u003e\n\u003cp\u003eExplain ancillary diagnostic techniques including immunohistochemistry and molecular diagnostics in the approach to difficult soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eDescribe the most important diagnostic clues in arriving at a specific diagnosis in the most common patterns seen in soft tissue tumor.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCLPSTV25_ESyllabus.pdf\u003c\/p\u003e\n\u003cp\u003eClinicopathologic Correlation in Inflammatory Skin Disease.mp4\u003c\/p\u003e\n\u003cp\u003eCommon Problems in Fatty Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eCutaneous Anatomy From Embryology to the Origin of Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eDiagnostic Challenges in Cutaneous Soft Tissue Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eDiagnostic Dilemmas in Cutaneous Adnexal Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eFibroblastic and Fibrohistiocytic Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eMyxology Myxoid Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePattern-Based Approach to Soft Tissue Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePractical Issues in Melanocytic Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eSpindle Cell Tumors An Approach for the Practicing General Pathologist.mp4\u003c\/p\u003e\n\u003cp\u003eThe Most Common Spindle Cell Tumors of Deep Soft Tissue It’s Getting Easier!.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405721653444,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Classic-Lectures-in-Pathology-What-You-Need-to-Know-Soft-Tissue-Pathology.jpg?v=1784215349"},{"product_id":"uscap-navigating-challenging-entities-in-head-and-neck-endocrine-pathology-who-5th-edition-and-beyond-2025","title":"USCAP Navigating Challenging Entities in Head and Neck Endocrine Pathology WHO 5th Edition and Beyond 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: January 22, 2025\u003c\/p\u003e\n\u003cp\u003eHead and neck pathology is challenging given the broad diversity of entities that are part of the functional (rather than simply theoretical) vocabulary at these sites. With the beta releases of the 5th editions of both the Head and Neck and Endocrine World Health Organization (WHO) Classifications of Tumors in 2022, several new concepts and entities have arisen and still remain challenging. Furthermore, since the publication of WHO 5th edition, several provisional entities and concepts have emerged making it difficult to adapt these new changes into practice. Through this course, the participants will learn diagnostic features, practical reporting, key prognostic, and theragnostic information for a variety of new and uncommon tumor types spanning several head and neck and endocrine sites.\u003c\/p\u003e\n\u003cp\u003eThis course is a collaboration between the North American Society of Head and Neck Pathology (NASHNP) and USCAP.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize the key diagnostic features for the squamous cell carcinoma subtypes.\u003c\/p\u003e\n\u003cp\u003eRecognize key thyroid tumor subtypes with distinctive molecular and clinical correlates.\u003c\/p\u003e\n\u003cp\u003eRecognize the key diagnostic features for the squamous cell carcinoma subtypes.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSalivary Gland, Sinonasal Glandular and Miscellaneous Pathology – Raja R. Seethala, MD – Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eSalivary Gland, Sinonasal Glandular and Miscellaneous Pathology – Raja R. Seethala, MD – Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eSalivary Gland, Sinonasal Glandular and Miscellaneous Pathology – Raja R. Seethala, MD.pdf\u003c\/p\u003e\n\u003cp\u003eSalivary, Sinonasal Mesenchymal and Round Blue Cell Tumor Pathology – Justin A. Bishop, MD Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eSalivary, Sinonasal Mesenchymal and Round Blue Cell Tumor Pathology – Justin A. Bishop, MD Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eSalivary, Sinonasal Mesenchymal and Round Blue Cell Tumor Pathology – Justin A. Bishop, MD.pdf\u003c\/p\u003e\n\u003cp\u003eThyroid and Squamous Lesions – Doreen N. Palsgrove, MD – Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eThyroid and Squamous Lesions – Doreen N. Palsgrove, MD – Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eThyroid and Squamous Lesions – Doreen N. Palsgrove, MD.pdf\u003c\/p\u003e\n\u003cp\u003eThyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD – Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eThyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD – Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eThyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD 1.pdf\u003c\/p\u003e\n\u003cp\u003eThyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD 2.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722112196,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Navigating-Challenging-Entities-in-Head-and-Neck-Endocrine-Pathology-WHO-5th-Edition-and-Beyond-2025.png?v=1784215354"},{"product_id":"docmeded-2025-classic-lectures-in-pathology-what-you-need-to-know-breast-pathology","title":"DocmedED 2025 Classic Lectures in Pathology What You Need to Know Breast Pathology","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis activity is intended and designed to educate pathologists.\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eExplain the spectrum of benign spindle cell lesions in the breast.\u003c\/p\u003e\n\u003cp\u003eUtilize molecular classification of breast cancer.\u003c\/p\u003e\n\u003cp\u003eDifferentiate inflammatory and reactive lesions from other forms of breast pathologies.\u003c\/p\u003e\n\u003cp\u003eDiscuss breast cancer predictive factor testing (ER, PR \u0026amp; HER2).\u003c\/p\u003e\n\u003cp\u003eDescribe the diagnostic features and clinical significance of a variety of breast lesions with particular reference to the implications of these diagnoses in core needle biopsy specimens.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCLPBV25_ESyllabus.pdf\u003c\/p\u003e\n\u003cp\u003eA Practical Approach to Challenging Intraductal Proliferations of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003eAn Update on Papillary Lesions of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003eBenign Breast Disease Atypical Proliferative Lesions.mp4\u003c\/p\u003e\n\u003cp\u003eBreast Core Needle Biopsies Pitfalls and Pearls.mp4\u003c\/p\u003e\n\u003cp\u003eChallenging Breast Pathology Cases.mp4\u003c\/p\u003e\n\u003cp\u003eCurrent Issues and Controversies Regarding ER and HER2 Testing in Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eImmunohistochemistry in the Diagnostic Evaluation of Breast Lesions.mp4\u003c\/p\u003e\n\u003cp\u003eLobular Carcinoma In-Situ and Problematic In-Situ Breast Lesions.mp4\u003c\/p\u003e\n\u003cp\u003eManagement and Reporting of Breast Cancer Specimens Following Neoadjuvant Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eMyoepithelial and Combined Epithelial-Myoepithelial Lesions of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003ePapillary Lesions of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003ePathology of Recurrent and Metastatic Breast Carcinoma.mp4\u003c\/p\u003e\n\u003cp\u003eProblematic Papillary Breast Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePrognostic and Predictive Markers in Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSheep in Wolf’s Clothing Triple -Negative Breast Carcinomas With Good Prognoses.mp4\u003c\/p\u003e\n\u003cp\u003eSpindle Cell Lesions of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003eThe Challenge of Evaluating Post-Neoadjuvant Systemic Therapy Breast Specimens.mp4\u003c\/p\u003e\n\u003cp\u003eThe Spectrum of Triple Negative Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eTraditional and Newer Prognostic and Predictive Factors in Breast Cancer.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722210500,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Classic-Lectures-in-Pathology-What-You-Need-to-Know-Breast-Pathology.jpg?v=1784215356"},{"product_id":"docmeded-2025-fetal-echocardiography-normal-and-abnormal-hearts","title":"DocmedED 2025 Fetal Echocardiography Normal and Abnormal Hearts","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: physicians and sonographers in the fields of obstetric imaging, fetal echocardiography and pediatric cardiology\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAbout This CME Teaching Activity ▼\u003c\/p\u003e\n\u003cp\u003eThis CME teaching activity provides detailed information on the evaluation of the normal fetal heart both from an anatomic and functional approach. In keeping with progress in this field, detailed information on the use of three-dimensional ultrasound in fetal echocardiography and cardiac imaging in the early gestation is presented. The course also provides comprehensive evaluation of various cardiac malformations, involving abnormalities of the cardiac chambers and the outflow tracts.\u003c\/p\u003e\n\u003cp\u003eCongenital heart disease is the most common congenital malformation with a significant impact on neonatal morbidity and mortality. Prenatal diagnosis and management of congenital heart disease is a collaborative effort between maternal–fetal medicine specialists and pediatric cardiologists. The renowned course faculty represents the specialties and all are actively involved in caring for pregnancies complicated with fetal cardiac abnormalities.\u003c\/p\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis course will greatly benefit physicians and sonographers in the fields of obstetric imaging, fetal echocardiography and pediatric cardiology. Residents in obstetrics and gynecology, as well as fellows in maternal fetal medicine and pediatric cardiology, will also benefit greatly. It should also prove valuable to those physicians and sonographers wanting to gain a more in-depth knowledge of fetal echocardiography.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eOptimize ultrasound equipment for the use of 2D and Doppler in fetal echocardiography.\u003c\/p\u003e\n\u003cp\u003eDescribe the abnormalities of the venous system of the fetal heart.\u003c\/p\u003e\n\u003cp\u003eDiscuss in detail anomalies of the cardiac chambers to include septal defects and anomalies of the right and left ventricle.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFEV25_ESyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722407108,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Fetal-Echocardiography-Normal-and-Abnormal-Hearts.jpg?v=1784215358"},{"product_id":"docmeded-2025-surgical-pathology-update-diagnostic-pearls-for-the-practicing-pathologist-vol-ix","title":"DocmedED 2025 Surgical Pathology Update Diagnostic Pearls for the Practicing Pathologist Vol. IX","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos + pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: practicing surgical pathologists, including gastrointestinal, hepatobiliary\/pancreatic, breast, genitourinary, and gynecologic pathology\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis teaching acitivty has been designed to provide an overview of some of the most common areas encountered by practicing surgical pathologists, including gastrointestinal, hepatobiliary\/pancreatic, breast, genitourinary, and gynecologic pathology. The course provides an extensive overview of some of the most important diagnostic features which allow pathologists to make accurate diagnoses in each of these subspecialized areas, as well as how to assess essential diagnostic clues and avoid misdiagnoses. In each lecture, is a thorough discussion on the use of ancillary diagnostic techniques, including immunohistochemistry and molecular diagnostics.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis activity is primarily designed to educate practicing pathologists.\u003c\/p\u003e\n\u003cp\u003eEducational Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe the most common diagnostic pitfalls in diagnosing Barrett’s-related dysplasia.\u003c\/p\u003e\n\u003cp\u003eRecognize unusual forms of ulcerative colitis.\u003c\/p\u003e\n\u003cp\u003eIdentify the most common forms of dysplasia arising in inflammatory bowel disease.\u003c\/p\u003e\n\u003cp\u003eCite the most common diagnostic pitfalls in pancreaticobiliary pathology.\u003c\/p\u003e\n\u003cp\u003eDescribe the various patterns found in medical liver biopsies.\u003c\/p\u003e\n\u003cp\u003eRecognize the most common hepatocellular neoplasms and the utility of immunohistochemistry in their diagnosis.\u003c\/p\u003e\n\u003cp\u003eDiscuss the most common inflammatory lesions of the breast.\u003c\/p\u003e\n\u003cp\u003eIdentify the most common diagnostic pitfalls in recognizing triple-negative breast cancers on core needle biopsy.\u003c\/p\u003e\n\u003cp\u003eCite the most common diagnostic pitfalls in genitourinary pathology biopsy diagnosis.\u003c\/p\u003e\n\u003cp\u003eRecognize issues related to cancer grading in prostate core biopsies.\u003c\/p\u003e\n\u003cp\u003eIdentify various morphology and biomarkers associated with endometrial carcinoma.\u003c\/p\u003e\n\u003cp\u003eDescribe the most recent update in the classification of ovarian cancer.\u003c\/p\u003e\n\u003cp\u003eCite recent updates in the diagnosis of cervical and vulvar neoplasms.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eInflammatory Lesions of the Breast: An Algorithmic Approach\u003c\/p\u003e\n\u003cp\u003eEllen Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003eUnraveling the Diagnosis of Hepatocellular Neoplasms\u003c\/p\u003e\n\u003cp\u003eDaniela Allende, M.D., MBA\u003c\/p\u003e\n\u003cp\u003eTriple-Negative Breast Cancers on Core Needle Biopsy: Diagnostic Pitfalls\u003c\/p\u003e\n\u003cp\u003eMarissa White, M.D.\u003c\/p\u003e\n\u003cp\u003eDavid Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003ePitfalls in Diagnosis and Classification of Ovarian Borderline Tumors: Mimics That Matter and How to Stay Clear of the Trap\u003c\/p\u003e\n\u003cp\u003eDavid Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003eIBD and IBD-related Dysplasia with a Focus on Unusual Forms of Ulcerative Colitis\u003c\/p\u003e\n\u003cp\u003eJohn R. Goldblum, M.D.\u003c\/p\u003e\n\u003cp\u003eBarrett’s Esophagus and Barrett’s-Related Dysplasia: A Practical Approach to the Most Common Problems\u003c\/p\u003e\n\u003cp\u003eJohn R. Goldblum, M.D.\u003c\/p\u003e\n\u003cp\u003eUpdates in Pancreaticobiliary Pathology\u003c\/p\u003e\n\u003cp\u003eDaniela  Allende, M.D., MBA\u003c\/p\u003e\n\u003cp\u003eNear Misses and Great Catches in Medical Liver Pathology: What Surgical Pathologists Need to Know\u003c\/p\u003e\n\u003cp\u003eDaniela  Allende, M.D., MBA\u003c\/p\u003e\n\u003cp\u003eMarissa White, M.D.\u003c\/p\u003e\n\u003cp\u003eA Practical Approach to Cancer Grading in Prostate Core Biopsies\u003c\/p\u003e\n\u003cp\u003eMichelle S. Hirsch, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003eSpindle Cell Lesions of the Breast on Core Needle Biopsy\u003c\/p\u003e\n\u003cp\u003eEllen Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003eUpdates in Aggressive Renal Cell Carcinoma Subtypes\u003c\/p\u003e\n\u003cp\u003eMichelle S. Hirsch, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003eCommon Problems in Diagnosis and Terminology of Colorectal Polyps\u003c\/p\u003e\n\u003cp\u003eJohn R. Goldblum, M.D.\u003c\/p\u003e\n\u003cp\u003eBreast and Axillary Lymph Node Evaluation in the Neoadjuvant Setting\u003c\/p\u003e\n\u003cp\u003eEllen Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003eParadigm Shift in Routine Diagnosis of Cervical and Vulvar Cancer Toward a More Biologically and Clinically Meaningful Classification System in the Lower Genital Track\u003c\/p\u003e\n\u003cp\u003eDavid Chapel, M.D.\u003c\/p\u003e\n\u003cp\u003eMarissa White, M.D.\u003c\/p\u003e\n\u003cp\u003eDiagnostic Pearls and Pitfalls in Genitourinary Pathology\u003c\/p\u003e\n\u003cp\u003eMichelle S. Hirsch, M.D., Ph.D.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722702020,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Surgical-Pathology-Update-Diagnostic-Pearls-for-the-Practicing-Pathologist-Vol.-IX.jpg?v=1784215363"},{"product_id":"docmeded-2025-classic-lectures-in-trauma-imaging","title":"DocmedED 2025 Classic Lectures in Trauma Imaging","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists, emergency physicians, trauma surgeons, and other healthcare professionals involved in trauma imaging and care\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis teaching activity is designed to provide a comprehensive overview of trauma imaging, focusing on the latest techniques and advancements in the detection and evaluation of traumatic injuries across various regions of the body. Faculty will explore the imaging approaches for head trauma, spinal injuries, chest trauma, abdominal and pelvic trauma, and extremity injuries. Special attention will be given to how cutting-edge technologies such as dual-energy CT, artificial intelligence (AI), and other imaging modalities are improving the diagnosis and management of trauma patients.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis teaching activity is intended for radiologists, emergency physicians, trauma surgeons, and other healthcare professionals involved in trauma imaging and care.\u003c\/p\u003e\n\u003cp\u003eEducational Objectives\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDiscuss the role of advanced imaging techniques in head trauma, including traumatic brain injury detection.\u003c\/p\u003e\n\u003cp\u003eExplain the latest imaging approaches for thoracic trauma, including both vascular and non-vascular chest injuries.\u003c\/p\u003e\n\u003cp\u003eDiscuss the use of dual-energy CT in detecting abdominal and pelvic trauma, improving organ and vascular injury detection.\u003c\/p\u003e\n\u003cp\u003eDescribe imaging techniques for skeletal trauma, including axial and appendicular skeletal injuries.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role of artificial intelligence in whole body trauma CT scans, including its application in the detection and analysis of traumatic injuries.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAI in Whole Body Trauma Scans\u003c\/p\u003e\n\u003cp\u003eThorsten R. Fleiter, M.D.\u003c\/p\u003e\n\u003cp\u003eTrauma Whole Body CT: Where Are We Now?\u003c\/p\u003e\n\u003cp\u003eMark P. Bernstein, M.D., FASER\u003c\/p\u003e\n\u003cp\u003eNeuro Trauma: Can’t Miss Lesions\u003c\/p\u003e\n\u003cp\u003eKathleen R. Fink, M.D.\u003c\/p\u003e\n\u003cp\u003eHead Trauma\u003c\/p\u003e\n\u003cp\u003eYueyang Guo, M.D.\u003c\/p\u003e\n\u003cp\u003eImaging of Traumatic Brain Injury\u003c\/p\u003e\n\u003cp\u003eMax Wintermark, M.D., MAS, MBA\u003c\/p\u003e\n\u003cp\u003eImaging Cervical Spine Trauma: Pearls \u0026amp; Pitfalls\u003c\/p\u003e\n\u003cp\u003eMark P. Bernstein, M.D., FASER\u003c\/p\u003e\n\u003cp\u003eCervical Spine Trauma\u003c\/p\u003e\n\u003cp\u003eJohn F. Feller, M.D.\u003c\/p\u003e\n\u003cp\u003eSpine Trauma: What the Surgeon Wants to Know\u003c\/p\u003e\n\u003cp\u003eAshok Srinivasan, M.D., FACR\u003c\/p\u003e\n\u003cp\u003eAxial Skeletal Trauma\u003c\/p\u003e\n\u003cp\u003eKaren Cheng, M.D.\u003c\/p\u003e\n\u003cp\u003eAppendicular Skeletal Trauma\u003c\/p\u003e\n\u003cp\u003eKaren Cheng, M.D.\u003c\/p\u003e\n\u003cp\u003eThoracic Trauma in the Acute Care Setting\u003c\/p\u003e\n\u003cp\u003eRobert M. Steiner, M.D., FACR, FACC\u003c\/p\u003e\n\u003cp\u003eAortic and Cardiac Trauma\u003c\/p\u003e\n\u003cp\u003eSanjeev Bhalla, M.D.\u003c\/p\u003e\n\u003cp\u003eAcute Chest: ICU, ER, Trauma\u003c\/p\u003e\n\u003cp\u003eSharon Brouha, M.D., MPH\u003c\/p\u003e\n\u003cp\u003eNon-Vascular Chest Trauma\u003c\/p\u003e\n\u003cp\u003eSanjeev Bhalla, M.D.\u003c\/p\u003e\n\u003cp\u003eCT of Splenic \u0026amp; Renal Trauma\u003c\/p\u003e\n\u003cp\u003eMark P. Bernstein, M.D., FASER\u003c\/p\u003e\n\u003cp\u003eTraumatic Injuries of the Abdomen and Pelvis: Improving the Detection of Organ and Vascular Injuries with Dual Energy CT\u003c\/p\u003e\n\u003cp\u003eThorsten R. Fleiter, M.D.\u003c\/p\u003e\n\u003cp\u003eCT of Bowel \u0026amp; Pancreatic Trauma\u003c\/p\u003e\n\u003cp\u003eJorge A. Soto, M.D.\u003c\/p\u003e\n\u003cp\u003eState-of-the-Art Pelvic Trauma\u003c\/p\u003e\n\u003cp\u003eMark P. Bernstein, M.D., FASER\u003c\/p\u003e\n\u003cp\u003eAnkle Trauma\u003c\/p\u003e\n\u003cp\u003eManickam “Nicks” Kumaravel, M.D.\u003c\/p\u003e\n\u003cp\u003ePediatric Trauma\u003c\/p\u003e\n\u003cp\u003eSusan John, M.D.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405722800324,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Classic-Lectures-in-Trauma-Imaging.jpg?v=1784215364"},{"product_id":"cme-science-diagnostic-imaging-update-in-costa-rica-jw-marriott-guanacaste-february-2025","title":"CME Science Diagnostic Imaging Update in Costa Rica – JW Marriott Guanacaste February 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eKey Highlights:\u003c\/h3\u003e\n\u003cp\u003eSessions on MRI, CT, ultrasound, and interventional imaging.\u003c\/p\u003e\n\u003cp\u003eFocus on improving diagnostic accuracy for musculoskeletal, cardiac, and abdominal imaging.\u003c\/p\u003e\n\u003cp\u003eOpportunities to network with peers in a beautiful tropical setting\u003c\/p\u003e\n\u003ch3\u003eThe CME Science Diagnostic Imaging Update in Costa Rica is designed for professionals in the field of diagnostic imaging and radiology. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eRadiologists looking to enhance their expertise in advanced imaging techniques.\u003c\/p\u003e\n\u003cp\u003eTechnologists involved in diagnostic imaging procedures.\u003c\/p\u003e\n\u003cp\u003ePhysicians and healthcare providers interested in the latest developments in imaging for musculoskeletal, cardiac, and abdominal conditions.\u003c\/p\u003e\n\u003cp\u003eResidents and fellows aiming to expand their knowledge and network with experienced professionals.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMonday, February 10, 2025– Chest, CV and Abdominal\u003c\/p\u003e\n\u003cp\u003eTuesday, February 11, 2025 – Breast Imaging\u003c\/p\u003e\n\u003cp\u003eWednesday, February 12, 2025– Neuroradiology Imaging\u003c\/p\u003e\n\u003cp\u003eThursday, February 13, 2025 – Musculoskeletal Imaging\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723128004,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}]},{"product_id":"quality-medical-publishing-facial-and-nasal-support-and-soft-tissue-aesthetic-harmony-with-double-jaw-orthognathic-genioplasty-and-rhinoplasty-2025","title":"Quality Medical Publishing Facial and Nasal Support and Soft Tissue Aesthetic Harmony With Double Jaw Orthognathic, Genioplasty, and Rhinoplasty 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 7 videos, size: 14.63 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: oral and maxillofacial surgeons, plastic and reconstructive surgeons, orthodontists, aesthetic practitioners\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBy Derek Steinbacher, MD\u003c\/p\u003e\n\u003cp\u003eNow Available! Explore Expert Facial and Nasal Balancing Techniques With Dr. Steinbacher\u003c\/p\u003e\n\u003cp\u003eDouble jaw orthognathic surgery and genioplasty to reposition the facial bones for improved aesthetics\u003c\/p\u003e\n\u003cp\u003eFacial bone contouring, bone grafting, and alloplastic implants\u003c\/p\u003e\n\u003cp\u003eRhinoplasty techniques to address excessive prominence and access deviations, asymmetry, overprojection, and postmaxillary osteotomy (Le-Fort I) deformities\u003c\/p\u003e\n\u003cp\u003eFat grafting, buccal fat removal, and submental lipectomy\u003c\/p\u003e\n\u003cp\u003eAncillary hard- and soft-tissue procedures are also demonstrated to ensure the best aesthetic result.\u003c\/p\u003e\n\u003ch3\u003e7 Cases With Over 6 Hours of Operative Video:\u003c\/h3\u003e\n\u003cp\u003eCase 1: Aesthetic primary deprojection rhinoplasty for feminization\u003c\/p\u003e\n\u003cp\u003eCase 2: Aesthetic orthognathic surgery and facial\/malar implants to treat a concave profile with significant mandibular prominence, asymmetry, and midface\/malar hypoplasia\u003c\/p\u003e\n\u003cp\u003eCase 3: Aesthetic primary rhinoplasty with axis deviation, dorsal hump, and an underprojected tip\u003c\/p\u003e\n\u003cp\u003eCase 4: Aesthetic orthognathic surgery in a patient with prognathic\/prominent lower jaw\/mandible, midface retrusion, underbite, and nasal deformity\u003c\/p\u003e\n\u003cp\u003eCase 5: Aesthetic orthognathic surgery in a patient with convex profile, small mandible, gummy smile, open bite, and nasal deformity\u003c\/p\u003e\n\u003cp\u003eCase 6: Rhinoplasty in a postorthognathic patient to correct severe nasal prominence and axis deviation\u003c\/p\u003e\n\u003cp\u003eCase 7: Aesthetic orthognathic surgery (double jaw, genioplasty) in a skeletally mature bilateral cleft patient\u003c\/p\u003e\n\u003cp\u003eAvailable in HD streaming format. 7 cases with over 6 hours of operative video. March 2025.\u003c\/p\u003e\n\u003ch3\u003eThe target audience for a publication like “Facial and Nasal Support and Soft Tissue Aesthetic Harmony With Double Jaw Orthognathic, Genioplasty, and Rhinoplasty” by Quality Medical Publishing would likely include:\u003c\/h3\u003e\n\u003cp\u003eOral and Maxillofacial Surgeons: Professionals specializing in surgeries of the face, mouth, and jaw.\u003c\/p\u003e\n\u003cp\u003ePlastic and Reconstructive Surgeons: Particularly those focusing on facial aesthetics and rhinoplasty.\u003c\/p\u003e\n\u003cp\u003eOrthodontists: Interested in the interplay between jaw alignment and facial aesthetics.\u003c\/p\u003e\n\u003cp\u003eMedical Students and Residents: Training in related surgical specialties.\u003c\/p\u003e\n\u003cp\u003eResearchers and Academics: Focused on advancements in facial and soft tissue surgery.\u003c\/p\u003e\n\u003cp\u003eAesthetic Practitioners: Looking to enhance their understanding of surgical techniques for facial harmony.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723619524,"sku":null,"price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Quality-Medical-Publishing-Facial-and-Nasal-Support-and-Soft-Tissue-Aesthetic-Harmony-With-Double-Jaw-Orthognathic-Genioplasty-and-Rhinoplasty-2025.jpg?v=1784215375"},{"product_id":"docmeded-2025-uc-san-diego-presents-post-graduate-radiology-course","title":"DocmedED 2025 UC San Diego Presents Post Graduate Radiology Course","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThe course is designed for board certified radiologists, in private or academic practice. This course is also appropriate for trainees at various levels in diagnostic imaging and other practicing physicians desiring insight into the current roles of imaging in a managed care environment. In addition, allied health care professionals seeking an update on recent advances in radiology will also benefit from this course.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDemonstrate improved skills in performing and interpreting radiologic procedures.\u003c\/p\u003e\n\u003cp\u003eDevelop an organized approach to establishing an accurate differential diagnosis.\u003c\/p\u003e\n\u003cp\u003eDiscuss the latest in diagnostic methods.\u003c\/p\u003e\n\u003cp\u003eDiscuss emerging technologies and cost-effective utilization of imaging methods.\u003c\/p\u003e\n\u003cp\u003eDemonstrate an increased awareness of radiation risks and appropriate use criteria for imaging procedures.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e01 Is Your Job Killing You The Dangers of Sitting.mp4\u003c\/p\u003e\n\u003cp\u003e02 CTA Oncologic Applications.mp4\u003c\/p\u003e\n\u003cp\u003e03 Imaging of the Liver.mp4\u003c\/p\u003e\n\u003cp\u003e04 CT Evaluation of Small Bowel Obstruction.mp4\u003c\/p\u003e\n\u003cp\u003e05 Gynecological MRI for Malignant Diseases.mp4\u003c\/p\u003e\n\u003cp\u003e06 CT of the Abdominal Aorta Aneurysms, Dissections, and Repair.mp4\u003c\/p\u003e\n\u003cp\u003e08 Addressing the Adrenals.mp4\u003c\/p\u003e\n\u003cp\u003e1.bat\u003c\/p\u003e\n\u003cp\u003e10 Test Your Skills Body Imaging Quiz Cases.mp4\u003c\/p\u003e\n\u003cp\u003e11 Deep Learning and AI What You Need to Know as a Radiologist Today.mp4\u003c\/p\u003e\n\u003cp\u003e12 CT Evaluation of Cystic Pancreatic Tumors Pearls and Pitfalls.mp4\u003c\/p\u003e\n\u003cp\u003e13 The Danger Zone Error Rates Rise Daily When \u0026amp; Why.mp4\u003c\/p\u003e\n\u003cp\u003e14 Your Worst Fear What to Do (And What NOT to Do) If You Are Sued.mp4\u003c\/p\u003e\n\u003cp\u003e15 Dreaded Dementia Imaging of Neurodegeneration \u0026amp; Dementia.mp4\u003c\/p\u003e\n\u003cp\u003e16 Traumatic Trouble MRI of Spinal Injury.mp4\u003c\/p\u003e\n\u003cp\u003e17 Straightforward Spine Presurgical Spine Evaluation.mp4\u003c\/p\u003e\n\u003cp\u003e18 Straightforward Spine Postsurgical Spine Evaluation.mp4\u003c\/p\u003e\n\u003cp\u003e19 Disorders of the Ankle and Foot Emphasis on Bone and Joint Injuries.mp4\u003c\/p\u003e\n\u003cp\u003e19 Sinister Spine Spinal Infections.mp4\u003c\/p\u003e\n\u003cp\u003e20 Tissue Delamination Tendons, Ligaments, Cartilage, and Other Tissues.mp4\u003c\/p\u003e\n\u003cp\u003e21 Knee Injuries From Conventional Radiography to MR Imaging.mp4\u003c\/p\u003e\n\u003cp\u003e22 Rheumatoid Arthritis and Spondyloarthropathies Routine and Advanced Imaging.mp4\u003c\/p\u003e\n\u003cp\u003e23 Missed Meniscus Commonly Missed Meniscus Injuries.mp4\u003c\/p\u003e\n\u003cp\u003e24 Armed and Dangerous Shoulder Unknown Cases.mp4\u003c\/p\u003e\n\u003cp\u003e25 Sinister Synovium Synovial Pathologies.mp4\u003c\/p\u003e\n\u003cp\u003e26 Armed and Dangerous Elbow \u0026amp; Wrist Unknown Cases.mp4\u003c\/p\u003e\n\u003cp\u003e27 Great Balls of Fire Scrotal Sonography.mp4\u003c\/p\u003e\n\u003cp\u003e29 The Intricacies of Interstitial Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003e30 The Heart of the Matter Coronary Artery Imaging Tips to Improve Interpretation and Your Own Hea.mp4\u003c\/p\u003e\n\u003cp\u003e31 Test Your Skills Cardiac Quiz Cases.mp4\u003c\/p\u003e\n\u003cp\u003e32 What Lurks in the Lung Lung Cancer.mp4\u003c\/p\u003e\n\u003cp\u003e33 What Lurks in the Lung Other Cancers in the Lung.mp4\u003c\/p\u003e\n\u003cp\u003e34 Fever, Cough, \u0026amp; Infiltrate Oh my! Lung Infections.mp4\u003c\/p\u003e\n\u003cp\u003e35 Don’t Miss This Pulmonary Emboli.mp4\u003c\/p\u003e\n\u003cp\u003e36 To Drain or Not To Drain IR Perspectives for the Diagnostic Radiologist.mp4\u003c\/p\u003e\n\u003cp\u003e37 Stop It When and How to Stop Bleeding.mp4\u003c\/p\u003e\n\u003cp\u003e38 What You Don’t See CAN Hurt You Radiation Biology \u0026amp; Risks.mp4\u003c\/p\u003e\n\u003cp\u003e39 Defend Yourself Against the Invisible Enemy Tips to Protect You and Your Patient From Radiation.mp4\u003c\/p\u003e\n\u003cp\u003eUCSDPGV25_ESyllabus.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405723914436,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-UC-San-Diego-Presents-Post-Graduate-Radiology-Course.jpg?v=1784215381"},{"product_id":"uscap-114th-annual-meeting-2025","title":"USCAP 114th Annual Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists, pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 114th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) will take place from March 22 to March 27, 2025, in Boston, Massachusetts. This event is a hub for groundbreaking research, networking opportunities, and educational sessions led by legends in pathology. Attendees can explore the latest technology in the Exhibit Hall, participate in interactive microscopy courses, and engage with cutting-edge research through poster and platform sessions\u003c\/p\u003e\n\u003ch3\u003eThe USCAP 114th Annual Meeting is designed for a diverse audience within the pathology community. This includes:\u003c\/h3\u003e\n\u003cp\u003ePathologists: Both practicing professionals and those specializing in various subspecialties.\u003c\/p\u003e\n\u003cp\u003ePathologists-in-Training: Residents and fellows looking to deepen their knowledge and network.\u003c\/p\u003e\n\u003cp\u003eResearchers: Individuals presenting groundbreaking studies and engaging in discussions about the latest advancements.\u003c\/p\u003e\n\u003cp\u003eEducators: Professors and mentors sharing insights and learning from peers.\u003c\/p\u003e\n\u003cp\u003eIndustry Professionals: Representatives from companies showcasing innovative products and technologies in the Exhibit Hall.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Day in the Sign Out – A Day in the Sign Out_ Genitourinary Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eA Day in the Sign Out – A Day in the Sign Out_ Hematopathology.mp4\u003c\/p\u003e\n\u003cp\u003eA Day in the Sign Out- Genitourinary Pathology.pdf\u003c\/p\u003e\n\u003cp\u003eA Day in the Sign Out- Hematopathology.pdf\u003c\/p\u003e\n\u003cp\u003eArthur Purdy Stout Society of Surgical Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – American Association of Neuropathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – American Association of Ophthalmic Oncologists and Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – American Society for Clinical Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – American Society of Cytopathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – American Society of Dermatopathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Arthur Purdy Stout Society of Surgical Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Association for Molecular Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Association for Pathology Informatics.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Association of Indian Pathologists in North America.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Binford-Dammin Society of Infectious Disease Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Canadian Association of Pathologists – Association Canadienne des Pathologistes’.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Chinese American Pathologists Association.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Chinese Pathology Session.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – College of American Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Endocrine Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – European Society of Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Genitourinary Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Hans Popper Hepatopathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – History of Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Academy of Cytology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Society for IHC and Molecular Morphology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Society of Bone _ Soft Tissue Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Society of Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Society of Gynecological Pathologists.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – International Society of Urological Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Latin American Pathology Foundation.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – National Association of Medical Examiners.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – North American Society of Head and Neck Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Pakistani-American Pathologists’ Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Paleopathology Club.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Pancreatobiliary Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Papanicolaou Society for Cytopathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Pulmonary Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Renal Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Rodger C. Haggitt Gastrointestinal Pathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Society for Cardiovascular Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Society for Hematopathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Society for Pediatric Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eCompanion Meeting – Society for Ultrastructural Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Bone and Soft Tissue Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Cardiovascular Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Cytopathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Dermatopathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Endocrine Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Gastrointestinal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Genitourinary Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Gynecologic Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Head and Neck Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Hematopathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Infectious Disease Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Liver Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Neuropathology and Ophthalmic Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Pancreatobiliary Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Pediatric Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Pulmonary Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Renal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eEvening Specialty Conference – Evening Specialty Conference – Surgical Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eExhibitor Seminar – Exhibitor Seminar_ ACD, BioTechne – RNAscope_ Lightning Lunch and Learn.mp4\u003c\/p\u003e\n\u003cp\u003eExhibitor Seminar – Exhibitor Seminar_ MUSE Microscopy – Embrace the Future of Digital Pathology. Take a Bold Leap, Not Just a Step!.mp4\u003c\/p\u003e\n\u003cp\u003eExhibitor Seminar – Exhibitor Seminar_ Roche – A new frontier in B-Cell Lymphoma diagnosis_ Novel ultrasensitive assay using in-situ hybridization.mp4\u003c\/p\u003e\n\u003cp\u003eExhibitor Seminar – Exhibitor Seminar_ Roche – Redefining Gastric Cancer Care_ Precision Diagnostics, Computational Pathology, and Biomarker Advances.mp4\u003c\/p\u003e\n\u003cp\u003eExhibitor Seminar – Exhibitor Seminar_ Roche – Roche Workshop – Building the Future of Image Analysis in Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eHans Popper Hepatopathology Society.mp4\u003c\/p\u003e\n\u003cp\u003eHistology Bootcamp – Histology Bootcamp_ Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eHistology Bootcamp – Histology Bootcamp_ Renal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eHistology Bootcamp- Breast Pathology.pdf\u003c\/p\u003e\n\u003cp\u003eHistology Bootcamp- Renal Pathology.pdf\u003c\/p\u003e\n\u003cp\u003eIAP Education Symposium – IAP Education Symposium_ The Morphology _ Molecular Global Divide_ The Challenge to Keep Pathology Classification Systems Relevant Across All Resource-Levels.mp4\u003c\/p\u003e\n\u003cp\u003eLuminaries in Pathology – Luminaries in Pathology_ Gynecologic.mp4\u003c\/p\u003e\n\u003cp\u003eLuminaries in Pathology – Luminaries in Pathology_ Neuropathology.mp4\u003c\/p\u003e\n\u003cp\u003eLuminaries in Pathology- Gynecologic.pdf\u003c\/p\u003e\n\u003cp\u003eLuminaries in Pathology- Neuropathology.pdf\u003c\/p\u003e\n\u003cp\u003eMaude Abbott Lecture.mp4\u003c\/p\u003e\n\u003cp\u003eMaude Abbott Lecture.pdf\u003c\/p\u003e\n\u003cp\u003eNathan Kaufman Timely Topics Lecture.pdf\u003c\/p\u003e\n\u003cp\u003ePlatform – Monday AM – Hematopathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform – Monday AM – Liver Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform – Monday PM – Liver Pathology.pdf\u003c\/p\u003e\n\u003cp\u003ePlatform – Tuesday PM – Career Development.pdf\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Bone and Soft Tissue Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Dermatopathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – General Surgical Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Genitourinary Pathology (including renal tumors).mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Gynecologic and Obstetric Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Head and Neck Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday AM – Liver Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Cardiovascular Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Cytopathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Education.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Gastrointestinal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Genitourinary Pathology (including renal tumors).mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Liver Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Pathology of the Pancreas, Gallbladder, Ampulla, and Extra-Hepatic Biliary Tree.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Monday PM – Quality and Patient Safety.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Autopsy and Forensics.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Breast Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Cytopathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Gastrointestinal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Gynecologic and Obstetric Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Hematopathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Informatics.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Medical Renal Pathology (including renal transplantation).mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Medical Renal Pathology (including renal transplantation)_2.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Neuropathology and Ophthalmic Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday AM – Pediatric and Perinatal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Bone and Soft Tissue Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Career Development.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Endocrine Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Gastrointestinal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Genitourinary Pathology (including renal tumors).mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Gynecologic and Obstetric Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Infectious Disease Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Pathobiology and Emerging Techniques.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology.mp4\u003c\/p\u003e\n\u003cp\u003ePlatform Session – Platform – Tuesday PM – Quality and Patient Safety.mp4\u003c\/p\u003e\n\u003cp\u003ePlenary – Maude Abbott Lecture.mp4\u003c\/p\u003e\n\u003cp\u003ePlenary – Nathan Kaufman Timely Topics Lecture.mp4\u003c\/p\u003e\n\u003cp\u003eState of the Academy and USCAP Honors.mp4\u003c\/p\u003e\n\u003cp\u003eUSCAP Honors – State of the Academy and USCAP Honors.mp4\u003c\/p\u003e\n\u003cp\u003eUSCAP Journals – Publish, Don’t Perish_ A Guide to Publication Ethics.mp4\u003c\/p\u003e\n\u003cp\u003eUSCAP Journals – The Best of the USCAP Journals.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724078276,"sku":null,"price":136.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-114th-Annual-Meeting-2025.jpg?v=1784215384"},{"product_id":"uscap-urologic-pathology-practice-in-the-eyes-of-genitourinary-pathology-society-gups-presidents-2025","title":"USCAP Urologic Pathology Practice in the Eyes of Genitourinary Pathology Society (GUPS) Presidents 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: March 19, 2025\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eJoin USCAP and GUPS for an overview of the rapidly evolving field of urologic pathology and the clinical management of urologic cancers – featuring GUPS’ past, present, and future presidents.\u003c\/p\u003e\n\u003cp\u003eUtilizing more than 72 index cases, this course will keep you up to date with the improved integration of histopathology, immunohistochemistry, artificial intelligence, and molecular concepts of urologic cancers as well as the growing roles for surveillance and neoadjuvant or adjuvant therapies.\u003c\/p\u003e\n\u003cp\u003eIn addition, you’ll learn about the clinically significant new tumor types as well as modified grading and staging criteria and new reporting requirements.This course is a collaboration between the Genitourinary Pathology Society (GUPS) and USCAP.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize, correctly diagnose, and classify new GU tumor types\u003c\/p\u003e\n\u003cp\u003eCorrectly apply new and modified grading criteria for GU cancers\u003c\/p\u003e\n\u003cp\u003eCorrectly apply new and modified staging criteria for GU cancers\u003c\/p\u003e\n\u003cp\u003eLearn new reporting requirements for GU tumors\u003c\/p\u003e\n\u003cp\u003eUnderstand the role of histomorphological classification in precision patient management\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBladder and Testes – Ming Zhou, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eKidney and Testes – Kiril Trpkov, MD, FRCPC.pdf\u003c\/p\u003e\n\u003cp\u003eProstate and Bladder – Cristina Magi-Galluzzi, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eProstate and Kidney – Rajal B. Shah, MD.pdf\u003c\/p\u003e\n\u003cp\u003eProstate and Kidney Slide – Rajal B. Shah, MD.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724242116,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Urologic-Pathology-Practice-in-the-Eyes-of-Genitourinary-Pathology-Society-GUPS-Presidents-2025.png?v=1784215386"},{"product_id":"uscap-modern-surgical-pathology-through-the-expert-eyes-of-apss-uscap-sixth-edition-2025","title":"USCAP Modern Surgical Pathology Through the Expert Eyes of APSS-USCAP Sixth Edition 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: April 7, 2025\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eThis course attempts to help pathologists eliminate diagnostic errors by highlighting pitfalls and providing approaches to resolve them using routine microscopic examination and immunohistochemistry. The roles of adjunctive molecular tests will be discussed as appropriate. Thus, this course will address both medical knowledge and competence with the goal of improving clinical practice.\u003c\/p\u003e\n\u003cp\u003eThis course is a collaboration between the Arthur Purdy Stout Society of Surgical Pathologists (APSS) and USCAP.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eEliminate diagnostic errors by recognizing typical pitfalls and utilizing provided approaches to resolving these pitfalls in surgical pathology using both routine microscopic examination of H\u0026amp;E-stained sections and immunohistochemical stains.\u003c\/p\u003e\n\u003cp\u003eDiscuss the uses and limitations of immunohistochemistry in diagnostic surgical pathology.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role of newer adjunctive molecular tests where appropriate.\u003c\/p\u003e\n\u003cp\u003eAddress both medical knowledge and competence with the goal of improving clinical practice.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBone and Soft Tissue Pathology Part 1 – Greg Charville, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eBone and Soft Tissue Pathology Part 1 – Greg Charville, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eBone and Soft Tissue Pathology Part 2 – Greg Charville, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eBone and Soft Tissue Pathology Part 2 – Greg Charville, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eBreast Pathology Part 1 – Stuart Schnitt, MD.pdf\u003c\/p\u003e\n\u003cp\u003eBreast Pathology Part 1 – Stuart Schnitt, MD.ts\u003c\/p\u003e\n\u003cp\u003eBreast Pathology Part 2 – Stuart Schnitt, MD.pdf\u003c\/p\u003e\n\u003cp\u003eBreast Pathology Part 2 – Stuart Schnitt, MD.ts\u003c\/p\u003e\n\u003cp\u003eDermatopathology Part 1 – Shyam Raghavan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eDermatopathology Part 1 – Shyam Raghavan, MD.ts\u003c\/p\u003e\n\u003cp\u003eDermatopathology Part 2 – Shyam Raghavan, MD.pdf\u003c\/p\u003e\n\u003cp\u003eDermatopathology Part 2 – Shyam Raghavan, MD.ts\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Pathology Part 1 – Elizabeth Montgomery, MD.pdf\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Pathology Part 1 – Elizabeth Montgomery, MD.ts\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Pathology Part 2 – Elizabeth Montgomery, MD.pdf\u003c\/p\u003e\n\u003cp\u003eGastrointestinal Pathology Part 2 – Elizabeth Montgomery, MD.ts\u003c\/p\u003e\n\u003cp\u003eGenitourinary Pathology Part 1 – Jesse McKenney, MD.pdf\u003c\/p\u003e\n\u003cp\u003eGenitourinary Pathology Part 1 – Jesse McKenney, MD.ts\u003c\/p\u003e\n\u003cp\u003eGenitourinary Pathology Part 2 – Jesse McKenney, MD.pdf\u003c\/p\u003e\n\u003cp\u003eGenitourinary Pathology Part 2 – Jesse McKenney, MD.ts\u003c\/p\u003e\n\u003cp\u003eGynecological Pathology Part 1 – Gulisa Turashvili, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eGynecological Pathology Part 1 – Gulisa Turashvili, MD, PhD.ts\u003c\/p\u003e\n\u003cp\u003eGynecological Pathology Part 2 – Gulisa Turashvili, MD, PhD.pdf\u003c\/p\u003e\n\u003cp\u003eGynecological Pathology Part 2 – Gulisa Turashvili, MD, PhD.ts\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724766404,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Modern-Surgical-Pathology-Through-the-Expert-Eyes-of-APSS-USCAP-Sixth-Edition-2025.png?v=1784215395"},{"product_id":"uscap-pathology-of-the-breast-and-female-genital-tract-2025","title":"USCAP Pathology of the Breast and Female Genital Tract 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 14 videos, size: 33.7 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: April 11, 2025\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eThis course is a collaboration between the Chinese American Pathologists Association (CAPA) and USCAP.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize updated diagnostic criteria and disease classifications in breast and gynecological pathology.\u003c\/p\u003e\n\u003cp\u003eRecognize unusual but important breast and gynecological disease entities.\u003c\/p\u003e\n\u003cp\u003eApply immunohistochemical and molecular genetic ancillary studies for diagnosis and differential diagnoses.\u003c\/p\u003e\n\u003cp\u003eUnderstand the clinical implications when applying new diagnostic knowledge.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAtypical and Metastatic Breast Lesions Part 1 – Popi Siziopikou, MD, PhD\u003c\/p\u003e\n\u003cp\u003eAtypical and Metastatic Breast Lesions Part 2 – Popi Siziopikou, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePanel Discussion Part 1\u003c\/p\u003e\n\u003cp\u003ePanel Discussion Part 2\u003c\/p\u003e\n\u003cp\u003ePapillary and Fibroepithelial Lesions Part 1 – Xiaoxian (Bill) Li, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePapillary and Fibroepithelial Lesions Part 2 – Xiaoxian (Bill) Li, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePathology of the Ovary Part 1 – Anais Malpica, MD\u003c\/p\u003e\n\u003cp\u003ePathology of the Ovary Part 2 – Anais Malpica, MD\u003c\/p\u003e\n\u003cp\u003ePathology of the Uterine Corpus Part 1 – Pei Hui, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePathology of the Uterine Corpus Part 2 – Pei Hui, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePathology of the Vulva, Vagina, and Cervix Part 1 – Bin Yang, MD, PhD\u003c\/p\u003e\n\u003cp\u003ePathology of the Vulva, Vagina, and Cervix Part 2 – Bin Yang, MD, PhD\u003c\/p\u003e\n\u003cp\u003eRare Breast Lesions (that all pathologists should know) Part 1 – Edi Brogi, MD, PhD\u003c\/p\u003e\n\u003cp\u003eRare Breast Lesions (that all pathologists should know) Part 2 – Edi Brogi, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405724864708,"sku":null,"price":104.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Pathology-of-the-Breast-and-Female-Genital-Tract-2025.png?v=1784215397"},{"product_id":"american-society-of-clinical-oncology-genitourinary-cancers-symposium-2025","title":"American Society of Clinical Oncology Genitourinary Cancers Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: oncologists, urologists, radiation oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025 is a premier event focused on the latest advancements in prostate, bladder, kidney, and other genitourinary cancers. It brings together oncologists, researchers, and healthcare professionals to discuss cutting-edge treatments, clinical trials, and emerging therapies.\u003c\/p\u003e\n\u003ch3\u003eHere are some key details:\u003c\/h3\u003e\n\u003cp\u003eLocation: San Francisco, CA\u003c\/p\u003e\n\u003ch3\u003eProgram Highlights:\u003c\/h3\u003e\n\u003cp\u003eProstate Cancer: Advances in radioligand therapies and androgen receptor pathway inhibitors.\u003c\/p\u003e\n\u003cp\u003eBladder Cancer: Innovations in antibody drug conjugates and immunotherapy.\u003c\/p\u003e\n\u003cp\u003eKidney Cancer: Biomarkers and new treatment strategies.\u003c\/p\u003e\n\u003cp\u003eUpper Tract Urothelial Carcinoma: Kidney-sparing approaches and perioperative therapies.\u003c\/p\u003e\n\u003ch3\u003eThe American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025 is tailored for professionals involved in genitourinary oncology, including:\u003c\/h3\u003e\n\u003cp\u003eMedical oncologists specializing in prostate, bladder, kidney, and other genitourinary cancers.\u003c\/p\u003e\n\u003cp\u003eUrologists and radiation oncologists focused on multimodal treatment strategies.\u003c\/p\u003e\n\u003cp\u003eResearchers and scientists presenting groundbreaking studies on biomarkers and emerging therapies.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest advancements in immunotherapy, targeted treatments, and surgical innovations.\u003c\/p\u003e\n\u003cp\u003ePharmaceutical and biotech professionals exploring novel drug developments.\u003c\/p\u003e\n\u003cp\u003ePatient advocates and policy experts working to improve cancer care accessibility.\u003c\/p\u003e\n\u003cp\u003eThe symposium offers multidisciplinary perspectives, interactive sessions, and networking opportunities to enhance patient outcomes.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThursday, February 13, 2025\u003c\/p\u003e\n\u003cp\u003e7:00 AM-\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003e7:00 AM-\u003c\/p\u003e\n\u003cp\u003e6:45 AM\u003c\/p\u003e\n\u003cp\u003eExhibits Open\u003c\/p\u003e\n\u003cp\u003e8:00 AM-\u003c\/p\u003e\n\u003cp\u003e9:40 AM\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session A: Prostate CancerKosj Yamoah, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research InstituteChanning Judith Paller, MD—Chair\u003c\/p\u003e\n\u003cp\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPeter Hoskin, MD, FRCP, FRCR\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eABSTRACT 308: Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.\u003c\/p\u003e\n\u003cp\u003eABSTRACT 309: Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs).\u003c\/p\u003e\n\u003cp\u003eEdwin Posadas, MD, FACP\u003c\/p\u003e\n\u003cp\u003eCedars-Sinai Medical Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eABSTRACT 20: Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).\u003c\/p\u003e\n\u003cp\u003eTanya B. Dorff, MD\u003c\/p\u003e\n\u003cp\u003eCity of Hope Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eUnderstanding Radioligand Therapies for Advanced Prostate CancerAngela Y Jia, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity Hospitals Seidman Cancer Center and Case Western Reserve UniversityDevaki Shilpa Surasi, MBBS—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas at MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003ePSMA-Based Therapy in Advanced Disease: Touching on Combination SequencingWilliam Kevin Kelly, DO\u003c\/p\u003e\n\u003cp\u003eThomas Jefferson University Hospital\u003c\/p\u003e\n\u003cp\u003eBeyond PSMA-Targeted Agents for Advanced Disease\u003c\/p\u003e\n\u003cp\u003eDanny Mena Cortes\u003c\/p\u003e\n\u003cp\u003eNuclear Medicine World\u003c\/p\u003e\n\u003cp\u003eSeeing Is Believing: Radiographic Criteria to Assess Response\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session A: Prostate Cancer\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session A: Prostate Cancer\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrainee and Early-Career Networking LuncheonView the networking faculty list here\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Management of Biochemical Recurrence After Radiation Therapy for Localized Prostate CancerMichael Cookson, MD, MMHC, FACS—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Oklahoma College of MedicineBarbara Jereczek-Fossa, MD—Chair\u003c\/p\u003e\n\u003cp\u003eIEO European Institute of Oncology IRCCSMichael Cookson, MD, MMHC, FACS\u003c\/p\u003e\n\u003cp\u003eUniversity of Oklahoma College of Medicine\u003c\/p\u003e\n\u003cp\u003eRecurrence After Radiation Therapy: Evaluation, Management, and Outcomes\u003c\/p\u003e\n\u003cp\u003eHeather H. Cheng, MD, PhD\u003c\/p\u003e\n\u003cp\u003eUniversity of Washington\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eJuanita Crook, FRCPC\u003c\/p\u003e\n\u003cp\u003eThe University of British Columbia\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eThomas Polascik, MD\u003c\/p\u003e\n\u003cp\u003eDuke University Division of Urologic Surgery\u003c\/p\u003e\n\u003cp\u003eUrology (Ablative Focal)\u003c\/p\u003e\n\u003cp\u003eAshley Ross, MD, PhD\u003c\/p\u003e\n\u003cp\u003eNorthwestern University Feinberg School of Medicine\u003c\/p\u003e\n\u003cp\u003eUrology (Salvage Surgery)\u003c\/p\u003e\n\u003cp\u003eAlicia K. Morgans, MD, MPH, FASCO\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer Institute\u003c\/p\u003e\n\u003cp\u003eThe Impact of Salvage Therapies: Functional Outcomes and Quality of Life\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eKeynotePeter Hoskin, MD, FRCP, FRCR – Chair\u003c\/p\u003e\n\u003cp\u003eMount Vernon Cancer Centre, University College London, and University of Manchester\u003c\/p\u003e\n\u003cp\u003eIntroduction of Dr. DahutWilliam L. Dahut, MD\u003c\/p\u003e\n\u003cp\u003eAmerican Cancer Society\u003c\/p\u003e\n\u003cp\u003eCreative Innovation: Driving Science to Improve Patient-Centered CareQuestion and Answer\u003c\/p\u003e\n\u003cp\u003e3:05 PM-\u003c\/p\u003e\n\u003cp\u003e3:30 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:30 PM-\u003c\/p\u003e\n\u003cp\u003e4:45 PM\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Evolving Landscape of the Management of Oligometastatic DiseaseKaren E. Hoffman, MD, MHSc, MPH—Chair\u003c\/p\u003e\n\u003cp\u003eThe University of Texas MD Anderson Cancer CenterNicholas David James—Chair\u003c\/p\u003e\n\u003cp\u003eInstitute of Cancer Research, The Royal Marsden Hospital NHS Foundation TrustABSTRACT 15: World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration.\u003c\/p\u003e\n\u003cp\u003eKenneth L. Gage, MD, PhD\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research Institute\u003c\/p\u003e\n\u003cp\u003eRadiology\u003c\/p\u003e\n\u003cp\u003eBrandon A. Mahal, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of Miami\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eKasmintan A. Schrader, PhD, MBBS\u003c\/p\u003e\n\u003cp\u003eBC Cancer\u003c\/p\u003e\n\u003cp\u003eGenetics\u003c\/p\u003e\n\u003cp\u003eSandy Srinivas, MD\u003c\/p\u003e\n\u003cp\u003eStanford School of Medicine\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003e5:00 PM-\u003c\/p\u003e\n\u003cp\u003e5:45 PM\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session A: Prostate CancerMarjory Jolicoeur, MD, PhD, FRCPC—Chair\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session A (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session A (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Prostate CancerMarjory Jolicoeur, MD, PhD, FRCPC\u003c\/p\u003e\n\u003cp\u003eHôpital Charles-LeMoyne\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderChanning Judith Paller, MD\u003c\/p\u003e\n\u003cp\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003e6:00 PM-\u003c\/p\u003e\n\u003cp\u003e6:45 PM\u003c\/p\u003e\n\u003cp\u003eWomen’s Networking Reception\u003c\/p\u003e\n\u003cp\u003eFriday, February 14, 2025\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003eExhibits Open\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session B: Urothelial CarcinomaElizabeth A. Guancial, MD—Chair\u003c\/p\u003e\n\u003cp\u003eFlorida Cancer Specialists \u0026amp; Research InstituteNicholas I. Simon, MD, MSc—Chair\u003c\/p\u003e\n\u003cp\u003eNational Cancer InstituteAndrea B Apolo, MD\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eElizabeth R. Plimack, MD, FASCO, MS\u003c\/p\u003e\n\u003cp\u003eFox Chase Cancer Center, Temple Health\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eScot Anthony Niglio, MD, MS\u003c\/p\u003e\n\u003cp\u003eNational Institutes of Health Division of Occupational Health and Safety\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Non-Muscle Invasive Bladder Cancer: Exploring Therapies Beyond Bacillus Calmette-GuérinBrian Christopher Baumann, MD—Chair\u003c\/p\u003e\n\u003cp\u003eSpringfield ClinicBogdana Schmidt, MD, MPH—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Utah\u003c\/p\u003e\n\u003cp\u003eThe Changing World of Non-Muscle Invasive Bladder CancerCase Presentation\u003c\/p\u003e\n\u003cp\u003eGirish S. Kulkarni, MD, PhD\u003c\/p\u003e\n\u003cp\u003eDepartment of Surgical Oncology, Princess Margaret Cancer Center, University Health Network\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003eMark Tyson, MPH\u003c\/p\u003e\n\u003cp\u003eMayo Clinic Arizona\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003eTracy L Rose, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of North Carolina at Chapel Hill\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session B: Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session B: Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eBreakout Session: Emerging Trends and Advances in Germ Cell TumorsAditya Bagrodia, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San Diego HealthAnja Lorch, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversitätsspital ZürichNabil Adra, MD\u003c\/p\u003e\n\u003cp\u003eIndiana University Health Melvin and Bren Simon Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eHigh-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications\u003c\/p\u003e\n\u003cp\u003eAxel Heidenreich, MD\u003c\/p\u003e\n\u003cp\u003eUniversity Hospital of Cologne\u003c\/p\u003e\n\u003cp\u003ePrimary Retroperitoneal Lymph Node Dissection in Stage II Seminoma: Management Strategies and Current Controversies\u003c\/p\u003e\n\u003cp\u003eDarren R. Feldman, MD\u003c\/p\u003e\n\u003cp\u003eMemorial Sloan Kettering Cancer Center\u003c\/p\u003e\n\u003cp\u003eLandscape of New Trials and Targets in Refractory Germ Cell Tumors\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eThe ABCs of ADCs: Unleashing the Power of Antibody-Drug Conjugates in Advanced Bladder CancerKent William Mouw, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer Institute, Brigham and Women’s HospitalBenjamin Garmezy, MD—Chair\u003c\/p\u003e\n\u003cp\u003eSarah Cannon Research InstituteDi Maria Jiang, MD, MSc, FRCPC\u003c\/p\u003e\n\u003cp\u003ePrincess Margaret Hospital, University Health Network\u003c\/p\u003e\n\u003cp\u003eTargeting Bladder Cancer With Antibody Drug Conjugates\u003c\/p\u003e\n\u003cp\u003eFunda Meric-Bernstam, MD, FASCO\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003eHER2 Antibody-Drug Conjugate Therapy: A New Frontier in Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eDaniel Castellano, MD\u003c\/p\u003e\n\u003cp\u003eServicio de Oncología Médica, Hospital Universitario 12 de Octubre\u003c\/p\u003e\n\u003cp\u003eOvercoming Challenges of Antibody-Drug Conjugate Toxicity in Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eTerence W. Friedlander, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San Francisco Medical Center\u003c\/p\u003e\n\u003cp\u003eBetter Together? Exploring Novel Drug Combinations With Antibody-Drug Conjugates\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003ePanning for Gold: The Role of ctDNA as a Biomarker for Bladder CancerBernadett Szabados, MBBS—Chair\u003c\/p\u003e\n\u003cp\u003eBarts Cancer CentreJoaquim Bellmunt, MD—Chair\u003c\/p\u003e\n\u003cp\u003eDana-Farber Cancer InstituteRoger Li, MD\u003c\/p\u003e\n\u003cp\u003eH. Lee Moffitt Cancer Center and Research Institute\u003c\/p\u003e\n\u003cp\u003eCapturing What You Cannot See: How Can ctDNA Be Used to Improve Clinical Staging for Upper Tract Disease?\u003c\/p\u003e\n\u003cp\u003eAlexander William Wyatt, PhD\u003c\/p\u003e\n\u003cp\u003eVancouver Prostate Centre, University of British Columbia\u003c\/p\u003e\n\u003cp\u003eEvolution of Ctdna Detection with Next Generation Technology\u003c\/p\u003e\n\u003cp\u003eNimira S. Alimohamed, FRCPC\u003c\/p\u003e\n\u003cp\u003eArthur Child Comprehensive Cancer Centre, University of Calgary\u003c\/p\u003e\n\u003cp\u003ePotential Impact of ctDNA on Perioperative Management of Muscle-Invasive Bladder Cancer\u003c\/p\u003e\n\u003cp\u003eGillian Vandekerkhove, PhD, MSc\u003c\/p\u003e\n\u003cp\u003eVancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia\u003c\/p\u003e\n\u003cp\u003eBeneath the Surface: Unleashing the Potential of Ctdna across the Spectrum of Urothelial Carcinoma\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session B: Urothelial CarcinomaKatie S. Murray, DO, FACS, MS—Chair\u003c\/p\u003e\n\u003cp\u003eABSTRACT 666: Clinically advanced urothelial bladder cancer (CAUBC) in young onset bladder cancer (YOUC) patients: A genomic landscape study.\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session B (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session B (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Wine and Cheese Reception\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Urothelial CarcinomaElias Chandran, FRACP, MBBS\u003c\/p\u003e\n\u003cp\u003eNational Cancer Institute\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderArmine Smith, MD\u003c\/p\u003e\n\u003cp\u003eJohns Hopkins University School of Medicine\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003eSaturday, February 15, 2025\u003c\/p\u003e\n\u003cp\u003eComplimentary Continental Breakfast\u003c\/p\u003e\n\u003cp\u003ePoster Session C: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/p\u003e\n\u003cp\u003eOral Abstract Session C: Renal Cell CancerArpita Desai, MD—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, San FranciscoDaniel Shapiro—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of Wisconsin-MadisonTodd Matthew Morgan, MD\u003c\/p\u003e\n\u003cp\u003eWelcome of the Day\u003c\/p\u003e\n\u003cp\u003eTian Zhang, MD, MHS\u003c\/p\u003e\n\u003cp\u003eUT Southwestern University\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003eABSTRACT 618: Prospective COTRIMS (Cologne trial of retroperitoneal lymphadectomy in metastatic seminoma) trial: Final results.\u003c\/p\u003e\n\u003cp\u003eClint Cary, MD, MBA, MPH\u003c\/p\u003e\n\u003cp\u003eIndiana University Simon Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003eDiscussion\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003eBiomarkers and Adjuvant Therapy for Renal Cell Carcinoma: Current State and Future DirectionsShuchi Gulati, MD, MS, FACP—Chair\u003c\/p\u003e\n\u003cp\u003eUniversity of California, Davis Comprehensive Cancer CenterAxel Bex, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eSimpa Samuel Salami, MD, MPH\u003c\/p\u003e\n\u003cp\u003eUniversity of Michigan\u003c\/p\u003e\n\u003cp\u003eBiomarkers in Renal Cell Carcinoma: Dead End or Turning Point?\u003c\/p\u003e\n\u003cp\u003eSamra Turajlic, MD, PhD\u003c\/p\u003e\n\u003cp\u003eThe Francis Crick Institute\u003c\/p\u003e\n\u003cp\u003eThe Future of Biomarkers in Renal Cell Carcinoma\u003c\/p\u003e\n\u003cp\u003eLaurence Albiges, MD, PhD\u003c\/p\u003e\n\u003cp\u003eGustave Roussy, Université Paris Saclay\u003c\/p\u003e\n\u003cp\u003eAdjuvant Therapy in Renal Cell Cancer: A Practical Guide\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003ePoster Session C (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eTrials in Progress Poster Session C (Continued)\u003c\/p\u003e\n\u003cp\u003eWith Complimentary Boxed Lunch\u003c\/p\u003e\n\u003cp\u003eWomen in Genitourinary Cancers Networking LuncheonView the networking faculty list here\u003c\/p\u003e\n\u003cp\u003ePoster Walks: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral CancersBrittney Cotta, MD\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003ePoster Walk LeaderShuchi Gulati, MD, FACP, MS\u003c\/p\u003e\n\u003cp\u003eUC Davis Comprehensive Cancer Center\u003c\/p\u003e\n\u003cp\u003ePoster Walk Leader\u003c\/p\u003e\n\u003cp\u003e12:45 PM-\u003c\/p\u003e\n\u003cp\u003e​​​​​​​1:30 PM\u003c\/p\u003e\n\u003cp\u003eRapid Oral Abstract Session C: Renal Cell CancerBrittney Cotta, MD—Chair\u003c\/p\u003e\n\u003cp\u003eABSTRACT 444: Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO).\u003c\/p\u003e\n\u003cp\u003eABSTRACT 1: EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma.\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003eCase-Based Session: Failure of Immunotherapy in Renal Cell Cancer: What’s Next?Leslie K. Ballas, MD—Chair\u003c\/p\u003e\n\u003cp\u003eCedars-Sinai Medical CenterKathryn Hacker Gessner, MD, PhD—Chair\u003c\/p\u003e\n\u003cp\u003eUNC School of MedicineMaria T. Bourlon, MD, MSc, FASCO\u003c\/p\u003e\n\u003cp\u003eInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eMatthew T Campbell, MD, MS\u003c\/p\u003e\n\u003cp\u003eThe University of Texas MD Anderson Cancer Center\u003c\/p\u003e\n\u003cp\u003eMedical Oncology\u003c\/p\u003e\n\u003cp\u003eRaquibul Hannan, MD, PhD\u003c\/p\u003e\n\u003cp\u003eUniversity of Texas Southwestern Medical Center\u003c\/p\u003e\n\u003cp\u003eRadiation Oncology\u003c\/p\u003e\n\u003cp\u003eViraj A. Master, MD, PhD\u003c\/p\u003e\n\u003cp\u003eEmory School of Medicine\u003c\/p\u003e\n\u003cp\u003eUrology\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405726437572,"sku":null,"price":208.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Clinical-Oncology-Genitourinary-Cancers-Symposium-2025.jpg?v=1784215410"},{"product_id":"american-heart-association-international-stroke-conference-2025","title":"American Heart Association International Stroke Conference 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, and stroke specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe American Heart Association International Stroke Conference OnDemand 2025 showcases the latest scientific advancements, late-breaking clinical trials, and innovative treatments in cerebrovascular disease. The program covers a wide array of critical topics, including neuroendovascular therapies, acute stroke management, post-stroke recovery, and systemic factors impacting stroke care, equipping clinicians with cutting-edge strategies to improve patient outcomes globally.\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2025\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the results of late-breaking clinical trials and their immediate impact on stroke prevention and acute treatment guidelines.\u003c\/p\u003e\n\u003cp\u003eImplement advanced neurointerventional techniques, including newer generation flow diverters and complex thrombectomy procedures.\u003c\/p\u003e\n\u003cp\u003eAnalyze the intersection of neurocardiology and systemic conditions, such as hypertension and mechanical circulatory support, in stroke pathogenesis.\u003c\/p\u003e\n\u003cp\u003eAssess innovative tools for stroke diagnosis and triage, including deep clinical AI and robotic TCD for PFO detection.\u003c\/p\u003e\n\u003cp\u003eDevelop comprehensive, multidisciplinary strategies for post-stroke rehabilitation, cognitive recovery, and secondary prevention.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists, neurosurgeons, and stroke specialists who want updates on neurointerventions, late-breaking trials, and rehabilitation.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003e4th Annual Company Showcase\u003c\/p\u003e\n\u003cp\u003e75 Years of NINDS-supported Research to Advance Stroke Prevention Treatment and Recovery From Bench to Bedside and Beyond\u003c\/p\u003e\n\u003cp\u003eAcute Stenting during Endovascular Therapy for Large vessel Occlusions\u003c\/p\u003e\n\u003cp\u003eAcute Treatment Systemic Thrombolysis and Cerebroprotection Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eAcute Treatment Systemic Thrombolysis and Cerebroprotection Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eAdding Insult to Injury Stroke in the Context of Pre-existing Disability and Dementia\u003c\/p\u003e\n\u003cp\u003eAdvancements in Stroke services – INDIA Quality care Best Practices New Approaches an Indian Stroke Association ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eAdvances and Controversies in Pediatric Moyamoya Disease\u003c\/p\u003e\n\u003cp\u003eAdvancing Regional Thrombectomy Systems of Care Global Perspectives\u003c\/p\u003e\n\u003cp\u003eAdvancing Stroke Care Deepening the Collaboration Between Neurology and Cardiology\u003c\/p\u003e\n\u003cp\u003eAdvancing the Understanding of Dolichoectasia Current Status and Future Directions\u003c\/p\u003e\n\u003cp\u003eAHA Statements and Guidelines Stroke Primary Prevention\u003c\/p\u003e\n\u003cp\u003eAneurysms and Vascular Malformations Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eAspiration Risk Screening Updated Evidence and a Call for Advocacy\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – Adjunctive Neurostimulation Interventions and Therapies To Maximize Post-Stroke Rehabilitation and Recov…\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – Attacking the Swell Vascular Permeability and Cerebral Edema Post-Stroke\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond – What Do We Know About the Role of Inflammation in Intracranial Hemorrhage\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond -Understanding Sporadic CSVD Through the Lens of CADASIL And Other Monogenic CSVDS\u003c\/p\u003e\n\u003cp\u003eBest Interventions vs Conservative Management for Unruptured Brain Aneurysms Assessing the Risks and Benefits\u003c\/p\u003e\n\u003cp\u003eBrain Health Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eBuild a Thriving Telestroke Program Best Practices and Common Pitfalls\u003c\/p\u003e\n\u003cp\u003eCan We Bridge the Gap Implementing new approaches to address womens needs in stroke trials\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Diseases in Patients with Mechanical Circulatory Support Devices\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Inflammatory Disorders the Stroke Neurologist Needs to Know Blood Vessels on Fire\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Nursing and Advanced Practice Providers and Therapists Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Systems of Care Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eCerebrovascular Systems of Care Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eClinical Rehabilitation and Recovery Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eClinical Translation of Randomized Trials Challenges Opportunities and the Importance Of Designing Trials With Patient And Community En…\u003c\/p\u003e\n\u003cp\u003eClosing Main Event\u003c\/p\u003e\n\u003cp\u003eComplexities and Complications Lessons In Training Trainee Case Studies Session 1\u003c\/p\u003e\n\u003cp\u003eComplexities and Complications Lessons In Training Trainee Case Studies Session 2\u003c\/p\u003e\n\u003cp\u003eConsiderations and Learnings with Newer Generation Flow Diverters\u003c\/p\u003e\n\u003cp\u003eCracking the Code of Cryptogenic Stroke Robotic TCD for PFO Detection\u003c\/p\u003e\n\u003cp\u003eDeveloping Sustainable and Unique Models for Community Stroke Education\u003c\/p\u003e\n\u003cp\u003eDisrupting the Status Quo Aldosterone in the Pathogenesis of Hypertension\u003c\/p\u003e\n\u003cp\u003eEast Asia Specific Forms of Stroke RNF213 Related Vasculopathy a Japan Stroke Society ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eEndovascular thrombectomy for distal medium vessel occlusions How far is too far\u003c\/p\u003e\n\u003cp\u003eEnhanced Perspectives Advanced Visualization Through Deep Clinical AI\u003c\/p\u003e\n\u003cp\u003eEstablishing Stroke Centers of Excellence – Beyond Stroke services and Quality a World Stroke Organisation ASA Joint Symposium\u003c\/p\u003e\n\u003cp\u003eEvolution of Stroke Treatment and building a CSC with new 088 technology\u003c\/p\u003e\n\u003cp\u003eExploring the Future of ICAD Diagnosis and Management a JAHA Journal Session\u003c\/p\u003e\n\u003cp\u003eFast and Furious Stroke in the Real World – Addressing Challenges In Acute Stroke Management\u003c\/p\u003e\n\u003cp\u003eFrom Concept to Care Implementing Effective Cardiac Monitoring Pathways\u003c\/p\u003e\n\u003cp\u003eGame of Strokes\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eHealth Services Quality Improvement and Patient-Centered Outcomes Oral Abstracts III\u003c\/p\u003e\n\u003cp\u003eHealth Wanted AHA Resources to Spark Community Dialogue About Rural Health Inequities\u003c\/p\u003e\n\u003cp\u003eHigh Profile Thrombolysis Randomized Controlled Trials\u003c\/p\u003e\n\u003cp\u003eHot Topics on Hot Carotids\u003c\/p\u003e\n\u003cp\u003eImaging Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eImaging Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eIn-Hospital Care from the ICU to Discharge Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eInnate Immune Targets after Stroke\u003c\/p\u003e\n\u003cp\u003eInside the AHAs Research Enterprise Grant Funding and Other Opportunities\u003c\/p\u003e\n\u003cp\u003eInsights from the Field The Life of a Teleneurologist\u003c\/p\u003e\n\u003cp\u003eIntracerebral Hemorrhage Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eIntracerebral Hemorrhage Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eIts All in The Head Psychological Health is Brain Health\u003c\/p\u003e\n\u003cp\u003eLarge Vessel Disease from Arteries to Veins Non-Acute Treatment Oral Abstracts\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts III\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts IV\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts V\u003c\/p\u003e\n\u003cp\u003eLate-Breaking Science Oral Abstracts VI\u003c\/p\u003e\n\u003cp\u003eLeft Atrial Appendage Closure and the Heart-Brain Connection\u003c\/p\u003e\n\u003cp\u003eLeveraging Real-World Evidence to Enhance Stroke Outcomes\u003c\/p\u003e\n\u003cp\u003eManagement Decisions Surrounding Antithrombotic Treatment in Patients with ICH A Physicians Perspective\u003c\/p\u003e\n\u003cp\u003eModernizing Stroke Trials for the 21st Century -Scale Strategy and Technology\u003c\/p\u003e\n\u003cp\u003eNavigating the Pediatric Ischemic Stroke Landscape Innovations in Prehospital and Intrahospital Management\u003c\/p\u003e\n\u003cp\u003eNeuroendovascular Oral Abstracts I\u003c\/p\u003e\n\u003cp\u003eNeuroendovascular Oral Abstracts II\u003c\/p\u003e\n\u003cp\u003eNew and Alternative Thrombolytic Therapies a Stroke Journal session\u003c\/p\u003e\n\u003cp\u003eNew Horizons in Medical Therapy for Stroke Prevention\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Acute Care\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Care Across the Continuum\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Main Event\u003c\/p\u003e\n\u003cp\u003eNursing Symposium Stroke Program Optimization\u003c\/p\u003e\n\u003cp\u003eOpening Main Event\u003c\/p\u003e\n\u003cp\u003eOptimal Blood Pressure Management in Acute Cerebrovascular Disease\u003c\/p\u003e\n\u003cp\u003eOptimal Imaging for Patient Triage in the Late Time Window and with Large Cores Debate\u003c\/p\u003e\n\u003cp\u003eOptimizing Blood Pressure Variability BPV Management Strategies for Stroke Care\u003c\/p\u003e\n\u003cp\u003ePartnering with Patients to Improve Post-Stroke Care\u003c\/p\u003e\n\u003cp\u003ePathogenesis and Treatment of Non-acute Subdural Hematomas AANSCNS CV Section Session\u003c\/p\u003e\n\u003cp\u003ePediatric Cerebrovascular Disease Oral Abstracts\u003c\/p\u003e\n\u003cp\u003ePioneering Stroke Care Insights from the Creators and Implementers of Mobile Stroke Ambulances\u003c\/p\u003e\n\u003cp\u003eScaling Stroke Triage with AI – Virtual Innovation for Neuroscience Excellence VINE\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405727224004,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Heart-Association-International-Stroke-Conference-2025.jpg?v=1784215415"},{"product_id":"american-society-of-clinical-oncology-gastrointestinal-cancers-symposium-2025","title":"American Society of Clinical Oncology Gastrointestinal Cancers Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: oncologists, gastroenterologists, surgeons, radiation oncologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 ASCO Gastrointestinal (GI) Cancers Symposium, which offers the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care\u003c\/p\u003e\n\u003cp\u003eThe American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2025 will take place from Thursday, January 23 to Saturday, January 25, 2025. It offers cutting-edge science, solution-focused strategies, and multidisciplinary approaches in gastrointestinal cancer treatment, research, and care. The symposium includes sessions on emerging therapies, patient-centric management, and rapid oral abstracts on cancers of the esophagus and stomach.\u003c\/p\u003e\n\u003cp\u003eThe American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2025 is tailored for a diverse audience involved in the field of gastrointestinal oncology. This includes oncologists, gastroenterologists, surgeons, radiation oncologists, researchers, and other healthcare professionals dedicated to the treatment and management of gastrointestinal cancers. The symposium provides a platform for sharing the latest advancements in research, innovative therapies, and multidisciplinary approaches to patient care\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSyllabus: click here\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405728141508,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Clinical-Oncology-Gastrointestinal-Cancers-Symposium-2025.png?v=1784215430"},{"product_id":"docmeded-2025-pathology-review-practical-updates-in-breast-gastrointestinal-and-genitourinary-pathology-for-the-general-pathologist","title":"DocmedED 2025 Pathology Review Practical Updates in Breast, Gastrointestinal and Genitourinary Pathology for the General Pathologist","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 20 videos, size: 12.95 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: primarily intended and designed to educate practicing pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAbout This CME Teaching Activity ▼\u003c\/p\u003e\n\u003cp\u003eThis teaching activity has been designed to provide an extensive overview of some of the most common areas of diagnostic difficulty encountered by practicing surgical pathologists in the areas of breast, gastrointestinal, and genitourinary pathology. This course provides details of some of the most important diagnostic features which allow pathologists to make accurate diagnoses in each of these subspecialized areas, as well as how to assess essential diagnostic clues and avoid the most common misdiagnoses. In each lecture, there is a thorough discussion on the use of ancillary diagnostic techniques, including immunohistochemistry and molecular diagnostics.\u003c\/p\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis activity is primarily intended and designed to educate practicing pathologists.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eRecognize the most common and more recently described renal cell tumors.\u003c\/p\u003e\n\u003cp\u003eIdentify some of the most common pitfalls in the diagnosis of biopsies of the urinary bladder and prostate.\u003c\/p\u003e\n\u003cp\u003eList the most common tumors encountered in the male genitourinary tract.\u003c\/p\u003e\n\u003cp\u003eExplain the most appropriate handling and staging of renal tumors.\u003c\/p\u003e\n\u003cp\u003eDescribe some of the newest forms of esophagitis.\u003c\/p\u003e\n\u003cp\u003eIdentify the various patterns of gastritis and gastropathy.\u003c\/p\u003e\n\u003cp\u003eList the most common pitfalls in duodenal biopsy interpretation.\u003c\/p\u003e\n\u003cp\u003eDefine the most common inflammatory patterns in colorectal biopsy specimens.\u003c\/p\u003e\n\u003cp\u003eRecognize the most common diagnostic pitfalls in breast core biopsies.\u003c\/p\u003e\n\u003cp\u003eDescribe the most common changes in post neoadjuvant treatment breast specimens.\u003c\/p\u003e\n\u003cp\u003eExplain biomarker testing in breast cancer.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBiomarker Testing in Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eBladder Cancer Pathology Updates.mp4\u003c\/p\u003e\n\u003cp\u003eBreast Pathology in the Era of Genomics.mp4\u003c\/p\u003e\n\u003cp\u003eCommon Issues in Male Genital Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eGastritis and Gastropathy.mp4\u003c\/p\u003e\n\u003cp\u003eInflammatory Patterns in Colonic Biopsy Samples.ts\u003c\/p\u003e\n\u003cp\u003eInterpretations of Breast Core Biopsies An Assortment of Common Diagnostic Challenges.ts\u003c\/p\u003e\n\u003cp\u003ePathologic Evaluation of Breast Specimens Post Neoadjuvant Treatment.mp4\u003c\/p\u003e\n\u003cp\u003ePattern-Based Approach to Renal Cell Tumors.mp4\u003c\/p\u003e\n\u003cp\u003ePractical Approach to Duodenal Biopsy Interpretation .mp4\u003c\/p\u003e\n\u003cp\u003eProstate Cancer Pathology Updates.mp4\u003c\/p\u003e\n\u003cp\u003eRecognizing Sneaky Cancers in Gastric Biopsies and How to Work Them Up.mp4\u003c\/p\u003e\n\u003cp\u003eSlide Seminar Interesting Cases in Genitourinary Pathology.mp4\u003c\/p\u003e\n\u003cp\u003eSlide Seminar Special Subtypes of Triple Negative Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSlide Seminar Spindle Cell Lesions of the Breast.mp4\u003c\/p\u003e\n\u003cp\u003eStaging and Handling of Renal Tumors.mp4\u003c\/p\u003e\n\u003cp\u003eThe Differential Diagnosis of Ischemic Colitis.mp4\u003c\/p\u003e\n\u003cp\u003eThe Spectrum of Triple Negative Breast Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eWhat’s New in Esophagitis.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405728338116,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-Pathology-Review-Practical-Updates-in-Breast-Gastrointestinal-and-Genitourinary-Pathology-for-the-General-Pathologist.png?v=1784215424"},{"product_id":"docmeded-2025-digital-slide-pathology-review-a-case-based-approach-to-common-problems-in-surgical-pathology","title":"Docmeded 2025 Digital Slide Pathology Review A Case Based Approach to Common Problems in Surgical Pathology","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: primarily designed to educate practicing pathologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis activity is primarily designed to educate practicing pathologists.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this CME teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eDiscuss the most common patterns seen in soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eRecognize the most commonly used immunohistochemical and molecular techniques used in the diagnosis of soft tissue tumors.\u003c\/p\u003e\n\u003cp\u003eIdentify the limitations and potential pitfalls of immunohistochemistry and molecular testing in head and neck pathology.\u003c\/p\u003e\n\u003cp\u003eCite the most important changes in the WHO classification of cartilaginous neoplasms.\u003c\/p\u003e\n\u003cp\u003eDifferentiate the most common benign and malignant cartilaginous tumors.\u003c\/p\u003e\n\u003cp\u003eUtilize information on the uses and limitations of immunohistochemistry in resolving diagnostic problems in breast core needle biopsy specimens.\u003c\/p\u003e\n\u003cp\u003eRecognize the uses and limitations of immunohistochemistry in resolving diagnostic problems in spindle cell lesions of the breast.\u003c\/p\u003e\n\u003cp\u003eDescribe the most common differential diagnoses in genitourinary pathology.\u003c\/p\u003e\n\u003cp\u003eProvide accurate classification and appropriate use of ancillary studies in endometrial lesions.\u003c\/p\u003e\n\u003cp\u003eDiscuss the most common causes of inflammation and injury to the stomach.\u003c\/p\u003e\n\u003cp\u003eIdentify the diagnostic considerations of eosinophilic tumors of the kidney.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Pattern-Based Approach to Soft Tissue Tumors, Part 1 John R. Goldblum, M.D.\u003c\/p\u003e\n\u003cp\u003eBiopsies and Biomarkers in Genitourinary Pathology Michelle S. Hirsch, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003eCartilaginous Neoplasms: The Essentials Darcy Arendt Kerr, M.D.\u003c\/p\u003e\n\u003cp\u003eEndometrial Pathology for the Practicing Pathologist Marisa Rose Nucci, M.D.\u003c\/p\u003e\n\u003cp\u003eA Pattern-Based Approach to Soft Tissue Tumors, Part 2 John R. Goldblum, M.D.\u003c\/p\u003e\n\u003cp\u003eSquamous Lesions of the Head and Neck and Their Mimics Darcy Arendt Kerr, M.D.\u003c\/p\u003e\n\u003cp\u003eThe Differential Diagnosis of Eosinophilic Renal Epithelial Neoplasms Michelle S. Hirsch, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003eGastric Inflammation and Injury: When What You Say Actually Matters Rhonda K. Yantiss, M.D.\u003c\/p\u003e\n\u003cp\u003eUpdates from the WHO 2020 Classification of Tumors of the GYN Tract for the Practicing Pathologist Marisa Rose Nucci, M.D.\u003c\/p\u003e\n\u003cp\u003eDealing with Duodenitis: Sprue and Its Mimics Rhonda K. Yantiss, M.D.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405728469188,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Docmeded-2025-Digital-Slide-Pathology-Review-A-Case-Based-Approach-to-Common-Problems-in-Surgical-Pathology.png?v=1784215426"},{"product_id":"american-academy-of-dermatology-association-annual-meeting-2025","title":"American Academy of Dermatology Association Annual Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 817 videos, size: 65.4 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: dermatologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Annual Meeting On-Demand provides access to PowerPoint presentations and audio from hundreds of sessions recorded during the meeting in Orlando.\u003c\/p\u003e\n\u003cp\u003eThe target audience for the American Academy of Dermatology Association (AAD) Annual Meeting 2025 includes dermatologists and other professionals involved in dermatologic care. This event is designed to address professional practice gaps, educational needs, and emerging clinical research in dermatology. It provides opportunities for attendees to enhance their knowledge in areas like medical dermatology, dermatologic surgery, pediatric dermatology, and dermatopathology\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourses Advanced Cosmetic Surgery that Dermatologists Can Perform (C011) Alexander A. Dane DO FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Advanced Cosmetic Surgery that Dermatologists Can Perform (C011) Aria Vazirnia MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Advanced Cosmetic Surgery that Dermatologists Can Perform (C011) Ariel Ostad MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Advanced Cosmetic Surgery that Dermatologists Can Perform (C011) Hooman Khorasani MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Advanced Cosmetic Surgery that Dermatologists Can Perform (C011) Lauren Moy MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Botulinum Toxin Video Instruction and Live Panel Discussion (C013) Ada R. Trindade Almeida MD IFAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Botulinum Toxin Video Instruction and Live Panel Discussion (C013) Michael Kane MD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Botulinum Toxin Video Instruction and Live Panel Discussion (C013) Susan H. Weinkle MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Andre Vieira Braz MD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) DiAnne Davis MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Jeanette Black MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Jeremy Green MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Jody A. Comstock MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Michael Somenek MD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Rohit Kakar MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Sabrina G. Fabi MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Shino Bay Aguilera DO FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses Face Off Evidence-Based Debates on Today’s Hottest Injectable Controversies (C009) Susan H. Weinkle MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Andre Vieira Braz MD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Neil S. Sadick MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Robert A. Weiss MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Ronda S. Farah MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Sabrina G. Fabi MD FAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Suleima Arruda MD IFAAD.mp4\u003c\/p\u003e\n\u003cp\u003eCourses The Future of Cosmetic Dermatology (C012) Valeria Campos MD IFAAD.mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions A Clinician’s Perspective- Commentaries From the Journal of the American Academy of Dermatology (U022).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Addressing Unmet Needs in Diverse Populations- Therapeutic, Aesthetic, and Investigational Approaches (U029).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Allies and Bystanders (U086).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Dermatologic Infections in the Immunocompromised Host (U010).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Dermatoses of Infancy (U095).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Diagnostic Lessons Learned (U034).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions GI Skin- Cutaneous Manifestations of Gastrointestinal Inflammatory Disorders (U105).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Great Cases From My Files (U067).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Hair Transplantation (U094).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions High-Yield Updates in DRESS syndrome (U024).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Hyperhidrosis (U027).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Immunodermatology- Immunology for Dermies (U088).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Improving Cost Efficiency in Your Practice- Application of Six Sigma and Motorola-Toyota Product System Tools (U073).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Knowing Lichenoid Dermatoses- Common Pathways and Treatments (U046).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Medical Dermatology Potpourri- Challenges Faced and Lessons Learned (U100).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Medical Problems with Cosmetic Overtones (U083).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Merging Behavioral Health and Pediatric Dermatologic Care (U028).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Merkel Cell Carcinoma- Diagnosis, Management, and Controversies (U020).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Mistakes Happen- Best Practices for Disclosing Medical Errors to Patients (U104).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Multimodal Cosmetic Treatments- What to Combine When and How (U049).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Navigating Unchartered Waters- The Management of Autoimmune \u0026amp; Inflammatory Skin Disorders in Pregnant and Breastfeeding Patients (U102).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Neonatal Inpatient Consults (U053).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Opportunistic Infections and Drug Rashes Oh My- Managing the Cutaneous Complications of Solid Organ Transplantation (U009).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Pearls from Complex Mohs (U076).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Prurigo Nodularis (U019).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Staging, Work-up and Management of High Risk Cutaneous Squamous Cell Carcinoma (U103).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Sunlight- Friend or Foe (U066).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions The Evolving Toolbox for Treating Difficult Warts (U085).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Understanding the Skin Barrier (U060).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Vasculitis (U039).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions Welcome to the Jungle- Plant Dermatoses and Plant Extracts in Dermatology (U036).mp4\u003c\/p\u003e\n\u003cp\u003eFocus Sessions What to Do When Patch Testing is Negative (U059).mp4\u003c\/p\u003e\n\u003cp\u003eForum Dermoscopy for the Non-dermoscopist (F081) MD.mp4\u003c\/p\u003e\n\u003cp\u003eForum Malignant Melanoma- Molecular Diagnostics, Emerging Therapies, and the Microbiome (F096).mp4\u003c\/p\u003e\n\u003cp\u003eForum Navigating Prior Authorization in Dermatology- Challenges, Innovations, and Solutions (F091).mp4\u003c\/p\u003e\n\u003cp\u003eForum “Choose Your Own Adventure”- Crowdsourcing for the Management of Complex and Refractory Pediatric Dermatology Cases (F085).mp4\u003c\/p\u003e\n\u003cp\u003eSymposiums Psoriasis- Modern Therapeutic Approaches (S023) MD FAAD.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405728633028,"sku":null,"price":71.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Academy-of-Dermatology-Association-Annual-Meeting-2025.webp?v=1784215427"},{"product_id":"docmeded-2025-sru-annual-meeting-connecting-minds-advancing-ultrasound","title":"DocmedED 2025 SRU Annual Meeting Connecting Minds Advancing Ultrasound","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists, radiology fellows, radiology residents, scientists engaged in the advancement of ultrasound, and sonographers\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMaterial contained in this product was captured during the live 2024 SRU Annual Meeting.\u003c\/p\u003e\n\u003cp\u003eTarget Audience ▼\u003c\/p\u003e\n\u003cp\u003eThis activity is designed to educate radiologists, radiology fellows, radiology residents, scientists engaged in the advancement of ultrasound, and sonographers. It should also be of benefit to those physicians who order sonographic studies.\u003c\/p\u003e\n\u003cp\u003eScientific Sponsor ▼\u003c\/p\u003e\n\u003cp\u003eEducational Symposia\u003c\/p\u003e\n\u003cp\u003eEducational Objectives ▼\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this teaching activity, you should be able to:\u003c\/h3\u003e\n\u003cp\u003eLearn emerging ultrasound techniques and updates to reporting systems related to ultrasound.\u003c\/p\u003e\n\u003cp\u003eDiscuss uses of contrast-enhanced ultrasound in the performance of diagnostic and interventional procedures.\u003c\/p\u003e\n\u003cp\u003eEnhance non-interpretive skills within your ultrasound practice and improve efficiency.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e3D Ultrasound of Fetal Anomalies\u003c\/p\u003e\n\u003cp\u003eBiliary\u003c\/p\u003e\n\u003cp\u003eCalf Pain\u003c\/p\u003e\n\u003cp\u003eCEUS in the Interventional Suite\u003c\/p\u003e\n\u003cp\u003eCEUS LI-RADS Updates\u003c\/p\u003e\n\u003cp\u003eCreate and Send Out a Podcast for Teaching Ultrasound\u003c\/p\u003e\n\u003cp\u003eDemystifying the US Evaluation of the TIPS Shunt\u003c\/p\u003e\n\u003cp\u003eDifficult Cases: Maximizing the Radiology\/Endocrinology Team\u003c\/p\u003e\n\u003cp\u003eEndometriosis, it’s Everywhere: Find it the SRU Consensus Way\u003c\/p\u003e\n\u003cp\u003eFemale Pelvis\u003c\/p\u003e\n\u003cp\u003eFloor of the Mouth, Keep Looking Up\u003c\/p\u003e\n\u003cp\u003eHead and Neck\u003c\/p\u003e\n\u003cp\u003eHernias\/Groin Pain\u003c\/p\u003e\n\u003cp\u003eHow I Craft a PowerPoint Lecture\u003c\/p\u003e\n\u003cp\u003eHow to Evolve the Role of an Advanced Sonographer\u003c\/p\u003e\n\u003cp\u003eHow to Get Your Paper Published From an Author’s Perspective\u003c\/p\u003e\n\u003cp\u003eHow to Get Your Paper Published From an Editor’s Perspective\u003c\/p\u003e\n\u003cp\u003eHow to Implement Ultrasound Machine Protocols Linked to Dictation Templates\u003c\/p\u003e\n\u003cp\u003eI’ll Take Gynecologic US for $400″: Testing Your Diagnostic Skills Jeopardy Style\u003c\/p\u003e\n\u003cp\u003eI’m Only Here for O-RADS: Pearls and Pitfalls\u003c\/p\u003e\n\u003cp\u003eInflammatory Arthritis Assessment in Ultrasound\u003c\/p\u003e\n\u003cp\u003eInnovations in US of the Adnexa: Applications of CEUS\u003c\/p\u003e\n\u003cp\u003eInterpretation of HD Mapping and AVF US\u003c\/p\u003e\n\u003cp\u003eInterventional\u003c\/p\u003e\n\u003cp\u003eIt’s Me, Hydronephrosis, I’m the Problem, It’s Me\u003c\/p\u003e\n\u003cp\u003eLessons Learned After a Lifetime in Ultrasound\u003c\/p\u003e\n\u003cp\u003eLive CEUS Demo – Demystifying Bubbles\u003c\/p\u003e\n\u003cp\u003eLiver\u003c\/p\u003e\n\u003cp\u003eLiver Lesions: How I Do It (Panel Discussion)\u003c\/p\u003e\n\u003cp\u003eLumps and Bumps\u003c\/p\u003e\n\u003cp\u003eLymphatic Mapping with Contrast-enhanced Ultrasound\u003c\/p\u003e\n\u003cp\u003eMSK\u003c\/p\u003e\n\u003cp\u003eNeck Imaging with Multimodality Correlation\u003c\/p\u003e\n\u003cp\u003eNeonatal Brain\u003c\/p\u003e\n\u003cp\u003eNeonatal Spine\u003c\/p\u003e\n\u003cp\u003eNon-GYN Findings on GYN US – Think Outside the Box\u003c\/p\u003e\n\u003cp\u003eOB\u003c\/p\u003e\n\u003cp\u003ePanel Discussion – CEUS in Practice\u003c\/p\u003e\n\u003cp\u003eParathyroid Imaging: Hiding in Plain Sight\u003c\/p\u003e\n\u003cp\u003ePediatric After Hours Emergencies\u003c\/p\u003e\n\u003cp\u003ePediatric Breast\u003c\/p\u003e\n\u003cp\u003ePediatric Head and Neck\u003c\/p\u003e\n\u003cp\u003ePediatric MSK\u003c\/p\u003e\n\u003cp\u003ePediatrics\u003c\/p\u003e\n\u003cp\u003ePee-kaboo: Uncovering Genitourinary Infections by Ultrasound\u003c\/p\u003e\n\u003cp\u003ePeer Learning in the Pelvis: Commonly Missed Cases\u003c\/p\u003e\n\u003cp\u003ePenile Ultrasound: Evaluation of Structure and Function\u003c\/p\u003e\n\u003cp\u003ePeripheral Arterial Disease with Bypass Grafts\/Stents\u003c\/p\u003e\n\u003cp\u003ePost-Pregnancy Uterus\u003c\/p\u003e\n\u003cp\u003ePost-surgical Neck Evaluation\u003c\/p\u003e\n\u003cp\u003eProblem Solving in Gallbladder US with Contrast\u003c\/p\u003e\n\u003cp\u003ePrompt Engineering – The New Buzzword!\u003c\/p\u003e\n\u003cp\u003eQuantitative Ultrasound: Measuring Liver Fat (A Scientist’s Perspective)\u003c\/p\u003e\n\u003cp\u003eRenal\u003c\/p\u003e\n\u003cp\u003eRenal CEUS\u003c\/p\u003e\n\u003cp\u003eRenal Transplant\u003c\/p\u003e\n\u003cp\u003eRevisiting the Carotid Stenosis Criteria\u003c\/p\u003e\n\u003cp\u003eRobust and Reproducible CEUS Perfusion Quantification of Liver Lesions\u003c\/p\u003e\n\u003cp\u003eScrotal\u003c\/p\u003e\n\u003cp\u003eSecond and Third Trimester Emergency Ultrasound\u003c\/p\u003e\n\u003cp\u003eSoft Tissue Masses and Dermatology\u003c\/p\u003e\n\u003cp\u003eSRUF Seed Grant: Cerebral Microvascular Imaging in Neonatal Extracorporeal Membrane Oxygenation\u003c\/p\u003e\n\u003cp\u003eSRUF Seed Grant: Phantom-Based Validation of Ultrasound Liver Fat Quantification Tools\u003c\/p\u003e\n\u003cp\u003eSucceed as an Academic Teleradiologist\u003c\/p\u003e\n\u003cp\u003eThat Was Then, This Is Now: Cases Implementing the SRU 1st Trimester US Lexicon\u003c\/p\u003e\n\u003cp\u003eThe Alphabet Soup of Infertility Imaging: SIS, HyCoSy, PCOS\u003c\/p\u003e\n\u003cp\u003eThe Porta Hepatis: You Only See What You Look For\u003c\/p\u003e\n\u003cp\u003eThyroid Nodules – Making Sense of Borderline Cases\u003c\/p\u003e\n\u003cp\u003eTips, Tricks, and Challenges in Upper Abdominal Doppler\u003c\/p\u003e\n\u003cp\u003eTIRADS Updates\u003c\/p\u003e\n\u003cp\u003eTransplant\u003c\/p\u003e\n\u003cp\u003eUltrasound of Nerve Entrapment Syndromes\u003c\/p\u003e\n\u003cp\u003eUS Guided Therapies for Benign Thyroid Findings\u003c\/p\u003e\n\u003cp\u003eUS of the Postprocedure Uterus: Cesarean Section, IUD, Ablation and More\u003c\/p\u003e\n\u003cp\u003eVascular\u003c\/p\u003e\n\u003cp\u003eVascular Lumps and Bumps\u003c\/p\u003e\n\u003cp\u003eWaveforms Explained\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405728796868,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/DocmedED-2025-SRU-Annual-Meeting-Connecting-Minds-Advancing-Ultrasound.jpg?v=1784215429"},{"product_id":"harvard-pulmonary-and-critical-care-medicine-2025","title":"Harvard Pulmonary and Critical Care Medicine 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pulmonologists, critical care physicians, internists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eComprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases\u003c\/p\u003e\n\u003cp\u003ePulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.\u003c\/p\u003e\n\u003cp\u003eOVERVIEW\u003c\/p\u003e\n\u003ch3\u003eThis comprehensive course provides education and updates to optimize your care of patients with:\u003c\/h3\u003e\n\u003cp\u003eIPF\u003c\/p\u003e\n\u003cp\u003eARDS\u003c\/p\u003e\n\u003cp\u003eSarcoidosis\u003c\/p\u003e\n\u003cp\u003eLung transplantation\u003c\/p\u003e\n\u003cp\u003eBronchiectasis\u003c\/p\u003e\n\u003cp\u003eCystic fibrosis\u003c\/p\u003e\n\u003cp\u003eLung nodules\u003c\/p\u003e\n\u003cp\u003eLung cancer\u003c\/p\u003e\n\u003cp\u003eSepsis\u003c\/p\u003e\n\u003cp\u003ePleural disease\u003c\/p\u003e\n\u003cp\u003ePneumonia\u003c\/p\u003e\n\u003cp\u003eTuberculosis\u003c\/p\u003e\n\u003cp\u003eThromboembolism\u003c\/p\u003e\n\u003cp\u003eChronic cough\u003c\/p\u003e\n\u003cp\u003eCOPD\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eOccupational and environmental lung disease\u003c\/p\u003e\n\u003cp\u003eInterstitial lung disease\u003c\/p\u003e\n\u003cp\u003eGERD\u003c\/p\u003e\n\u003cp\u003eNeurologic issues in the ICU\u003c\/p\u003e\n\u003cp\u003eSleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003ePost-acute sequelae of COVID-19\u003c\/p\u003e\n\u003cp\u003eSurgical emergencies\u003c\/p\u003e\n\u003cp\u003eAtypical mycobacterial disease\u003c\/p\u003e\n\u003cp\u003ePulmonary hypertension\u003c\/p\u003e\n\u003cp\u003eCardiopulmonary disorders\u003c\/p\u003e\n\u003cp\u003eComplications from cardiac arrest\u003c\/p\u003e\n\u003cp\u003eHypersensitivity pneumonitis\u003c\/p\u003e\n\u003cp\u003eAcute respiratory failure\u003c\/p\u003e\n\u003cp\u003eREASONS TO ATTEND IN 2025\u003c\/p\u003e\n\u003ch3\u003eAll sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:\u003c\/h3\u003e\n\u003cp\u003eThe most current guidelines for treating sepsis\u003c\/p\u003e\n\u003cp\u003eEvidence-based treatment of ARDS\u003c\/p\u003e\n\u003cp\u003eState of the art in interventional pulmonology\u003c\/p\u003e\n\u003cp\u003eHigh-flow oxygen therapy for respiratory failure\u003c\/p\u003e\n\u003cp\u003eUpdates on biologics in asthma and other lung disease\u003c\/p\u003e\n\u003cp\u003eNew concepts in the use of vasopressors in septic shock\u003c\/p\u003e\n\u003cp\u003eNew drugs and combinations in pulmonary hypertension\u003c\/p\u003e\n\u003cp\u003eNew evidence on sedation, analgesia, and early mobility in the ICU\u003c\/p\u003e\n\u003cp\u003ePoint-of-care pulmonary ultrasound in the intensive care unit\u003c\/p\u003e\n\u003cp\u003eLung microbiome: emerging implications for lung health\u003c\/p\u003e\n\u003cp\u003eEmerging evidence for targeted temperature management\u003c\/p\u003e\n\u003cp\u003eEvaluating occupational and environmental lung disease\u003c\/p\u003e\n\u003cp\u003eSteroid-sparing agents for interstitial lung disease\u003c\/p\u003e\n\u003cp\u003ePulmonary embolus: the latest treatment strategies\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management of the critically ill patient\u003c\/p\u003e\n\u003cp\u003eGuidance to conduct end-of-life discussions\u003c\/p\u003e\n\u003cp\u003eUpdates in pulmonary pathology\u003c\/p\u003e\n\u003cp\u003eNew treatment options in cystic fibrosis\u003c\/p\u003e\n\u003cp\u003eHandling neurologic and surgical emergencies in the medical ICU\u003c\/p\u003e\n\u003cp\u003eNew approaches that improve outcomes for patients with unexplained chronic cough\u003c\/p\u003e\n\u003cp\u003eParticipants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.\u003c\/p\u003e\n\u003cp\u003eOptional Half-Day Program\u003c\/p\u003e\n\u003cp\u003e(No additional fees apply)\u003c\/p\u003e\n\u003cp\u003eSleep Medicine for Pulmonologists\u003c\/p\u003e\n\u003cp\u003eThis sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.\u003c\/p\u003e\n\u003cp\u003eOffered on Friday afternoon, May 2, participants of Pulmonology and Critical Care Medicine 2025 can participate in this half-day program at no additional cost.\u003c\/p\u003e\n\u003ch3\u003eHighlights of this practical, interactive educational experience include:\u003c\/h3\u003e\n\u003cp\u003eUpdates for diagnosis and management of sleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management algorithms\u003c\/p\u003e\n\u003cp\u003eNew technologies vs. the “gold standard” polysomnogram\u003c\/p\u003e\n\u003cp\u003eReimbursement and telemedicine\u003c\/p\u003e\n\u003cp\u003eImproved adherence to therapy\u003c\/p\u003e\n\u003cp\u003eParticipants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.\u003c\/p\u003e\n\u003cp\u003eInterventional Pulmonology\u003c\/p\u003e\n\u003ch3\u003eThis course covers advances in interventional pulmonology:\u003c\/h3\u003e\n\u003cp\u003eDiagnostic procedures\u003c\/p\u003e\n\u003cp\u003eTherapeutic interventions\u003c\/p\u003e\n\u003cp\u003eAs an alternative to surgery\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003ePulmonologists\u003c\/p\u003e\n\u003cp\u003eCritical Care Physicians\u003c\/p\u003e\n\u003cp\u003eInternists\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eResidents and Fellows\u003c\/p\u003e\n\u003cp\u003eSleep Medicine for Pulmonologists\u003c\/p\u003e\n\u003cp\u003eOptional Half-Day Program\u003c\/p\u003e\n\u003cp\u003eUpdates for diagnosis and management of sleep-disordered breathing\u003c\/p\u003e\n\u003cp\u003eState-of-the-art management algorithms\u003c\/p\u003e\n\u003cp\u003eNew technologies vs. the “gold standard” polysomnogram\u003c\/p\u003e\n\u003cp\u003eReimbursement and telemedicine\u003c\/p\u003e\n\u003cp\u003eImproved adherence to therapy\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 GERD in Pulmonology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 GERD in Pulmonology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Looking Deeper Patterns and Insights from Chest Radiology.pptx\u003c\/p\u003e\n\u003cp\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Pulmonary Pathology Interstitial Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Q \u0026amp; A Session with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Q \u0026amp; A Session with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to Empiric Antibiotics in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to Empiric Antibiotics in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Approach to the Immunocompromised Critically Ill Patient.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Fluid Responsiveness.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Fluid Responsiveness.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Novel Ventilator Modes The Hype and the Reality.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Vasopressors in Septic Shock Old Friends and New.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Advanced Cardiac Support in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Advanced Cardiac Support in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Neurologic Issues in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Neurologic Issues in the ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 New Approaches to the Unexplained Chronic Cough.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 New Approaches to the Unexplained Chronic Cough.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Occupational and Environmental Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Occupational and Environmental Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Palliative Care in Advanced Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Palliative Care in Advanced Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prognosis and Uncertainty in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Surgical Emergencies in the Medical ICU.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Surgical Emergencies in the Medical ICU.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 The Microbiome and Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 The Microbiome and Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 TTM and Neuroprognostication After Cardiac Arrest.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Aspergillus Lung Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Aspergillus Lung Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Asthma What’s New in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Asthma What’s New in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 COPD 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 COPD 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Interventional Pulmonology in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Pleural Disease 2025 Updates.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Pleural Disease 2025 Updates.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Q \u0026amp; A with Speakers 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Q \u0026amp; A with Speakers 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Tuberculosis in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Tuberculosis in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Complex Sleep Apnea 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Noninvasive Ventilation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Obstructive Sleep Apnea.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Embolism An Update.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Hypertension Categorization and Evaluation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Pulmonary Hypertension Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Sleep Diagnostics.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Vasculitis and ANCA.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Vasculitis and ANCA.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5.mp4\u003c\/p\u003e\n\u003cp\u003ePulmonary Schedule.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729747140,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Pulmonary-and-Critical-Care-Medicine-2025.png?v=1784215435"},{"product_id":"society-of-critical-care-medicine-congress-digital-2025","title":"Society of Critical Care Medicine Congress Digital 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: critical care medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Congress Digital\u003c\/p\u003e\n\u003cp\u003eSCCM’s Critical Care Congress highlights extraordinary advances being made in the treatment of critically ill and injured patients.\u003c\/p\u003e\n\u003cp\u003eGain access to recorded sessions from the in-person event plus bonus content through Congress Digital!\u003c\/p\u003e\n\u003cp\u003eYou can expect the latest knowledge, research, and strategies for optimizing care as provided by the multiprofessional team.\u003c\/p\u003e\n\u003cp\u003e175+ expert-led sessions on an array of clinical topics\u003c\/p\u003e\n\u003cp\u003e120+ Accredited continuing education credits (home study) and maintenance of certification points\u003c\/p\u003e\n\u003cp\u003eLearning with flexibility, the perfect fit for busy clinicians\u003c\/p\u003e\n\u003cp\u003eThe Society of Critical Care Medicine (SCCM) Congress Digital 2025 is designed for healthcare professionals involved in critical care medicine. This includes physicians, nurses, pharmacists, respiratory therapists, researchers, and other specialists who work in intensive care units (ICUs), emergency medicine, anesthesiology, and related fields. The event aims to provide cutting-edge research, clinical insights, and networking opportunities for those dedicated to improving patient outcomes in critical and intensive care settings\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCongress Digital Only Sessions 1 AKI in Patients With Cirrhosis Acute Disease Quality Initiative and International Club of Ascites Report From the Joint Multidisciplinary Meeting.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 102 Pharmacologic Therapy for Acute RV Failure.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 103 RV Mechanical Circulatory Support Devices.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 104 Complexity of Hemodynamic Assessment During Shock in Cirrhosis.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 105 Acute Kidney Injury in Cirrhosis Think Broadly and Exclude Other Causes Before Anchoring to Hepatorenal Syndrome.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 107 Stratification of Management Approach Based on Ventriculoarterial Coupling in Patients With Cirrhosis and Circulatory Shock.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 11 Beyond the Antiarrhythmics.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 113 Something Is Wrong With My Heparin! It Won’t Anticoagulate.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 114 Why Do I Have Clot in My ECMO Circuit..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 116 Using Biomarkers to Guide Antimicrobial Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 117 Machine Learning as a Tool for Sepsis Detection.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 118 Update on the Advanced Burn Life Support Resuscitation Guidelines.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 119 What’s New in Burn Resuscitation Monitoring.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 12 Pharmacotherapeutic Challenges in the Perioperative Period Preventing and Treating Arrhythmia.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 123 Threat Levels.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 125 The Art of Defusion.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 129 What Happened to Bronchiolitis Season..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 130 Noninvasive Ventilation as Preoxygenation to Prevent Hypoxemia During Tracheal Intubation.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 131 Does True Rapid Sequence Intubation With Neuromuscular Blockade Decrease Complications During Tracheal Intubation..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 132 Ensuring Health Equity and Predicting Functional Outcomes After a Devastating Event.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 134 Approaches to Withdrawal of Life Supports in the United States and Abroad.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 14 DISH, DRESS, and Retiform Purpura.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 16 Cultural and RacialEthnic Trauma in the ICU Causes and Effects.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 17 Well-Being Strategies to Mitigate Cultural and RacialEthnic Trauma in the ICU Faculty did not submit audio, only slides.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 18 Extracorporeal Support for Respiratory and Cardiovascular Illness in the Obstetric Population.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 19 New American College of Obstetrics and Gynecology Guidelines on Transfusion During Cesarean Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 2 Education, Training, and Advocacy in Pediatric AKI and Kidney Support Therapy The Latest Recommendations From the Pediatric ADQI.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 20 Amniotic Fluid Embolism Pathophysiology, Clinical Presentation, New Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 21 Peripartum Cardiomyopathy What’s New.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 22 How Do We Know That Sepsis Care Is Inequitable.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 23 The Root Causes of Inequitable Sepsis Care.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 24 Latent Class Analysis.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 25 Target Trial Emulation Study Design.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 26 Implementation Science.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 27 CLABSIs.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 28 Unplanned Extubations.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 29 Venous Thromboembolism.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 32 Initial Evaluation of the Critically Ill Traveler.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 36 Prevalence of Falling and Fear of Falling in ICU Survivors.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 37 Impact of Social Needs and Social Determinants of Health on Outcomes of ICU Survivors.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 38 Screening, Evaluation, and Referrals in an ICU Recovery Clinic.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 4 Women in Critical Care Where Are We Faculty did not submit audio, slides only.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 40 Return to Work and Return to Driving After ICU Admission.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 41 Rapid Screening for Chronic Cardiac Disease Using Pattern Recognition An EASy Approach.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 42 Stump the Intensivist! Sepsis Cases With POCUS Diagnostic Difficulties.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 43 Avoiding Resuscitation Traps in Patients With Preexisting Pulmonary Hypertension.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 44 Ensuring Adequate Perfusion and Avoiding Complications of Resuscitation When the Pump Is Not Pumping.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 45 One Size Does Not Fit All Fluid Management in Patients With Diastolic Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 47 How to Convince the ICU Team to Yield the Steering Wheel.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 48 Rehab Isn’t All Walking Around the Hospital, We Need Exergames to Tailor to Patient Interests.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 5 Toward the Glass Ceiling How Were the Moves Made.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 50 How to Modify Healthcare Systems in Facilitating the Change From a Patient’s Itinerary to a Tailored Trajectory.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 51 TEE for hemodynamic and procedural guidance in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 52 TEE in Cardiopulmonary Resuscitation.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 54 To Prophylax or Not to Prophylax, That Is the Question.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 55 What Is Different in Pediatrics..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 56 Neuroprognostication in Cardiac Arrest.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 57 We Can Provide Cardiopulmonary Support Indefinitely . . . Should We..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 58 When Is the Appropriate Time to Consult Palliative Care..mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 6 Breaking Through! Barriers to the Advancement of Women in Critical Care Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 60 The Impact of Regionalization of Pediatric Inpatient Care on Healthcare Access for U.S. Children.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 61 New Paradigms in Transplant.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 62 Working in the Night Shortens Your Happiness.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 64 Hospitals Are 24 7 Operations.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 66 Mechanical Circulatory Support in Obstetric Cardiovascular Emergencies.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 7 Asthma Exasperation Management of Patients Who Are Failing Standard Therapies.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 74 Recent Advances in Treatment of C difficile Infections.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 75 Advancements in Diagnostic Methods and Best Practices for Preventing C difficile Infections.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 76 You Have to Know How to Use a PA Catheter in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 77 Do you Ever Need a PA catheter. No, You Can Use Something Else.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 78 Clinical Impact and Barriers to Proper Sleep in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 79 Rocking the Patient Back to Sleep Nonpharmacologic Options for Sleep Faculty did not submit audio, only slides.pdf\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 8 Clinical Pearls BD DNC Testing.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 80 Prescribing and Deprescribing to Get Some Good Sleep in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 84 Managing Sodium Disorders in Patients With Brain Injury.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 85 How to Interpret and Treat Patients With Thyroid Alterations in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 9 Controversies Legal and Ethical Conflicts Around BD DNC.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 95 Evolution of Telecritical Care Multidisciplinary Teams.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 98 The Obesity Paradox.mp4\u003c\/p\u003e\n\u003cp\u003eCongress Digital Only Sessions 99 Drug Dosing in Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 10 Is Plasticity a Brain Benefit..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 101 Plasma Power Advanced Biomarkers in Early Detection of Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 108 Variation in Corticosteroid Prescribing Practices for Patients With Septic Shock.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 11 Sex and Adaptation for Kidney Injury.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 110 State of the Profession.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 111 Recruitment and Retention of Respiratory Therapists in Critical Care.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 112 Opportunities for Respiratory Therapists in Critical Care Research.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 114 Epidemiology and Outcomes of Inhalation Injury in Children.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 115 Airway Management in Inhalation Injury.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 116 What to Do When Things Get Worse Despite Normal Inhalation Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 12 Epidemiology and Initial Management for Critical Care Rheumatology.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 121 Medical Optimization as Bridge to Transplant.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 122 Management of Acute Kidney Injury During ACLF.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 123 The Changing Epidemiology of Pediatric Critical Care Access, Delivery, and Outcomes in the United States.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 128 Dealing With Contrarian Mindsets and Oppositional Defiant Personalities.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 129 Clinical Practice Guidelines for Pediatric Critical Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 13 Vasculitis Emergencies.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 130 Pharmacologic Management of Pediatric Critical Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 131 Initial Presentation and Management of Pediatric Critical Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 132 Nonpharmacologic Management of Pediatric Critical Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 137 Critical Priorities for Data in Critical Care.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 138 A Path to AI RCTs for Clinical Decision Support.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 139 Tools for Becoming AI Ready.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 14 Advanced Management of Rheumatologic Emergencies in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 140 Pediatric Considerations in Data Science.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 141 Hemodynamic Management in Sepsis and End Points in Resuscitation.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 142 Does the Site of Infection Matter..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 143 Tailoring Antibiotics in Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 149 Rationale Behind Vasopressor Selection and Utilization.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 15 Navigating Rheumatologic Treatments in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 154 Using Cognitive Load Theory to Measure Workload and Impact on Burnout.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 155 Cognitive Overload During ICU Multidisciplinary Rounds.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 156 Nursing Workload and Its Impact on ICU Culture and Performance.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 159 Please, This Kid Is Too Much for the Floor.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 160 Sure, the Docs Agree, but What About the People at the Bedside..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 162 The Impact of professional education on health disparities.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 165 What Is the Right Type of Research in LMICs..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 167 Where Do We Start With AI and Research in Global Outreach Critical Care Medicine..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 17 Frailty, Comorbidities, and Delirium, Oh My! Addressing Complexity in the Older Trauma Patient.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 170 Leveraging AI and the EMR to Mitigate Diagnostic Error.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 171 Whole Blood or Components..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 172 Diagnostics and Evaluation of Coagulopathy.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 173 Complications of Transfusions.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 174 Contextualizing the Agents and Use Cases for Opioid Use Disorder.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 175 Untangling Pain, Withdrawal, Abuse, and Addiction.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 176 Amplifying the Analgesic Palette for Pain Management.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 178 What Has Neuromonitoring Taught Us About Mechanisms of Brain injury in Pediatric ECMO..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 183 Exracorporeal Support Beyond CRRT in Children With ALF.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 184 Special Considerations for Nutrition in Children With Liver Failure.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 187 Redefining the Intensivist.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 188 Defining the Core Knowledge and Skills of Every Intensivist.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 189 The RRT Does Not Need a Doc.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 19 The Goldilocks of Dosing.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 190 The RRT Does Need a Doc.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 191 The Role and Potential Treatment of Endothelial Activation and Dysfunction in Shock.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 192 The Role and Potential Treatment of Metabolic Mitochondrial Dysfunction in Shock.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 193 The Role and Potential Treatment of Systemic Inflammation in Shock.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 20 Feed the Beast AKI Is Not a Barrier to the Gut.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 21 Kidney Support Therapy Is More Than RRT.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 22 Acid, Base, Fluid, and More.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 23 Guiding Principles for Data Harmonization and Standardization in Critical Care.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 24 Discovery Core Critical Care Data Dictionary (C2D2) with Common Data Elements.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 25 W.H.O Registries.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 26 Bioinformatics to Build a Learning Healthcare System.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 28 Using LHSs to Generate Evidence and Improve Quality, Safety, and Equity in Pediatric Care.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 29 Overcoming Language and Cultural Barriers in the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 3 Updates in Antibiotic Breakpoints.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 32 How to Continue to Draw Physicians Into Critical Care and Maintain Diversity.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 33 How Do We Best Prepare APPs for a Career in the ICU..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 4 Interpretation and Application of Antibiotic Breakpoints to Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 45 Environmental Aspects of the ICU That Cause Sleep and Circadian Dysregulation and the Current Evidence to Improve Them.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 46 What Is Known About the Impact of the ICU on MT Levels and the Circadian Rhythms of Critically Ill Adults and Children..mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 51 The Structure of Clinical Data and How Information Flies.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 52 Data Extraction From Clinical Data Sources.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 53 Discovery’s Data Science Campaign Data Harmonization Efforts.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 55 Clinician Reports of Barriers to Engaging Patients and Families in Research.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 6 How Families and Caregivers Can Help With Prevention and treatment of ICU Delirium.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 61 Management of Mechanical Ventilation After Initiation of VV ECMO.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 62 Waking and Mobilizing Patients Requiring VV ECMO.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 69 Unveiling the Future Harnessing Artificial Intelligence to Improve the ICU Experience.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 7 Preventing Delirium in Older Adults Admitted to the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 72 Novel Therapeutics for ECMO Anticoagulation.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 73 Novel Monitoring for ECMO Anticoagulation.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 74 Novel ECMO Designs to Minimize Bleeding and Clotting.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 76 Global Critical Care in a War Zone.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 77 Sustainability in Global Critical Care Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 78 Approaches to Provision of Palliative Care in the ICU for Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 79 Advance Care Planning in Older ICU Patients with Dementia.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 8 The Age Spectrum of Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 84 ICU Sustainability in Japan.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 85 European Initiatives in Green Critical Care.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 87 Panel Discussion and Closing Remarks.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 9 The Rx Axis by Age and Sex.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 90 The Goldilocks of TTM and Potential Exceptions to the Rule.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 92 Is all mobility beneficial. Differentiating Effective vs. Harmful Mobility Practices.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 93 Focused Adult USG Guidelines Update.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 96 Potential Solutions in International PICU Research.mp4\u003c\/p\u003e\n\u003cp\u003eOne-Hour Sessions from Live Congress 97 Challenges to Research in the Pediatric ICU.mp4\u003c\/p\u003e\n\u003cp\u003eSymposia 1 Key Information From ADQI Expert Consensus Guidelines on AKI in Cirrhosis.mp4\u003c\/p\u003e\n\u003cp\u003eSymposia 2 Pretransplant Management of Multiorgan Failure in ACLF Cirrhosis.mp4\u003c\/p\u003e\n\u003cp\u003eSymposia 3 Peritransplant and Posttransplant ICU Management.mp4\u003c\/p\u003e\n\u003cp\u003eThought Leader Sessions from Live Congress 1 2025 SCCM Congress Opening Session and Presidential Address.mp4\u003c\/p\u003e\n\u003cp\u003eTwo-Hour Sessions from Live Congress 1 The Relationship Between Autoimmune Disease and Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eTwo-Hour Sessions from Live Congress 2 Immunomodulation in Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eTwo-Hour Sessions from Live Congress 6 POCUS in ARDS.mp4\u003c\/p\u003e\n\u003cp\u003eTwo-Hour Sessions from Live Congress 8 Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 1 Hector R. Wong Award for Precision Medicine in Sepsis Presentation.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 10 Association of Fluid Volume with uNGAL as a Biomarker of Kidney Injury in Pediatric Septic Shock.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 11 Rapid Improvement in Airway Safety using a Model of Continuous Improvement.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 12 Psychosocial risk screening for parent posttraumatic stress symptoms post PICU discharge.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 13 Determining Caregivers’ Logic in Saying No to Research (DECLINE).pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 14 Psychological Outcomes of Family Caregivers During Hospitalization of ECMO Survivors.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 15 The Relationship between Social Determinants of Health and PICU Delirium.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 19 Photobiomodulation in the Treatment of Acute Traumatic Brain Injury.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 2 SCCM Early Stage Research Award Presentation.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 20 The Impact of CPR Duration on Neurological Outcomes in IHCA Patients Classified by NEWS..mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 22 Metabolomic Changes with Acetate and Butyrate Supplementation After Controlled Cortical Impact.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 23 Predicting early seizures in children hospitalized after mild to moderate traumatic brain injury.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 24 ICP responsivity, a Metric to Evaluate Cerebrovascular Dynamics in Pediatric Traumatic Brain Injury.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 25 Early Acute Kidney Injury Prediction in Two Multicenter Datasets- Designing for Implementation.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 27 Low Prevalence of New Mental Health Visits following PICU Admission- A Multi-Institution Study.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 28 End Tidal Alveolar Dead Space Fraction Calculated with Venous PCO2 is Associated with Mortality Risk.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 29 Association Between Sepsis Recognition Compliance and Pediatric Sepsis Outcomes in the PICU.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 31 A Multicenter Comparison of Cisatracurium vs Atracurium in Acute Respiratory Distress Syndrome.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 32 Impact of a Pharmacy Intervention on Medication Errors During Transition out of the ICU.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 33 Multimodal analgesic prescribing in U.S. adults after an ICU hospitalization for major surgery.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 35 Risk Factors for Thromboischemic Complications after Andexanet Alfa Reversal of Factor Xa Inhibitors.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 36 Pediatric severe sepsis proteome associates with inborn error of immunity related variant genotype.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 37 Small Molecule Drugs for the Treatment of Lethal Sepsis in a Rat Model.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 4 Gold Medal Award Presentation.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 40 Optimizing Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Trauma Patients.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 43 Predictors of Weaning Failure in Asthma Exacerbation Mechanically Ventilated Patients.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 44 Functional Cardiac Output Using Ventilation Approximates Cardiac Output in a Pig Endotoxemia Model.pdf\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 45 Industry Insight Sessions.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 5 Silver Medal Award Presentation.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 6 Bronze Medal Award Presentation.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 7 Characterization of Sepsis Cardiomyopathy in a Nonhuman Primate Model of Sepsis.mp4\u003c\/p\u003e\n\u003cp\u003eUnaccredited Education Sessions 8 Combination of Endotoxin Activity and SOFA Defines Severity in Septic Shock.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405729943748,"sku":null,"price":143.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Society-of-Critical-Care-Medicine-Congress-Digital-2025.png?v=1784215436"},{"product_id":"american-society-for-radiation-oncology-annual-refresher-course-2025","title":"American Society for Radiation Oncology Annual Refresher Course 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiation oncologists, radiation oncology residents, medical and clinical physicists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThe meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this  activity, participants should be able to do the following:\u003c\/h3\u003e\n\u003cp\u003eDescribe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.\u003c\/p\u003e\n\u003cp\u003eSafely utilize the latest radiation technologies to improve patient care.\u003c\/p\u003e\n\u003cp\u003eDescribe the data and clinical use of protons and heavy ions in the management of patients.\u003c\/p\u003e\n\u003cp\u003eAppropriately and safely incorporate the treatment of oligometastases into clinical practice.\u003c\/p\u003e\n\u003cp\u003eDescribe the management of benign diseases with radiation.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eHead and Neck\u003c\/p\u003e\n\u003cp\u003eGynecologic: Endometrial and Cervical\u003c\/p\u003e\n\u003cp\u003ePhysics: Protons and Heavy Ions\u003c\/p\u003e\n\u003cp\u003eGastrointestinal: Upper and Lower\u003c\/p\u003e\n\u003cp\u003eeContouring for Upper GI\u003c\/p\u003e\n\u003cp\u003eCentral Nervous System\u003c\/p\u003e\n\u003cp\u003eLung\u003c\/p\u003e\n\u003cp\u003eRadiobiology of Benign Disease\u003c\/p\u003e\n\u003cp\u003eBreast\u003c\/p\u003e\n\u003cp\u003eeContouring for Breast\u003c\/p\u003e\n\u003cp\u003eGenitourinary\u003c\/p\u003e\n\u003cp\u003eOligometastatic Cancers and SBRT\u003c\/p\u003e\n\u003cp\u003eSarcomas\u003c\/p\u003e\n\u003cp\u003eLymphomas\u003c\/p\u003e\n\u003cp\u003eeContouring for Lymphomas\u003c\/p\u003e\n\u003cp\u003ePediatrics\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405730369732,"sku":null,"price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-for-Radiation-Oncology-Annual-Refresher-Course-2025.png?v=1784215438"},{"product_id":"american-roentgen-ray-society-annual-meeting-2025","title":"American Roentgen Ray Society Annual Meeting 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: radiologists, abdominal imaging, emergency radiologists, musculoskeletal radiologists, neuroradiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe American Roentgen Ray Society (ARRS) Annual Meeting 2025 is a premier event for radiology professionals, offering a year’s worth of education in one place. Here are some key details:\u003c\/h3\u003e\n\u003cp\u003eLocation: Marriott Marquis San Diego Marina, San Diego, California\u003c\/p\u003e\n\u003cp\u003eFormat: In-person and online, with on-demand access to sessions through May 1, 2026\u003c\/p\u003e\n\u003cp\u003eSessions: Over 100 sessions and 200+ CME opportunities led by expert radiologists\u003c\/p\u003e\n\u003cp\u003eTopics Covered: Abdominal Imaging, Artificial Intelligence, Breast Imaging, Chest Imaging, Quality Improvement, and more\u003c\/p\u003e\n\u003ch3\u003eThe American Roentgen Ray Society (ARRS) Annual Meeting 2025 is designed for radiology professionals seeking to advance their expertise. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eGeneral Diagnostic Imaging Specialists\u003c\/p\u003e\n\u003cp\u003eAbdominal Imaging Experts\u003c\/p\u003e\n\u003cp\u003eEmergency Radiologists\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal Radiologists\u003c\/p\u003e\n\u003cp\u003eBreast Imaging Specialists\u003c\/p\u003e\n\u003cp\u003eNeuroradiologists\u003c\/p\u003e\n\u003cp\u003eCardiothoracic Imaging Experts\u003c\/p\u003e\n\u003cp\u003eNuclear Medicine Physicians\u003c\/p\u003e\n\u003cp\u003ePediatric Imaging Specialists\u003c\/p\u003e\n\u003cp\u003eInterventional Radiologists\u003c\/p\u003e\n\u003cp\u003eThis event attracts over 2,500 radiologists between the live and virtual programming, offering comprehensive education and networking opportunities\u003c\/p\u003e\n\u003cp\u003e2025 ARRS Annual Meeting in San Diego\u003c\/p\u003e\n\u003cp\u003eThe general Annual Meeting registration provides registrants with access to more than 136 educational sessions\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAbdominal Imaging\u003c\/p\u003e\n\u003cp\u003eArtificial Intelligence\u003c\/p\u003e\n\u003cp\u003eBreast Imaging\u003c\/p\u003e\n\u003cp\u003eCardiac\u003c\/p\u003e\n\u003cp\u003eChest\u003c\/p\u003e\n\u003cp\u003eEmergency Radiology\u003c\/p\u003e\n\u003cp\u003eGastrointestinal\u003c\/p\u003e\n\u003cp\u003eGeneral Radiology\u003c\/p\u003e\n\u003cp\u003eGenitourinary\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal\u003c\/p\u003e\n\u003cp\u003eNeuroradiology\u003c\/p\u003e\n\u003cp\u003eNuclear Medicine\u003c\/p\u003e\n\u003cp\u003ePediatric\u003c\/p\u003e\n\u003cp\u003eQuality in Practice\u003c\/p\u003e\n\u003cp\u003eUltrasound\u003c\/p\u003e\n\u003cp\u003eVascular\/Interventional\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405730926788,"sku":null,"price":338.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Roentgen-Ray-Society-Annual-Meeting-2025.png?v=1784215443"},{"product_id":"meetings-by-mail-cleveland-clinic-24th-annual-pain-management-symposium-2025","title":"Meetings By Mail Cleveland Clinic 24th Annual Pain Management Symposium 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: anesthesia providers and interventional pain specialists, orthopedic and spine surgeons, neurologists, neurosurgeons, primary care physician\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: 4\/15\/25\u003c\/p\u003e\n\u003cp\u003eTopics include: spinal procedures, joint replacement pain, chronic interventions, regulatory and ethical challenges, pharmacological treatments, neuromodulation, PRP, stem cells, persistent spinal syndromes, opioids, marijuana, special populations, focused nurse sessions and much more!\u003c\/p\u003e\n\u003ch3\u003eThe Cleveland Clinic 24th Annual Pain Management Symposium 2025 is designed for healthcare professionals specializing in pain management and related fields. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eAnesthesia providers and interventional pain specialists.\u003c\/p\u003e\n\u003cp\u003ePhysical medicine and rehabilitation specialists.\u003c\/p\u003e\n\u003cp\u003eOrthopedic and spine surgeons.\u003c\/p\u003e\n\u003cp\u003eNeurologists and neurosurgeons.\u003c\/p\u003e\n\u003cp\u003eHeadache and palliative care specialists.\u003c\/p\u003e\n\u003cp\u003ePrimary care physicians managing chronic pain.\u003c\/p\u003e\n\u003cp\u003ePhysician assistants, nurse practitioners, and residents\/fellows interested in pain medicine.\u003c\/p\u003e\n\u003cp\u003eThe symposium covers state-of-the-art pain management techniques, including interventional and non-interventional approaches, neuromodulation, and the impact of expanded marijuana use on pain treatment.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e\n\u003cp\u003eSession 1 ACDF vs. ACDA What’s the Evidence.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Artificial Intelligence and Pain Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Closed Loop Spinal Cord Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Guidelines for Use of Corticosteroids for Chronic Pain Interventions.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Infection Control Guidelines for Chronic Pain Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Percutaneous Cervical Spine Procedures Guidelines, Technical Aspects and Safety.mp4\u003c\/p\u003e\n\u003cp\u003eSession 1 Persistent Pain After Joint Replacement Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Advocacy in Pain Medicine At the Table or On the Menu.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Private Equity and Pain Practice Challenges, Opportunities and Threats.mp4\u003c\/p\u003e\n\u003cp\u003eSession 2 Unethical Behavior as Encountered by the State Medical Board.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Basivertebral Nerve Ablation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Interspinous Spacers.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Intradiscal Biologics for the Treatment of Chronic Discogenic Low Back Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Minimally Invasive Sacroiliac Joint Fusion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Nav 1.8 Inhibitors.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 3 Percutaneous Thermal Radiofrequency Ablation of Spinal Metastases.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Dorsal Root Ganglion Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 High Frequency Bioelectric Nerve Block.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 High Frequency.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Intrathecal Drug Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Long Term Outcomes of Closed Loop Spinal Cord Stimulation.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Neuromodulation Peripheral Stimulation for Low Back Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 4 Peripheral Nerve Stimulation, Patient Selection, Technique and Pitfalls.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Evaluating the Patient With Sacroiliac Joint Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Evidence Based Approach to Infectious Complications of Neuromodulation Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Navigating Difficult Patient Interactions in Patients With Chronic Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 6 Topical Capsaicin.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Platelet Rich Plasma.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Regulatory Considerations in Regenerative Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eSession 7 Stem Cells.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Keeping it Bipedal Biomechanics of Sagittal and Coronal Balance.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Panel Discussion.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Pseudoarthrosis.mp4\u003c\/p\u003e\n\u003cp\u003eSession 8 Vertebrogenic and Discogenic Pain.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Low Dose Naltrexone for Pain Management.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Optimizing Interventional Therapy Referrals.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Optimum and Appropriate Use of Urine Drug Screening in Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003eSession 9 Setting Patient Expectations for Interventional Procedures.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Pain in CRPS.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Pain in the Geriatric Population.mp4\u003c\/p\u003e\n\u003cp\u003eSession 10 Thoracic Outlet Syndrome.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Acute Pain Management in the Chronic Marijuana User.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Chronic Pain Management in Opioid Misuse Disorders.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Current Opioid Landscape and CDC Prescribing Guidelines.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Marijuana Between Fantasies and Realities.mp4\u003c\/p\u003e\n\u003cp\u003eSession 11 Panel Discussion.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405731877060,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Meetings-By-Mail-Cleveland-Clinic-24th-Annual-Pain-Management-Symposium-2025.jpg?v=1784215447"},{"product_id":"uscap-annual-meeting-long-course-keeping-it-real-merging-traditional-and-contemporary-practices-in-musculoskeletal-pathology-2025","title":"USCAP Annual Meeting Long Course Keeping it Real Merging Traditional and Contemporary Practices in Musculoskeletal Pathology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: April 14, 2025\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eProvide a practical overview of updated diagnostic criteria of existing neoplasms and newly described entities that have emerged since 2013, emphasizing those that are more likely to impact patient management.\u003c\/p\u003e\n\u003cp\u003eDiscuss important advances in ancillary testing techniques that are anticipated to improve our prognostic and diagnostic capabilities for bone and soft tissue tumors.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEmerging Molecular-defined Bone and Soft Tissue Diagnoses- When do they matter.pdf\u003c\/p\u003e\n\u003cp\u003eEmerging Molecular-defined Bone and Soft Tissue Diagnoses- When do they matter.ts\u003c\/p\u003e\n\u003cp\u003eGiant Cell Rich Tumors of Bone and Soft Tissue.pdf\u003c\/p\u003e\n\u003cp\u003eGiant Cell Rich Tumors of Bone and Soft Tissue.ts\u003c\/p\u003e\n\u003cp\u003eMethylation Profiles in Bone and Soft Tissue Tumors. Does it Help Classify the Unclassifiable.pdf\u003c\/p\u003e\n\u003cp\u003eMethylation Profiles in Bone and Soft Tissue Tumors. Does it Help Classify the Unclassifiable.ts\u003c\/p\u003e\n\u003cp\u003eNeoplastic and Non-Neoplastic Lesions of the Synovium.pdf\u003c\/p\u003e\n\u003cp\u003eNeoplastic and Non-Neoplastic Lesions of the Synovium.ts\u003c\/p\u003e\n\u003cp\u003eReplacing Molecular Testing with Next-Generation Immunohistochemistry- I Can Diagnose that Soft Tissue Tumor with a Single Antibody.pdf\u003c\/p\u003e\n\u003cp\u003eReplacing Molecular Testing with Next-Generation Immunohistochemistry- I Can Diagnose that Soft Tissue Tumor with a Single Antibody.ts\u003c\/p\u003e\n\u003cp\u003eUnraveling Round Cell Sarcomas – A Contemporary Diagnostic Guide Beyond Ewing Sarcoma.pdf\u003c\/p\u003e\n\u003cp\u003eUnraveling Round Cell Sarcomas – A Contemporary Diagnostic Guide Beyond Ewing Sarcoma.ts\u003c\/p\u003e\n\u003cp\u003eUpdates in Non-neoplastic Bone Pathology- Common Problems and Pitfalls and How to Avoid Them.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Non-neoplastic Bone Pathology- Common Problems and Pitfalls and How to Avoid Them.ts\u003c\/p\u003e\n\u003cp\u003eUpdates in Peripheral Nerve Sheath and Adipocytic Tumors.pdf\u003c\/p\u003e\n\u003cp\u003eUpdates in Peripheral Nerve Sheath and Adipocytic Tumors.ts\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732171972,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Annual-Meeting-Long-Course-Keeping-it-Real-Merging-Traditional-and-Contemporary-Practices-in-Musculoskeletal-Pathology-2025.png?v=1784215453"},{"product_id":"ucsf-radiology-annual-review-2025","title":"UCSF Radiology Annual Review 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWebinar Live\u003c\/p\u003e\n\u003cp\u003eDate: Monday, April 28, 2025 to Friday, May 2, 2025\u003c\/p\u003e\n\u003cp\u003eCourse Director: Soonmee Cha MD\u003c\/p\u003e\n\u003cp\u003eCourse Number: RAD25024\u003c\/p\u003e\n\u003cp\u003eCOURSE HIGHLIGHTS\u003c\/p\u003e\n\u003cp\u003e• Five full-day sessions Monday thru Friday (Pacific Time)\u003c\/p\u003e\n\u003cp\u003e• Covers all major subspecialties and imaging modalities\u003c\/p\u003e\n\u003cp\u003e• Includes didactic lectures, rapid-fire cases, and multiple-choice questions\u003c\/p\u003e\n\u003cp\u003e• Bonus lectures on essential physics, safety, and non-interpretive skills\u003c\/p\u003e\n\u003cp\u003e• Over 40 UCSF Radiology faculty from all subspecialties\u003c\/p\u003e\n\u003cp\u003eOVERVIEW\u003c\/p\u003e\n\u003cp\u003eto the radiologist on-call and in-training\u003c\/p\u003e\n\u003cp\u003eOBJECTIVES\u003c\/p\u003e\n\u003ch3\u003eAt the completion of this course, the attendee should be able to:\u003c\/h3\u003e\n\u003cp\u003e1. Identify imaging fundamentals of each of the radiology sub-specialties (organ systems);\u003c\/p\u003e\n\u003cp\u003e2. Prescribe the appropriate utilization of imaging modalities (CT, MR, US, PET, Mammography) for different medical conditions;\u003c\/p\u003e\n\u003cp\u003e3. Implement the appropriate imaging protocols for routine clinical presentations;\u003c\/p\u003e\n\u003cp\u003e4. Recognize indications and markers for interventional procedures, as well as assessment of outcomes;\u003c\/p\u003e\n\u003cp\u003e5. Apply classifications of pathophysiological mechanisms underlying human disease to facilitate differential diagnosis;\u003c\/p\u003e\n\u003cp\u003e6. Refine imaging criteria to optimize image quality\/findings and improve diagnostic interpretation.\u003c\/p\u003e\n\u003cp\u003eRadiologists and Physicians (MD\/DO)\u003c\/p\u003e\n\u003cp\u003eRadiologic Technologists\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eAdvanced Practice Professionals\u003c\/p\u003e\n\u003cp\u003eRadiologists in Training\u003c\/p\u003e\n\u003cp\u003eThe course covers major subspecialties like GI, GU, Thoracic, Breast, Neuro, MSK, US\/ObGyn, and Pediatrics, along with modalities such as CT, MR, and Ultrasound. It also includes essentials for Interventional Radiology, Nuclear Medicine, and Safety\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1 Bowel and Abdomen.pdf\u003c\/p\u003e\n\u003cp\u003e2 Rapid Fire Pancreatic CORE Cases.pdf\u003c\/p\u003e\n\u003cp\u003e3 Liver Disease.pdf\u003c\/p\u003e\n\u003cp\u003e4 Biliary Tract.pdf\u003c\/p\u003e\n\u003cp\u003e5 Splenic Masses.pdf\u003c\/p\u003e\n\u003cp\u003e6 Mesentery.pdf\u003c\/p\u003e\n\u003cp\u003e7 Fluoroscopy.pdf\u003c\/p\u003e\n\u003cp\u003e8 Benign Gynecologic Disease.pdf\u003c\/p\u003e\n\u003cp\u003e9 Malignant Gynecologic Disease.pdf\u003c\/p\u003e\n\u003cp\u003e10 Rapid Fire Renal CORE Cases.pdf\u003c\/p\u003e\n\u003cp\u003e11 Renal \u0026amp; Adrenal Masses.pdf\u003c\/p\u003e\n\u003cp\u003e12 Bladder, Prostate, Urethra.pdf\u003c\/p\u003e\n\u003cp\u003e13 Rapid-fire Cases GIGU.pdf\u003c\/p\u003e\n\u003cp\u003e14 Rapid-fire Cases Ultrasound.pdf\u003c\/p\u003e\n\u003cp\u003e15 Congenital Cardiac Anomalies \u0026amp; Post-repair.pdf\u003c\/p\u003e\n\u003cp\u003e16 Patterns of Lung Diseases.pdf\u003c\/p\u003e\n\u003cp\u003e17 Pleura \u0026amp; Mediastinal Masses.pdf\u003c\/p\u003e\n\u003cp\u003e18 Lung CA and Metastases.pdf\u003c\/p\u003e\n\u003cp\u003e19 Imaging of Airways Disease.pdf\u003c\/p\u003e\n\u003cp\u003e20 Rapid Fire Cases Chest X-rays.pdf\u003c\/p\u003e\n\u003cp\u003e21 Masses \u0026amp; Asymmetries.pdf\u003c\/p\u003e\n\u003cp\u003e22 Calcifications.pdf\u003c\/p\u003e\n\u003cp\u003e23 Palpable Lumps.pdf\u003c\/p\u003e\n\u003cp\u003e24 Breast MRI.pdf\u003c\/p\u003e\n\u003cp\u003e25 Breast US.pdf\u003c\/p\u003e\n\u003cp\u003e26 Rad-Path Correlation.pdf\u003c\/p\u003e\n\u003cp\u003e27 Rapid Fire Breast Cases.pdf\u003c\/p\u003e\n\u003cp\u003e28 Multiple-Choice Galore.pdf\u003c\/p\u003e\n\u003cp\u003e29 Rapid-Fire Pediatric GI.pdf\u003c\/p\u003e\n\u003cp\u003e30 Rapid-Fire Pediatric CORE Cases.pdf\u003c\/p\u003e\n\u003cp\u003e31 Pediatric Emergencies.pdf\u003c\/p\u003e\n\u003cp\u003e32 Pediatric Genitourinary Diseases.pdf\u003c\/p\u003e\n\u003cp\u003e33 Neurovascular anatomy Normal \u0026amp; malformations.pdf\u003c\/p\u003e\n\u003cp\u003e34 Cerebrovascular Diseases Infarcts \u0026amp; Hemorrhages.pdf\u003c\/p\u003e\n\u003cp\u003e35 Brain Tumors and Mimics.pdf\u003c\/p\u003e\n\u003cp\u003e36 Pediatric Neuro Diseases.pdf\u003c\/p\u003e\n\u003cp\u003e37 Head \u0026amp; Neck Primer.pdf\u003c\/p\u003e\n\u003cp\u003e38 Degenerative Spinal Diseases.pdf\u003c\/p\u003e\n\u003cp\u003e39 Spinal Cord Tumors.pdf\u003c\/p\u003e\n\u003cp\u003e40 Rapid Fire Core Cases.pdf\u003c\/p\u003e\n\u003cp\u003e42 Liver Renal Doppler.pdf\u003c\/p\u003e\n\u003cp\u003e43 Abdominal (GI) US Cases What you need to know.pdf\u003c\/p\u003e\n\u003cp\u003e44 Uterus \u0026amp; Adnexa US.pdf\u003c\/p\u003e\n\u003cp\u003e45 1st Trimester.pdf\u003c\/p\u003e\n\u003cp\u003e46 2nd \u0026amp; 3rd Trimesters.pdf\u003c\/p\u003e\n\u003cp\u003e47 Male GU.pdf\u003c\/p\u003e\n\u003cp\u003e48 US Q\u0026amp;A.pdf\u003c\/p\u003e\n\u003cp\u003e49 Rapid Fire Core Cases.pdf\u003c\/p\u003e\n\u003cp\u003e50 Ultrasound Technical Tips \u0026amp; Artifacts.pdf\u003c\/p\u003e\n\u003cp\u003e51 Radiology Safety CT MR Contrast.pdf\u003c\/p\u003e\n\u003cp\u003e52 Nuc Med Rapid Fire Cases.pdf\u003c\/p\u003e\n\u003cp\u003e53 Nuc Med Quality \u0026amp; Safety Part 1.pdf\u003c\/p\u003e\n\u003cp\u003e54 Nuc Med Quality \u0026amp; Safety Part 2.pdf\u003c\/p\u003e\n\u003cp\u003e55 Angiographic Anatomy.pdf\u003c\/p\u003e\n\u003cp\u003e56 Venous \u0026amp; Lymphatic Interventions.pdf\u003c\/p\u003e\n\u003cp\u003e57 Biliary, Renal \u0026amp; Oncologic Interventions.pdf\u003c\/p\u003e\n\u003cp\u003e58 Patient Care in IR Informed Consent Sedation Contrast Medication.pdf\u003c\/p\u003e\n\u003cp\u003e59 Nuc Med Part 1 GI GU MSK QA.pdf\u003c\/p\u003e\n\u003cp\u003e60 Nuc Med Part 2 Cardiac PET Thyroid.pdf\u003c\/p\u003e\n\u003cp\u003e61 Metabolic Disease.pdf\u003c\/p\u003e\n\u003cp\u003e62 Bone Tumor Cases.pdf\u003c\/p\u003e\n\u003cp\u003e63 Arthritis.pdf\u003c\/p\u003e\n\u003cp\u003e64 Trauma postop MSK.pdf\u003c\/p\u003e\n\u003cp\u003e65 Congenital Normal Variants.pdf\u003c\/p\u003e\n\u003cp\u003e66 Infection Bone Marrow.pdf\u003c\/p\u003e\n\u003cp\u003e67 Rapid Fire MSK Cases.pdf\u003c\/p\u003e\n\u003cp\u003eAgenda.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732335812,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-Radiology-Annual-Review-2025.jpg?v=1784215453"},{"product_id":"harvard-infectious-diseases-in-adults-2025","title":"Harvard Infectious Diseases In Adults 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eState-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions.\u003c\/p\u003e\n\u003cp\u003eOVERVIEW\u003c\/p\u003e\n\u003ch3\u003eThis comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:\u003c\/h3\u003e\n\u003cp\u003eOptimal decision-making in the prevention, diagnosis, and treatment of infectious diseases\u003c\/p\u003e\n\u003cp\u003eNewer antimicrobials and treatment strategies for highly resistant infections\u003c\/p\u003e\n\u003cp\u003ePrevention and treatment of infections in immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eUpdate on antifungal diagnostics and therapy\u003c\/p\u003e\n\u003cp\u003eState-of-the-art and multidisciplinary approaches to common infections\u003c\/p\u003e\n\u003cp\u003eClinical approaches to complex, rare, and “don’t-miss” infections\u003c\/p\u003e\n\u003cp\u003eNew, evolving, emerging, and re-emerging infectious diseases\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eWhat’s new in HIV prevention and management\u003c\/p\u003e\n\u003cp\u003eThe latest on COVID-19, including long COVID\u003c\/p\u003e\n\u003cp\u003eHighlights of the 2025 Program\u003c\/p\u003e\n\u003cp\u003eExpanded Case-Based and Problem-Solving Education\u003c\/p\u003e\n\u003ch3\u003eTreating Highly Resistant Infections, including:\u003c\/h3\u003e\n\u003cp\u003eMRSA and VISA (vancomycin-intermediate Staph aureus)\u003c\/p\u003e\n\u003cp\u003eExtended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods\u003c\/p\u003e\n\u003cp\u003eCarbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms\u003c\/p\u003e\n\u003cp\u003eVancomycin-resistant enterococci (VRE)\u003c\/p\u003e\n\u003cp\u003eAspergillus and non-aspergillus mold infections\u003c\/p\u003e\n\u003cp\u003eCandida auris\u003c\/p\u003e\n\u003cp\u003eNontuberculous mycobacteria (NTM)\u003c\/p\u003e\n\u003cp\u003eCommon Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment\u003c\/p\u003e\n\u003ch3\u003eUpdates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:\u003c\/h3\u003e\n\u003cp\u003eRespiratory viral infections, including COVID-19\u003c\/p\u003e\n\u003cp\u003eNew and updated vaccines\u003c\/p\u003e\n\u003cp\u003eInfections in the expanding populations of immunocompromised hosts\u003c\/p\u003e\n\u003cp\u003eInfections in persons with substance use disorder\u003c\/p\u003e\n\u003cp\u003eInfections of travelers and foreign-born persons\u003c\/p\u003e\n\u003cp\u003eSystemic fungal infections\u003c\/p\u003e\n\u003cp\u003eNative and device-related orthopedic infections\u003c\/p\u003e\n\u003cp\u003eCentral nervous system (CNS) infections\u003c\/p\u003e\n\u003cp\u003eEar, nose, and throat (ENT) and eye infections\u003c\/p\u003e\n\u003cp\u003eSkin and soft tissue infections\u003c\/p\u003e\n\u003cp\u003eBronchiectasis and pneumonia\u003c\/p\u003e\n\u003cp\u003eHIV and its infectious and noninfectious complications\u003c\/p\u003e\n\u003cp\u003ePEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection\u003c\/p\u003e\n\u003cp\u003eSexually transmitted infections (STIs), including mpox and PEP for prevention of STIs\u003c\/p\u003e\n\u003cp\u003eHepatitis B and C infections\u003c\/p\u003e\n\u003cp\u003eTick- and mosquito-borne infections\u003c\/p\u003e\n\u003cp\u003eClostridioides difficile infection\u003c\/p\u003e\n\u003cp\u003eComplicated urinary tract infections\u003c\/p\u003e\n\u003cp\u003eIntra-abdominal infections\u003c\/p\u003e\n\u003cp\u003eChallenging, Rare, and Emerging Infectious Diseases\u003c\/p\u003e\n\u003ch3\u003eComprehensive updates on:\u003c\/h3\u003e\n\u003cp\u003eRare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus\u003c\/p\u003e\n\u003cp\u003eRe-emergence of vaccine-preventable diseases, including poliomyelitis\u003c\/p\u003e\n\u003cp\u003ePulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus\u003c\/p\u003e\n\u003cp\u003eGlobal infectious diseases of clinical importance\u003c\/p\u003e\n\u003cp\u003eClinical Decision-Making\u003c\/p\u003e\n\u003ch3\u003eHear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:\u003c\/h3\u003e\n\u003cp\u003eSelecting the best antimicrobial and duration of treatment\u003c\/p\u003e\n\u003cp\u003eRapid detection and empiric treatment of life-threatening infectious diseases\u003c\/p\u003e\n\u003cp\u003eChoosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials\u003c\/p\u003e\n\u003cp\u003eOptimizing empiric antimicrobial therapy: what to start, and when to narrow or stop\u003c\/p\u003e\n\u003ch3\u003eOur multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:\u003c\/h3\u003e\n\u003cp\u003eAntimicrobial stewardship to prevent resistance and reduce cost\u003c\/p\u003e\n\u003cp\u003eInfection control to reduce transmission in health care settings\u003c\/p\u003e\n\u003cp\u003eEarly inpatient ID consultations to improve outcomes\u003c\/p\u003e\n\u003cp\u003eStrategies for management of infection in persons who inject drugs (PWID)\u003c\/p\u003e\n\u003cp\u003eOptimized for Remote Education\u003c\/p\u003e\n\u003cp\u003eThe 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.\u003c\/p\u003e\n\u003cp\u003eNew in 2025\u003c\/p\u003e\n\u003ch3\u003eThe 2025 program adds coverage of:\u003c\/h3\u003e\n\u003cp\u003eVaccine updates\u003c\/p\u003e\n\u003cp\u003eThe latest on respiratory viral infections\u003c\/p\u003e\n\u003cp\u003eInfectious disease outbreaks of concern: highly pathogenic avian flu and Marburg virus\u003c\/p\u003e\n\u003cp\u003eID and critical care\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003ch3\u003ePhysicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:\u003c\/h3\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eHospital Medicine\u003c\/p\u003e\n\u003cp\u003eInternal Medicine\u003c\/p\u003e\n\u003cp\u003eFamily Practice\u003c\/p\u003e\n\u003cp\u003ePulmonary and Critical Care Medicine\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine\u003c\/p\u003e\n\u003cp\u003e…and others who care for patients with infectious diseases\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Schedule.pdf\u003c\/p\u003e\n\u003cp\u003e2. Uyeki Plenary will not be recorded (please read).pdf\u003c\/p\u003e\n\u003cp\u003e3. CPC Embargo (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 An Antibiotic Allergy Toolkit.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 An Antibiotic Allergy Toolkit.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Antimicrobial Stewardship.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Antimicrobial Stewardship.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Infection Control 101 for the ID Clinician.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Infection Control 101 for the ID Clinician.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Introduction and Road Map Infectious Diseases of Adults.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Introduction and Road Map Infectious Diseases of Adults.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Live Q \u0026amp; A 4.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Panel Workshop #1 Resistant Gram-Positive Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Panel Workshop #2 Resistant Gram-Negative Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Plenary Highly Pathogenic Avian Influenza Uyeki Plenary will not be recorded (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Principles of Antimicrobial Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Principles of Antimicrobial Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Skin and Soft Tissue Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Skin and Soft Tissue Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Antifungal Diagnostics and Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Update on Antifungal Diagnostics and Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Bone and Joint Infections A Conceptual Framework.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Bone and Joint Infections A Conceptual Framework.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Encephalitis and Meningitis The Newest Guidelines and Best.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Encephalitis and Meningitis The Newest Guidelines and Best.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 New and Emerging Viruses.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 New and Emerging Viruses.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #3 Native Bone Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #3 Native Bone Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Staphylococcus aureus D‚j… Vu All Over Again.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Staphylococcus aureus D‚j… Vu All Over Again.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Advances in Viral Hepatitis HBV and HCV.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Advances in Viral Hepatitis HBV and HCV.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Critical Care ID.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Critical Care ID.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Endocarditis and Cardiac Device Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Endocarditis and Cardiac Device Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Live Q \u0026amp; A 4.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 The Syndemic of SUD and Infection Updated Approaches for 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 The Syndemic of SUD and Infection Updated Approaches for 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Flummoxing Cases in Fungal Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Flummoxing Cases in Fungal Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 1.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 2.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Live Q \u0026amp; A 3.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Navigating New Vaccines Updates and Recommendations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Navigating New Vaccines Updates and Recommendations.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 What’s New in the Care of People with HIV in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 What’s New in the Care of People with HIV in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Cases in Global Infectious Diseases.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Cases in Global Infectious Diseases.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Eye and ENT Infections What You Need to Know in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Eye and ENT Infections What You Need to Know in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Full Live.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Kim – Viral Hepatitis.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Embargo (please read).pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Presentation of Case – audience only.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 The Latest on Major Respiratory Viral Infections.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 The Latest on Major Respiratory Viral Infections.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Tuberculosis Update.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Tuberculosis Update.pdf\u003c\/p\u003e\n\u003cp\u003eHarvard CME _ Infectious Diseases in Adults.pdf\u003c\/p\u003e\n\u003cp\u003eNEJM CPC Embargo Notice.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732532420,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Infectious-Diseases-In-Adults-2025.jpg?v=1784215452"},{"product_id":"american-society-of-echocardiography-26th-annual-ascexam-reasce-review-course-2025","title":"American Society of Echocardiography 26th Annual ASCeXAM ReASCE Review Course 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: cardiologists, sonographer\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRelease Date: May 5, 2025\u003c\/p\u003e\n\u003cp\u003eCourse\/Activity Information\u003c\/p\u003e\n\u003ch3\u003eLearning Objectives:\u003c\/h3\u003e\n\u003ch3\u003eUpon completion of this course, participants should be better able to:\u003c\/h3\u003e\n\u003cp\u003eExplain the essential physical principles of cardiac ultrasound.\u003c\/p\u003e\n\u003cp\u003eRecognize common ultrasound artifacts and their genesis.\u003c\/p\u003e\n\u003cp\u003eEstimate systolic function using standard M-mode and 2D echocardiography, as well as newer modalities such as strain imaging and 3D echocardiography.\u003c\/p\u003e\n\u003cp\u003eIdentify and quantitate valvular heart disease severity.\u003c\/p\u003e\n\u003cp\u003eDescribe the application of Doppler in the assessment of hemodynamics and diastolic function.\u003c\/p\u003e\n\u003cp\u003ePerform clinically relevant calculations of valve areas and intracardiac pressures.\u003c\/p\u003e\n\u003cp\u003eExplain proven techniques for interpreting stress echocardiographic examinations.\u003c\/p\u003e\n\u003cp\u003eDifferentiate features of cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy.\u003c\/p\u003e\n\u003cp\u003eList appropriate applications of echocardiography.\u003c\/p\u003e\n\u003cp\u003eRecognize newer applications of echocardiography such as myocardial contrast.\u003c\/p\u003e\n\u003ch3\u003eAccreditation Statement:\u003c\/h3\u003e\n\u003cp\u003eThe American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\u003c\/p\u003e\n\u003cp\u003eSuccessful completion of this CME activity enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program and the American Board of Pediatrics (ABP) MOC program. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points.   Participants should claim only the credit commensurate with the extent of their participation in the activity. Physicians will earn MOC points equivalent to the amount of CME credits claimed for the activity.\u003c\/p\u003e\n\u003cp\u003eARDMS, CCI, and Sonography Canada recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.\u003c\/p\u003e\n\u003cp\u003eCardiologists\u003c\/p\u003e\n\u003cp\u003eFellows \/ Early Career Physicians\u003c\/p\u003e\n\u003cp\u003eHealthcare professionals preparing for the ASCeXAM certification exam\u003c\/p\u003e\n\u003cp\u003eThis course provides comprehensive cardiovascular ultrasound education, covering topics such as valvular heart disease, strain and 3D imaging, contrast echocardiography, ischemic heart disease, congenital heart disease, and more\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples Questions.mp4\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.mp4\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.pdf\u003c\/p\u003e\n\u003cp\u003eArtifacts Theory and Illustrative Examples.vtt\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.mp4\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.pdf\u003c\/p\u003e\n\u003cp\u003eBasic Ultrasound Physics.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eCardiac Masses \u0026amp; Cardiac Sources of Embolism.pdf\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D) Questions.mp4\u003c\/p\u003e\n\u003cp\u003eChamber Quantification Left Ventricle, Left Atrium, Aorta (2D \u0026amp; 3D).pdf\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.mp4\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.pdf\u003c\/p\u003e\n\u003cp\u003eCommonly Encountered Congenital Heart Disease in Adults.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eComplications of Myocardial Infarction Questions.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eConcepts of Imaging and Knobology Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eCongenital Heart Disease An Approach for Simple and Complex Anomalies Questions.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eContrast Echocardiography Questions.mp4\u003c\/p\u003e\n\u003cp\u003eCourse Outline.pdf\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.mp4\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.pdf\u003c\/p\u003e\n\u003cp\u003eDeformation Imaging.vtt\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDegenerative Mitral Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eDifferent Variants of Aortic Stenosis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 4.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Part 4.vtt\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta Questions.mp4\u003c\/p\u003e\n\u003cp\u003eDiseases of the Aorta.pdf\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEcho-Doppler Assessment of Right and Left Ventricular Hemodynamics.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Diastolic Function and Findings in Normal Aging.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Mitral Valve Prostheses.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiographic Evaluation of Pericardial Disease Constriction vs. Restriction.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Heart Failure, LVADs and Heart Transplant.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEchocardiography in Systemic Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis \u0026amp; Its Complications The Role of Echo – 16788464.vtt\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography Questions.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography.mp4\u003c\/p\u003e\n\u003cp\u003eEndocarditis and Its Complications The Role of Echocardiography.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eEvaluation of Aortic Prosthesis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eFunctional Mitral Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics Questions.mp4\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.mp4\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.pdf\u003c\/p\u003e\n\u003cp\u003eFundamentals in Doppler Physics.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass Questions.mp4\u003c\/p\u003e\n\u003cp\u003eGlobal \u0026amp; Regional Systolic Function Basics of Remodeling, Hypertrophy, \u0026amp; Left Ventricular Mass.pdf\u003c\/p\u003e\n\u003cp\u003eHand Held Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.mp4\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.pdf\u003c\/p\u003e\n\u003cp\u003eHand Held Echo.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eHemodynamic Assessment of Mitral Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eHow to Assess Aortic Stenosis Question.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy Questions.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.mp4\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.pdf\u003c\/p\u003e\n\u003cp\u003eHypertrophic Cardiomyopathy.vtt\u003c\/p\u003e\n\u003cp\u003eMitral Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis Questions.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.mp4\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.pdf\u003c\/p\u003e\n\u003cp\u003eMitral Stenosis.vtt\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.mp4\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.pdf\u003c\/p\u003e\n\u003cp\u003eMore Formulas I Know for the Exam.vtt\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications Questions.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.pdf\u003c\/p\u003e\n\u003cp\u003eNormal TEE Examination Applications, Pitfalls, Probe Insertion and Manipulation, Risks and Complications.vtt\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns Questions.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.mp4\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.pdf\u003c\/p\u003e\n\u003cp\u003eNormal TTE Examination, Doppler Echocardiography and Normal Antegrade Flow Patterns.vtt\u003c\/p\u003e\n\u003cp\u003eOverview of the ASCeXAM Exam.mp4\u003c\/p\u003e\n\u003cp\u003eOverview of the ASCeXAM Exam.vtt\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.mp4\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.pdf\u003c\/p\u003e\n\u003cp\u003ePregnancy and Heart Disease.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer of Interventional Echo.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 1.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.mp4\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.pdf\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Part 2.vtt\u003c\/p\u003e\n\u003cp\u003ePrimer on Fetal Echo Questions.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.pdf\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eQuantitation of Aortic Regurgitation Questions.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 1.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 1.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 2.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 2.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 3.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Part 3.vtt\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases Questions.mp4\u003c\/p\u003e\n\u003cp\u003eSpectral Doppler and M-Mode Echo Cases.pdf\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations Questions.mp4\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.mp4\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.pdf\u003c\/p\u003e\n\u003cp\u003eStress Echocardiography Theoretical and Practical Considerations.vtt\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart Questions.mp4\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.mp4\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.pdf\u003c\/p\u003e\n\u003cp\u003eThe Athlete’s Heart.vtt\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease Questions.mp4\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.mp4\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.pdf\u003c\/p\u003e\n\u003cp\u003eTricuspid and Pulmonary Valve Disease.vtt\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.mp4\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.pdf\u003c\/p\u003e\n\u003cp\u003eWhich Formulas Should I Know for the Exam.vtt\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405732827332,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Echocardiography-26th-Annual-ASCeXAM-ReASCE-Review-Course-2025.png?v=1784215454"},{"product_id":"harvard-emergency-medicine-updates-current-practices-2025","title":"Harvard Emergency Medicine Updates \u0026 Current Practices 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: emergency medicine physicians, primary care physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eJoin us for a dynamic one-week live-stream virtual postgraduate course hosted by the Massachusetts General Hospital (MGH) Department of Emergency Medicine. Designed for emergency physicians, specialty physicians, primary care doctors, physician assistants, nurse practitioners, nurses, and EMTs, this live-streaming course offers a unique opportunity to learn from leading experts in the field. Over the course of five days, you’ll delve into a comprehensive range of topics, including:\u003c\/h3\u003e\n\u003cp\u003e5 Tests to Consider Avoiding in Your PEM Patients: Why It’s Good for You And Good for Them\u003c\/p\u003e\n\u003cp\u003eAcute Compartment Syndromes\u003c\/p\u003e\n\u003cp\u003eAdvances in the Treatment of Ventricular Fibrillation and Sudden Cardiac Death\u003c\/p\u003e\n\u003cp\u003eApplying Systems Engineering and Innovation to Improve ED Patient Experience\u003c\/p\u003e\n\u003cp\u003eApproach to the Sick Trauma Patient\u003c\/p\u003e\n\u003cp\u003eARDS\u003c\/p\u003e\n\u003cp\u003eBurns\u003c\/p\u003e\n\u003cp\u003eCardiac Arrest\u003c\/p\u003e\n\u003cp\u003eCirculatory Shock Quiz Bowl\u003c\/p\u003e\n\u003cp\u003eConsiderations in Anticoagulation Reversal\u003c\/p\u003e\n\u003cp\u003eCritical Care Double Feature: Push-Dose Pressors, and Phenobarbital for Alcohol Withdrawal\u003c\/p\u003e\n\u003cp\u003eDiagnosis and Treatment of Pulmonary Embolism\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine Burnout\u003c\/p\u003e\n\u003cp\u003eEmergency Preparedness\u003c\/p\u003e\n\u003cp\u003eEscalation Alert: Best Practice Communication to Keep ED Staff and Patients Safe\u003c\/p\u003e\n\u003cp\u003eEye Emergencies\u003c\/p\u003e\n\u003cp\u003eFever POCUS Algorithm\u003c\/p\u003e\n\u003cp\u003eGeriatric Falls\u003c\/p\u003e\n\u003cp\u003eHand Emergencies\u003c\/p\u003e\n\u003cp\u003eManaging Critically Ill Patients with Septic Shock\u003c\/p\u003e\n\u003cp\u003eMild Head Trauma\u003c\/p\u003e\n\u003cp\u003eNecrotizing Soft Tissue Infection\u003c\/p\u003e\n\u003cp\u003eNeonatal Resuscitation\u003c\/p\u003e\n\u003cp\u003ePediatric Trauma \u0026amp; Concussion\u003c\/p\u003e\n\u003cp\u003ePhysiologically Difficult Airway Cases\u003c\/p\u003e\n\u003cp\u003ePoint-of-Care Ultrasound (EFAST, Cardiac, Lung, Procedures)\u003c\/p\u003e\n\u003cp\u003ePostpartum Hemorrhage\u003c\/p\u003e\n\u003cp\u003ePriapism Management\u003c\/p\u003e\n\u003cp\u003eReading Cardiac Ischemia on ECGs: the Basics\u003c\/p\u003e\n\u003cp\u003eScaling Humanitarian Aid, from Ebola to Ukraine\u003c\/p\u003e\n\u003cp\u003eSepsis Updates\u003c\/p\u003e\n\u003cp\u003eSexually Transmitted Infections\u003c\/p\u003e\n\u003cp\u003eShock and Awe: Six Strategies to Prevent Hemodynamic Collapse\u003c\/p\u003e\n\u003cp\u003eThe Digital Transformation of Emergency Medicine\u003c\/p\u003e\n\u003cp\u003eUpdates in Ischemic Stroke\u003c\/p\u003e\n\u003cp\u003eVirtual Observation: Lessons Learned From Redefining The Walls of the ED\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eEmergency Medicine Physicians\u003c\/p\u003e\n\u003cp\u003ePrimary Care Physicians\u003c\/p\u003e\n\u003cp\u003eOther Specialty Physicians\u003c\/p\u003e\n\u003cp\u003ePhysician Assistants\u003c\/p\u003e\n\u003cp\u003eNurse Practitioners\u003c\/p\u003e\n\u003cp\u003eNurses\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants will be able to:\u003c\/h3\u003e\n\u003cp\u003eIdentify underlying tachy-dysrhythmia.\u003c\/p\u003e\n\u003cp\u003eIdentify most up-to-date therapeutics for cardiac arrest.\u003c\/p\u003e\n\u003cp\u003eIntegrate the latest evidence-based practice strategies in treating patients with acute hemorrhagic stroke.\u003c\/p\u003e\n\u003cp\u003eUtilize latest evidence-based algorithms and strategies in management of PE and DVT.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2025 Final EMU Schedule.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 1. Hamid Shokoohi – Septic Shock Management.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 2. N Stuart Harris – Wilderness Medicine, High Altitude Illness.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 3. Suzanne Leslie – Postpartum Hemorrhage.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 4. Rob Sheridan – Burns.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 4.1 Burns (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 5. Jarone Lee – Supporting Humanitarian Disasters with Digital Health.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 6. Sayon Dutta – Predictive Model Evaluation.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 7. Donna Felsenstein – STIs.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 8. Raghu Seethala – Vasopressors and Shock.pdf\u003c\/p\u003e\n\u003cp\u003eApril 28 AM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eApril 28 PM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eApril 29 1. Mike Filbin – Sepsis Updates.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 2. Annette Ilg – Airway Advances.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 3. Shan Liu – Geriatric Falls.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 4. Jonathan Sonis – EMTALA Medical Screening Exams.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 5. Kevin Schwartz – Bronchiolitis What’s Known What’s New.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 6. Lauren Nentwich – ED Evaluation of Acute Psychiatric Complaints.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 7. Sean Kivlehan – Cardiac Arrest.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 8. Shuhan He – Clinical Informatics Emergency Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eApril 29 AM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eApril 29 PM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eApril 30 1. Nicole Duggan POCUS PIV and LP.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 2. POCUS – eFAST (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 3. Carrie Walsh – CME TTE and Lung POCUS.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 4. Sig Kharasch – Pediatric POCUS.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 5. Ben White – Patient Experience Session.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 6. Ben White – Innovation in Emergency Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 7. Operationalizing Health Equity in the ED (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 8. Peter Hou – ARDS.pdf\u003c\/p\u003e\n\u003cp\u003eApril 30 AM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eApril 30 PM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eMay 1 1. Frailty (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 2. Atypical Presentations of disease in older adults (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 3. Pierre Borczuk – Mild head trauma.pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 4. Keith Marill – Update on Ventricular Fibrillation Cardiac Arrest.pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 5. Kori Zachrison – Acute Stroke Updates.pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 6. Pulmonary Embolism (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 7. Paul Jansson – Push-Dose Pressors, Severe Alcohol Withdrawal.pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 8. Rama Salhi – Resuscitating the Sick and Dying Trauma Patient.pdf\u003c\/p\u003e\n\u003cp\u003eMay 1 AM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eMay 1 PM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eMay 2 1. Medical Jargon (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 2. Andrew Eyre – Scrotal Pain.pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 3. Social Determinants of Health Why Health Equity is the Business of Emergency Medicine (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 4. Environmental Impacts of Healthcare and What Emergency Physicians Can Do (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 5. Nicole Nadeau – What’s New in PEM Literature.pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 6. Current Practice in Newborn Fever (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 7. Acute Compartment Syndrome (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 8. EKG’s (coursemedicalshop.com created according to customer requirements).pdf\u003c\/p\u003e\n\u003cp\u003eMay 2 AM sessions.mp4\u003c\/p\u003e\n\u003cp\u003eMay 2 PM sessions.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405733843140,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}]},{"product_id":"association-for-molecular-pathology-molecular-genetic-pathology-review-course-2025","title":"Association for Molecular Pathology Molecular Genetic Pathology Review Course 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologists, geneticists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eJoin our faculty of molecular genetic pathology experts to prepare for a certification exam, earn continuing education credits, receive a refresher in molecular pathology core concepts, and stay up to date in the field. This virtual course will include didactic lectures, case studies, and opportunities for live question and answer sessions and in-depth discussions.\u003c\/p\u003e\n\u003cp\u003eLOCATION: Virtual online\u003c\/p\u003e\n\u003ch3\u003eObjectives:\u003c\/h3\u003e\n\u003cp\u003eTo assist attendees in preparing for the MGP Subspecialty Certification Exam (offered jointly by the American Board of Pathology and the American Board of Medical Genetics), as well as other certification exams in molecular pathology and molecular genetics, and\u003c\/p\u003e\n\u003cp\u003eTo enhance understanding of basic and applied molecular pathology knowledge of both fundamental and applied molecular pathology, including the use of commonly employed assays, as well as the molecular mechanisms underlying disease pathogenesis, diagnosis, prognosis, and treatment.\u003c\/p\u003e\n\u003cp\u003eParticipants should also be able to discuss the current molecular approaches to the diagnosis and prognosis of inherited diseases (including pharmacogenetics), molecular hematopathology, cytogenetics, solid and soft tissue tumors, molecular genetic testing of infectious diseases (including bacterial, fungal, viral, and parasitic pathogens), and DNA identity tests.\u003c\/p\u003e\n\u003ch3\u003eTopics:\u003c\/h3\u003e\n\u003cp\u003eMolecular Technologies and Lab Methods\u003c\/p\u003e\n\u003cp\u003eNGS Platforms and Informatics\u003c\/p\u003e\n\u003cp\u003eTest Validation, Statistics, and Bayes’ Theorem\u003c\/p\u003e\n\u003cp\u003eVariant interpretation\u003c\/p\u003e\n\u003cp\u003eIdentity Testing\u003c\/p\u003e\n\u003cp\u003eHLA Transplant Testing\u003c\/p\u003e\n\u003cp\u003eCytogenetics\u003c\/p\u003e\n\u003cp\u003eInherited Conditions\u003c\/p\u003e\n\u003cp\u003eMolecular Oncology\u003c\/p\u003e\n\u003cp\u003ePharmacogenomics\u003c\/p\u003e\n\u003cp\u003eMolecular Hematopathology\u003c\/p\u003e\n\u003cp\u003eInfectious Diseases\u003c\/p\u003e\n\u003cp\u003eLab Management and Lab Finances\u003c\/p\u003e\n\u003ch3\u003eTarget Audience:\u003c\/h3\u003e\n\u003ch3\u003ePathologists, geneticists, clinical laboratory directors, molecular pathology laboratory personnel, and trainees who:\u003c\/h3\u003e\n\u003cp\u003eThose preparing for relevant certification exams including but not limited MGP, LGG, ABCC, or ABB exams*\u003c\/p\u003e\n\u003cp\u003eThose seeking institutional credentialing\u003c\/p\u003e\n\u003cp\u003ePeople who are seeking a refresher in molecular pathology core concepts.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2 Technology Sanger Sequencing with Clinical Examples Kevin Fisher, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003e3 Identity Testing with Case Studies Jesse Cox, MD, PhD, A(ACHI).mp4\u003c\/p\u003e\n\u003cp\u003e4 Technology Nucleic Acid Amplification Techniques with Clinical Examples Eric Vail, MD.mp4\u003c\/p\u003e\n\u003cp\u003e5 NGS I Jason N. Rosenbaum, MD.mp4\u003c\/p\u003e\n\u003cp\u003e6 NGS II Jason N. Rosenbaum, MD.mp4\u003c\/p\u003e\n\u003cp\u003e7 Meet the Faculty Day 1.mp4\u003c\/p\u003e\n\u003cp\u003e9 Pharmacogenomics with Clinical Examples Ann Moyer, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003e10 NGS III Jason N. Rosenbaum, MD.mp4\u003c\/p\u003e\n\u003cp\u003e11 Cytogenetics I Chromosome Banding Analysis and FISH with Clinical Examples Adrian M. Dubuc, PhD, FACMG.mp4\u003c\/p\u003e\n\u003cp\u003e12 Cytogenetics II ‘Molecular’ Cytogenetic Approaches (Chromosomal Microarray ,Optical Genome Mapping, etc) with Clinical Examples Adrian M. Dubuc, PhD, FACMG.mp4\u003c\/p\u003e\n\u003cp\u003e13 Meet the Faculty Day 2.mp4\u003c\/p\u003e\n\u003cp\u003e14 Germline and Somatic Variant Interpretation with Clinical Examples Alanna Church, MD.mp4\u003c\/p\u003e\n\u003cp\u003e18 Germline Cancer Syndromes Diana Mandelker, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003e19 Meet the Faculty Day 3.mp4\u003c\/p\u003e\n\u003cp\u003e20 Molecular Oncology I with Clinical Examples Laura Tafe, MD.mp4\u003c\/p\u003e\n\u003cp\u003e21 Molecular Oncology II with Clinical Examples Laura Tafe, MD.mp4\u003c\/p\u003e\n\u003cp\u003e22 Molecular Oncology III with Clinical Examples Laura Tafe, MD.mp4\u003c\/p\u003e\n\u003cp\u003e23 Infectious Diseases I Overview of an Appropriate Infectious Diseases Molecular Menu and How It Should be Used with Clinical Examples Erin Graf, PhD, D(ABMM).mp4\u003c\/p\u003e\n\u003cp\u003e24 Infectious Diseases II Important Limitations and Stewardship Approaches to Infectious Disease Molecular Testing with Clinical Examples Erin Graf, PhD, D(ABMM).mp4\u003c\/p\u003e\n\u003cp\u003e25 Meet the Faculty Day 4.mp4\u003c\/p\u003e\n\u003cp\u003e26 Pattern Recognition in Myeloid Neoplasms with Clinical Examples Annette S. Kim, MD, PhD.mp4\u003c\/p\u003e\n\u003cp\u003e27 Molecular Pathology Pearls in Lymphoid Malignancies Rena Xian, MD.mp4\u003c\/p\u003e\n\u003cp\u003e28 HLA with Clinical Examples Ryan Pe¤a, MD, PhD, D(ABHI).mp4\u003c\/p\u003e\n\u003cp\u003e29 Key Molecular Laboratory Management Concepts that Impact Patient Care Erin Graf, PhD, D(ABMM).mp4\u003c\/p\u003e\n\u003cp\u003e30 Laboratory Finances Reimbursement, Laboratory Budgets and Implications for your Routine Practice Erin Graf, PhD, D(ABMM).mp4\u003c\/p\u003e\n\u003cp\u003e31 Meet the Faculty (includes closing remarks and adjournment).mp4\u003c\/p\u003e\n\u003cp\u003eAgenda – Association for Molecular Pathology.pdf\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734006980,"sku":null,"price":156.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Association-for-Molecular-Pathology-Molecular-Genetic-Pathology-Review-Course-2025.jpg?v=1784215462"},{"product_id":"harvard-updates-in-general-internal-medicine-for-specialists-2025","title":"Harvard Updates in General Internal Medicine for Specialists 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: internists, primary care physician, psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAdvances, Updates, Guidelines, and Best Practices in General Internal Medicine—Expressly for Specialists\u003c\/p\u003e\n\u003cp\u003eOverview\u003c\/p\u003e\n\u003cp\u003eIn this unique program, Harvard Medical School’s leading clinical faculty, representing more than 30 fields of medicine and surgery, share updates and provide recommendations to ensure you are current with the recent advances in both general internal medicine and select specialties. General Internal Medicine for Specialists covers the clinical breadth of internal medicine and the working knowledge specialists need in order to understand the most important advances outside your field of expertise.\u003c\/p\u003e\n\u003cp\u003eWhether you are a psychiatrist or pathologist, cardiologist or anesthesiologist, surgeon or hospitalist, you can rely on this program for updates and advances that impact day-to-day practice, clinical decisions, and patient care.\u003c\/p\u003e\n\u003cp\u003e2025 Updates, Strategies, and Tools to Improve Patient Care\u003c\/p\u003e\n\u003cp\u003eThe program’s curriculum provides broad and inclusive content ranging from clinical controversies to specific new and innovative therapies. General Internal Medicine for Specialists was developed by experienced practitioners, and sessions are presented by Harvard faculty and select guest speakers dedicated to peer-to-peer education. They will succinctly and effectively summarize material and provide focused updates, emphasizing specific recommendations for clinical practice and improved patient care.\u003c\/p\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003ch3\u003eTopics covered in the 2025 program include:\u003c\/h3\u003e\n\u003cp\u003eIschemic heart disease\u003c\/p\u003e\n\u003cp\u003eHepatitis\u003c\/p\u003e\n\u003cp\u003eStroke\u003c\/p\u003e\n\u003cp\u003eChronic obstructive lung disease\u003c\/p\u003e\n\u003cp\u003eDiabetes management\u003c\/p\u003e\n\u003cp\u003eMenopause management\u003c\/p\u003e\n\u003cp\u003eAnticoagulation\u003c\/p\u003e\n\u003cp\u003eNon-diabetes endocrinology\u003c\/p\u003e\n\u003cp\u003eCognitive decline\u003c\/p\u003e\n\u003cp\u003eCongestive heart failure\u003c\/p\u003e\n\u003cp\u003eCommon eye problems\u003c\/p\u003e\n\u003cp\u003eManagement of GI complaints\u003c\/p\u003e\n\u003cp\u003eBreast cancer risk\u003c\/p\u003e\n\u003cp\u003eRenal medicine\u003c\/p\u003e\n\u003cp\u003eSleep disorders\u003c\/p\u003e\n\u003cp\u003eBasic orthopedics\u003c\/p\u003e\n\u003cp\u003eAtrial fibrillation\u003c\/p\u003e\n\u003cp\u003eLipid management\u003c\/p\u003e\n\u003cp\u003eDisease prevention and health promotion\u003c\/p\u003e\n\u003cp\u003eOsteoporosis management\u003c\/p\u003e\n\u003cp\u003eAsthma\u003c\/p\u003e\n\u003cp\u003eProstate cancer\u003c\/p\u003e\n\u003cp\u003eColon cancer\u003c\/p\u003e\n\u003cp\u003eGenetic testing\u003c\/p\u003e\n\u003cp\u003eManaging obesity\u003c\/p\u003e\n\u003cp\u003eHeadaches\u003c\/p\u003e\n\u003cp\u003eAllergy medicine\u003c\/p\u003e\n\u003cp\u003eThyroid disorders\u003c\/p\u003e\n\u003cp\u003eHypertension\u003c\/p\u003e\n\u003cp\u003eCancer screening\u003c\/p\u003e\n\u003cp\u003eLower back pain\u003c\/p\u003e\n\u003ch3\u003eWhatever your specialty, you can rely on General Internal Medicine for Specialists for practical updates that ensure a working knowledge of current internal medicine practices and a familiarity with critical advances across a broad range of specialties. This program is designed to provide focused updates of general medicine topics for specialists, and to cover a vast amount of information efficiently and effectively, including:\u003c\/h3\u003e\n\u003cp\u003eCurrent guidelines and management strategies for diabetes, cardiovascular disease, lipid disorders, hypertension, chronic lung disease, sleep disturbances, cognitive decline\u003c\/p\u003e\n\u003cp\u003eStrategies for assessing and managing interacting comorbidities\u003c\/p\u003e\n\u003cp\u003ePotential adverse interactions between medications you prescribe and those prescribed by others\u003c\/p\u003e\n\u003cp\u003eFocused examination techniques in basic orthopedics\u003c\/p\u003e\n\u003cp\u003eWomen’s health topics\u003c\/p\u003e\n\u003cp\u003eUp-to-date therapies in cardiology, endocrinology, gastroenterology, neurology, oncology and more\u003c\/p\u003e\n\u003cp\u003eInter-specialty clinical decision-making\u003c\/p\u003e\n\u003cp\u003eThe most current evidence-based screening and prevention practices\u003c\/p\u003e\n\u003cp\u003eBreakthrough innovations with proven patient benefit\u003c\/p\u003e\n\u003cp\u003eHow medical practices can positively address health care inequities and disparities\u003c\/p\u003e\n\u003cp\u003eHow climate changes affect health\u003c\/p\u003e\n\u003cp\u003eLearn from the Best Clinical Faculty at Harvard Medical School\u003c\/p\u003e\n\u003cp\u003eThis program is led by active expert practitioners and committed teachers, each with extensive experience in the care of patients and in peer-to-peer presentations to colleagues. The Harvard faculty and select guest speakers will cover state-of-the-art advances and recommendations. You will take home relevant, up-to-date, and evidence-based strategies and tools to improve your patient care.\u003c\/p\u003e\n\u003ch3\u003eThe Harvard Updates in General Internal Medicine for Specialists 2025 course is designed for healthcare professionals specializing in various medical fields who need updates on general internal medicine. The target audience includes:\u003c\/h3\u003e\n\u003cp\u003eSpecialists in fields such as cardiology, psychiatry, anesthesiology, surgery, and hospital medicine.\u003c\/p\u003e\n\u003cp\u003eInternists and primary care physicians looking to expand their knowledge beyond their specialty.\u003c\/p\u003e\n\u003cp\u003eMedical trainees seeking advanced education in general internal medicine.\u003c\/p\u003e\n\u003cp\u003eHealthcare providers interested in the latest guidelines, treatments, and best practices across multiple specialties.\u003c\/p\u003e\n\u003cp\u003eThis program covers clinical updates, management strategies, and innovations in areas like cardiology, endocrinology, gastroenterology, neurology, and oncology.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 2025 Heart Failure Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Chronic Ischemic Heart Disease Treatment Choices in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Course Introduction.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Diseases of the Foregut.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Frequently Asked Questions in Hematology A Case-Based Approach.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Genetic Testing.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Ophthalmology in Primary Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 1 Updates in Stroke Prevention and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Asthma.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Colon Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Diabetes An Update for Subspecialists.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Hyperlipidemia 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Lung Cancer Therapy.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Overview of Sleep Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update in Renal Medicine.pdf\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.mp4\u003c\/p\u003e\n\u003cp\u003eDay 2 Update on Anticoagulants and Venous Thromboembolism.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Atrial Fibrillation.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Chronic Obstructive Pulmonary Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Common Outpatient Infections Current Treatment Recommendations.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Managing Obesity.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 New Practices for Managing Osteoporosis and Reducing Fractures.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Principles of Care for the Older Adult.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Prostate Cancer.pdf\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 3 Updates in Addressing Headaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Breast Cancer Current Approaches to Diagnosis and Treatment.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Infectious and Metabolic Liver Disease.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 1.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025 2.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Memory Loss, Alzheimer’s Disease, and Dementia Update 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Opioid Use Disorder.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Shoulder, Elbow, Wrist, Hand Pain Diagnosis and Management.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Treating Tobacco Use Optimizing for Enduring Outcomes.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Understanding Disparities in Specialty Care.pdf\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.mp4\u003c\/p\u003e\n\u003cp\u003eDay 4 Updates in Allergy What to Know in 2025.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Case Studies in Reproductive Endocrinology.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Common Thyroid Problems.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Disease Prevention and Health Promotion.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Healthcare Delivery in the Face of Climate Change.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Lower Back Pain Evaluation and Treatment Approaches.pdf\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.mp4\u003c\/p\u003e\n\u003cp\u003eDay 5 Women’s Health Managing Menopause.pdf\u003c\/p\u003e\n\u003cp\u003eGims Course Schedule.pdf\u003c\/p\u003e\n\u003cp\u003eMain Session.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734105284,"sku":null,"price":84.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Harvard-Updates-in-General-Internal-Medicine-for-Specialists-2025.png?v=1784215463"},{"product_id":"american-society-of-neuroradiology-on-demand-2025","title":"American Society of Neuroradiology On-Demand 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: neuroradiologists, radiologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMeeting Highlights\u003c\/p\u003e\n\u003cp\u003ePre-Meeting Symposium: “Embracing Humanity Through Neuroimaging”.\u003c\/p\u003e\n\u003cp\u003eSessions \u0026amp; Presentations: Cutting-edge research, invited lectures, and specialty programming from ASFNR, ASHNR, ASPNR, ASSR, and SNIS.\u003c\/p\u003e\n\u003cp\u003eSocial Events: Opening Reception \u0026amp; President’s Gala.\u003c\/p\u003e\n\u003cp\u003eVenue: Philadelphia Marriott Downtown\u003c\/p\u003e\n\u003ch3\u003eThe American Society of Neuroradiology (ASNR) On-Demand 2025 is designed for a diverse audience within the field of neuroradiology and neuroimaging. It primarily targets:\u003c\/h3\u003e\n\u003cp\u003eNeuroradiologists (both academic and private practice)\u003c\/p\u003e\n\u003cp\u003eRadiologists specializing in neuroimaging\u003c\/p\u003e\n\u003cp\u003eMedical professionals interested in neuroradiology advancements\u003c\/p\u003e\n\u003cp\u003eResearchers in neuroimaging and related fields\u003c\/p\u003e\n\u003cp\u003eMedical students, residents, and fellows pursuing neuroradiology\u003c\/p\u003e\n\u003cp\u003eIndustry professionals involved in neuroradiology technology and innovation\u003c\/p\u003e\n\u003cp\u003eThe event provides cutting-edge research, educational sessions, and clinical practice insights, making it valuable for both seasoned experts and those new to the field\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eASNR 2025 Schedule At-A-Glance\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734695108,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Neuroradiology-On-Demand-2025.jpg?v=1784215471"},{"product_id":"mayo-clinic-11th-annual-neuro-and-intensive-care-review-workshops-and-controversies-2025","title":"Mayo Clinic 11th Annual Neuro and Intensive Care Review, Workshops, and Controversies 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude:  videos +  pdf, size:  GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: neurologists, neurosurgeons, emergency medicine physicians\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCourse Directors: W. David Freeman, M.D., Alejandro A. Rabinstein, M.D., Sukhwinder (Johnny) S. Sandhu, M.D., Aaron B. Skolnik, M.D., and Eelco F. Wijdicks, M.D., Ph.D., Suzanne M. Brown, B.S.N., C.N.R.N., S.C.R.N., Christina I. Collins, D.N.P., A.R.N.P., Jodi D. Hellickson, APRN, CNS, M.S., Layton White, Jr., P.A.-C, P.A., Cathy L. Mielke, APRN, CNS, M.S., and Amanda D. Tomlinson, A.R.N.P., ACNP-BC.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eThis course is designed for medical professionals trained in neurology, neurosurgery, emergency medicine, critical care medicine, neurocritical care, pulmonary and critical care medicine, and anesthesia. ARNPs, PAs, paramedics\/EMS personnel, pharmacists, and physical, occupational, and speech therapists who care for patients with neurological emergencies may also benefit.\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eDefine common neurological and neurosurgical emergencies\u003c\/p\u003e\n\u003cp\u003eOutline strategies for best practice and evidence-based medicine updates in neuro-critical care\u003c\/p\u003e\n\u003cp\u003eDiscuss pathophysiologic management of neurocritical care conditions\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWednesday, May 21,  2025 Multi-Professional\/Allied Health Day\u003c\/p\u003e\n\u003cp\u003eModerators:  Suzanne Brown, BSN, RN, CNRN, SCRN, Christy Collins, DNP, APRN, Amanda Tomlinson, APRN, Jodi Hellickson, MS, APRN, CNS, Cathy Mielke, MS, APRN, CNS, Layton White Jr, PA-C\u003c\/p\u003e\n\u003cp\u003e12:30 p.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Light Hors d’oeuvres  \u0026amp; Exhibits  (Ritz-Carlton Ballroom 5 \u0026amp; 6)\u003c\/p\u003e\n\u003cp\u003e1:00\u003c\/p\u003e\n\u003cp\u003eKeynote Speaker: (Ritz-Carlton Ballroom 5 \u0026amp; 6)  “If you build it, will they come?  Future Directions for Implementing Research into Neurocritical Care Practice” Molly McNett, Ph.D., R.N., CNRN, FNCS, FAAN\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:45\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e3:00\u003c\/p\u003e\n\u003cp\u003eNeuro-Oncologic Emergencies Elizabeth Mutz, DNP APRN *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003ePalliative Medicine and Its Role in Critical Care Zaheera Lukman, D.O. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e4:00\u003c\/p\u003e\n\u003cp\u003eCardiac Device and Concern of Neurological Complications Breah L. Paciotti, P.A.-C, MPH\u003c\/p\u003e\n\u003cp\u003e4:30\u003c\/p\u003e\n\u003cp\u003ePharmacogenomics: Another Tool in the Neuro ICU Toolbox Daniel A. Jackson, Pharm.D., R.Ph. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e5:00\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e5:15\u003c\/p\u003e\n\u003cp\u003eElectronic (e-) Allied Health Poster Presentations with Distinguished Presentations\u003c\/p\u003e\n\u003cp\u003eThursday, May 22, 2025 Fundamentals of Neurocritical Care Day Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:00 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany )\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003eWelcome, Introduction, and Pretest (Tuscany D \u0026amp; E) W. David Freeman, M.D.\u003c\/p\u003e\n\u003cp\u003e7:45\u003c\/p\u003e\n\u003cp\u003eNeurocritical Care 2025: Yesterday’s Sci-Fi, Today’s Breakthroughs W. David Freeman, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:15\u003c\/p\u003e\n\u003cp\u003eTraumatic Brain Injury and Neurocritical Care Management: Challenging Cases Kristine O’Phelan, M.D. This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eMaster Class: Decisions, Decisions, Decisions Eelco Wijdicks, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003ePanel Q\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e9:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e9:45\u003c\/p\u003e\n\u003cp\u003eCritical Care Keynote: eCPR: The Future of Resuscitation or a Risky Gamble? (V) Pablo Moreno Franco, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e10:15\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e10:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e11:00\u003c\/p\u003e\n\u003cp\u003ePractical Neuroradiology in the ICU Sukhwinder (Johnny) S. Sandhu, M.D.\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e12:00 p.m.\u003c\/p\u003e\n\u003cp\u003eLunch and Learn Neuro Critical Care Interactive (N.C.C.I.) Mohammed Badi, MBBS, Mutaz Ombada, MBBS; Aaron Skolnik, M.D., Ashley Rogers, M.D.; Alejandro Rabinstein, M.D.; (V) Sukhwinder (Johnny) S. Sandhu, M.D.; Selby Chen, M.D.  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e1:15\u003c\/p\u003e\n\u003cp\u003eMixed Reality Training for Stroke and Neuro Critical Care Giselle Coelho, M.D., Ph.D.\u003c\/p\u003e\n\u003cp\u003e1:35\u003c\/p\u003e\n\u003cp\u003eUpdate in Aneurysmal Subarachnoid Hemorrhage Alejandro Rabinstein, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e2:20\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003eElectronic (e-) Poster Presentations (Tuscany D – E) Moderators: W. David Freeman, M.D.; Alejandro Rabinstein, M.D.; (V) and Sukhwinder (Johnny) S. Sandhu, M.D.\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eOptional Interactive Neuro and Critical Care Procedural Workshops (Tuscan Salons)\u003c\/p\u003e\n\u003cp\u003e1.)  Critical Care Procedures – Philip Lowman, M.D.; Levi Howard, D.O.; Christan Santos, APRN, D.N.P.; Joshua Propst PA-C.; Quintin Quinones, M.D., Ph.D., Leslie Simon D.O., Nader Amini, M.D., Mohamad Chymmasni  (Tuscany Salon A)\u003c\/p\u003e\n\u003cp\u003ea.       CVC, arterial line, intubation\/airway, bronchoscopy, tracheostomy\u003c\/p\u003e\n\u003cp\u003e2.) Neuro\/neurosurgical Procedures: Saif Salman, M.B.B.S.  (Tuscany Salon B)\u003c\/p\u003e\n\u003cp\u003ea.       EVD and CSF irrigation Techniques – Nick Brandmeir, M.D., Saif Salman, M.D.\u003c\/p\u003e\n\u003cp\u003eb.       Neurosurgical Training using realistic simulators: Giselle Coelho, M.D., Ph.D., Amra Sakusic, M.D., Ph.D., Saif Salman, M.D.\u003c\/p\u003e\n\u003cp\u003e3.)  Prehospital Emergency Stabilization: VR Haptics Thoracostomy, Hemorrhage, and Escharotomy: Madison Quinn, Justin Welzien, Joshua Losch, Aaron Skolnik, M.D. (Tuscany Salon C)\u003c\/p\u003e\n\u003cp\u003e4.) Ventilator workshop – Jeffrey Garland, M.D., Joseph Shiber, M.D. Matt Hendrickson R.T (Tuscany Salon G)\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy Workshop (Tuscany Salon D – E)\u003c\/p\u003e\n\u003cp\u003ePharmacotherapy Workshop Moderators: Mikaela M. Hofer, PharmD, RPh, BCPS, BCCP, Daniel A. Jackson, Pharm.D., R.Ph., Alejandro A. Rabinstein, M.D. (V)\u003c\/p\u003e\n\u003cp\u003e2.) Reversal of Anticoagulation in Intracranial Emergencies  Matthew W. Soto-Arenall, Pharm.D., R.Ph., MS, BCPS AQ Cards, BCACP, CACP, BCCCP\u003c\/p\u003e\n\u003cp\u003e3.) Osmolar Therapy Daniel A. Jackson, Pharm.D., R.Ph.\u003c\/p\u003e\n\u003cp\u003e4.) Antieipileptic Medications Mikaela M. Hofer, PharmD, RPh, BCPS, BCCCP\u003c\/p\u003e\n\u003cp\u003e*This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eICU EEG Workshop and Case-Based Debates (Tuscany Salon F)\u003c\/p\u003e\n\u003cp\u003eModerators: Brin Freund, M.D., Nidhi Kapoor, M.D., Badria Munir, M.B.B.S.\u003c\/p\u003e\n\u003cp\u003e5:30\u003c\/p\u003e\n\u003cp\u003eAdjourn \/  Exhibit Hall\u003c\/p\u003e\n\u003cp\u003eFriday, May 23, 2025 Acute Management, Surgical and Evidence-Based Updates Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:00 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e7:30\u003c\/p\u003e\n\u003cp\u003eWelcome, Opening Remarks (Tuscany D – E)\u003c\/p\u003e\n\u003cp\u003e7:45\u003c\/p\u003e\n\u003cp\u003eTransforming Critical Care Keynote: Brain-Injury and Inflammation Thomas Bleck, M.D. This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:15\u003c\/p\u003e\n\u003cp\u003eCODE ICH: A Call to Action W David Freeman, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e8:45\u003c\/p\u003e\n\u003cp\u003eRevolutionizing Neurologic Care: The Therapeutic Potential of Active CSF Exchange Nicholas Brandmeir, M.D.  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e9:15\u003c\/p\u003e\n\u003cp\u003e9:45\u003c\/p\u003e\n\u003cp\u003ePanel Question and Answer\u003c\/p\u003e\n\u003cp\u003e10:00\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e10:15\u003c\/p\u003e\n\u003cp\u003eNeuromuscular Emergencies: A Practical Approach Chris Kramer, M.D.\u003c\/p\u003e\n\u003cp\u003e10:45\u003c\/p\u003e\n\u003cp\u003eUpdate on Coma \u0026amp; Disorders of Consciousness J Brent Peel, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e11:15\u003c\/p\u003e\n\u003cp\u003eA Practical and Case-Based Approach to Encephalopathic ICU Patients Alejandro Rabinstein, M.D. (V)  *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e11:45\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e12:00\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e12:15 p.m.\u003c\/p\u003e\n\u003cp\u003eLunch \u0026amp; Learn: Case-Based Diagnosis and Treatment of Neuroimmunologic Disorders in the ICU and Update on the NIH ExTINGUISH Trial (Anti-NMDAR Encephalitis) Moderator: A. Rabinstein, M.D.\u003c\/p\u003e\n\u003cp\u003eSpeakers: Alfonso (Sebastian) S. Lopez Chiriboga, M.D., Gregory (Gregg) S. Day, M.D. *This presentation is eligible for ACPE credit\u003c\/p\u003e\n\u003cp\u003e1:00\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e1:10\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e1:15\u003c\/p\u003e\n\u003cp\u003eCross-Fire 1: Complex Ethical Situations and Cases: DNR vs Do Everything vs Self Fulfilling Prophecies Kimm McPhearson, D.O., Thomas Bleck, M.D. Moderator: Rohan Sharma, M.D.\u003c\/p\u003e\n\u003cp\u003e2:00\u003c\/p\u003e\n\u003cp\u003eCross-Fire 2: Pearls, Pitfalls, and Practicalities in Neurocritical Care (Panelists) Keith Dombrowski, M.D., Khalid Hanafy, M.D., Ph.D.(V), Marc Babi., M.D. Ph.D., J Brent Peel, M.D. Moderator: Rohan Sharma, M.D.\u003c\/p\u003e\n\u003cp\u003e2:30\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e2:45\u003c\/p\u003e\n\u003cp\u003eNeuro\/neurosurgical Procedure Workshop: EVD and Bolt Placement (manikins) (Tuscany A) Saif Salman, Vin Shen Ban, M.B.B.S., Giselle Coelho, M.D., Ph.D., John E Cebak, D.O., Ph.D., Selby Chen, M.D.\u003c\/p\u003e\n\u003cp\u003e3:15\u003c\/p\u003e\n\u003cp\u003eQ\u0026amp;A\u003c\/p\u003e\n\u003cp\u003e3:30\u003c\/p\u003e\n\u003cp\u003eBreak \/ Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e4:00\u003c\/p\u003e\n\u003cp\u003eElectronic Lightening ePosters #2 (Tuscany Salon D – E)\u003c\/p\u003e\n\u003cp\u003e5:00\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eReception at Bleu (Heavy Hors d’oeuvres and Cash Bar)\u003c\/p\u003e\n\u003cp\u003eSaturday, May 24, 2025  Neuro Emergencies Moderator: W. David Freeman, M.D\u003c\/p\u003e\n\u003cp\u003e7:30 a.m.\u003c\/p\u003e\n\u003cp\u003eRegistration \/ Continental Breakfast \u0026amp; Exhibit Hall (Tuscany Foyer)\u003c\/p\u003e\n\u003cp\u003e7:45 a.m.\u003c\/p\u003e\n\u003cp\u003eWelcome, Opening Remarks (Tuscany Salon D – E) Amanda Tomlinson ARNP. D.N.P.\u003c\/p\u003e\n\u003cp\u003eRapid Approaches to the Declining Neuro Patient – A combined partnership with Emergency Medicine and Critical Care\u003c\/p\u003e\n\u003cp\u003eABC’S Airway Breathing Circulation and Sedation: Charles Graham, M.D.\u003c\/p\u003e\n\u003cp\u003eApproach to the Patient with Coma: Courtney James, M.D.\u003c\/p\u003e\n\u003cp\u003eIntracranial Hypertension, Pressure Monitoring, and Complications: Jesse St Clair, M.D.\u003c\/p\u003e\n\u003cp\u003eAcute Seizure Management: Ashley (Rogers) Lorimer, M.D.\u003c\/p\u003e\n\u003cp\u003eRoundtable Discussion\u003c\/p\u003e\n\u003cp\u003eFaculty: Charles Graham, M.D., Michael Mohseni, M.D., Amanda Tomlinson, DNP, APRN, Ashley (Rogers) Lorimer, M.D., Courtney L James M.D., Jesse St Clair IV, M.D., A. Layton White PA-C, Wendy Camp, PA-C, Dr. Morgan Zegers D.O.\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405734760644,"sku":null,"price":110.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Mayo-Clinic-11th-Annual-Neuro-and-Intensive-Care-Review-Workshops-and-Controversies-2025.jpg?v=1784215472"},{"product_id":"uscap-fourth-edition-modern-surgical-pathology-through-the-expert-eyes-of-our-presidents-2023-update","title":"USCAP Fourth Edition Modern Surgical Pathology Through the Expert Eyes of Our Presidents 2023 (update)","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: pathologist\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: April 4, 2023\u003c\/p\u003e\n\u003cp\u003eAccess to this course expires on:  February 4, 2026 at 11:59 PM Pacific Time\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eRecent advances in immunohistochemical and molecular techniques have led to a paradigm shift such that we increasingly rely upon ancillary assays to facilitate or establish a diagnosis. This course is intended to emphasize the continued role of histomorphology in the classification of human diseases while highlighting the accomplishments of leaders in our field. All of the faculty members are current, or former presidents of the United States and Canadian Academy of Pathology and\/or the Arthur Purdy Stout Society of Surgical Pathologists. These individuals have tremendous knowledge to share with learners at all stages in their careers.\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eApply a pattern-based approach to non-neoplastic lung diseases\u003c\/p\u003e\n\u003cp\u003eDevelop a short differential diagnosis for mesenchymal tumors based on an assessment of morphologic features\u003c\/p\u003e\n\u003cp\u003eRecognize key diagnostic features in breast needle core biopsies\u003c\/p\u003e\n\u003cp\u003eDistinguish between syndromic polyps of the gastrointestinal tract\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eColorectal Cancer – Wendy L. Frankel, MD.pdf\u003c\/p\u003e\n\u003cp\u003eColorectal Cancer – Wendy L. Frankel, MD.ts\u003c\/p\u003e\n\u003cp\u003eDiagnostic Pitfalls and Other Risky Situations in Breast Pathology – Laura Collins, MD Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eDiagnostic Pitfalls and Other Risky Situations in Breast Pathology – Laura Collins, MD Part 1.ts\u003c\/p\u003e\n\u003cp\u003eDiagnostic Pitfalls and Other Risky Situations in Breast Pathology – Laura Collins, MD Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eDiagnostic Pitfalls and Other Risky Situations in Breast Pathology – Laura Collins, MD Part 2.ts\u003c\/p\u003e\n\u003cp\u003eInflammatory GI Cases – Rhonda Yantiss, MD Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eInflammatory GI Cases – Rhonda Yantiss, MD Part 1.ts\u003c\/p\u003e\n\u003cp\u003eInflammatory GI Cases – Rhonda Yantiss, MD Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eInflammatory GI Cases – Rhonda Yantiss, MD Part 2.ts\u003c\/p\u003e\n\u003cp\u003ePolyps and Polyposes – Wendy L. Frankel, MD.pdf\u003c\/p\u003e\n\u003cp\u003ePolyps and Polyposes – Wendy L. Frankel, MD.ts\u003c\/p\u003e\n\u003cp\u003eSoft Tissue Tumors – Christopher D.M. Fletcher, MD, FRCPath Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eSoft Tissue Tumors – Christopher D.M. Fletcher, MD, FRCPath Part 1.ts\u003c\/p\u003e\n\u003cp\u003eSoft Tissue Tumors – Christopher D.M. Fletcher, MD, FRCPath Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eSoft Tissue Tumors – Christopher D.M. Fletcher, MD, FRCPath Part 2.ts\u003c\/p\u003e\n\u003cp\u003eThoracic Pathology – Jeffrey Myers, MD Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eThoracic Pathology – Jeffrey Myers, MD Part 1.ts\u003c\/p\u003e\n\u003cp\u003eThoracic Pathology – Jeffrey Myers, MD Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eThoracic Pathology – Jeffrey Myers, MD Part 2.ts\u003c\/p\u003e\n\u003cp\u003eTumors and Tumor-like Lesions of the Genitourinary Tract – Victor Reuter, MD Part 1.pdf\u003c\/p\u003e\n\u003cp\u003eTumors and Tumor-like Lesions of the Genitourinary Tract – Victor Reuter, MD Part 1.ts\u003c\/p\u003e\n\u003cp\u003eTumors and Tumor-like Lesions of the Genitourinary Tract – Victor Reuter, MD Part 2.pdf\u003c\/p\u003e\n\u003cp\u003eTumors and Tumor-like Lesions of the Genitourinary Tract – Victor Reuter, MD Part 2.ts\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405735547076,"sku":null,"price":52.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Fourth-Edition-Modern-Surgical-Pathology-Through-the-Expert-Eyes-of-Our-Presidents-2023.png?v=1784215476"},{"product_id":"uscap-pearls-and-pitfalls-plain-or-splashy-in-daily-urologic-pathology-practice-2023","title":"USCAP Pearls and Pitfalls (Plain or Splashy) in Daily Urologic Pathology Practice 2023","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: Practicing academic and community pathologists, and pathologists-in-training\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eOriginal release date: May 18, 2023\u003c\/p\u003e\n\u003cp\u003eAccess to this course expires on:  May 18, 2026, 2026 at 11:59 PM Pacific Time\u003c\/p\u003e\n\u003cp\u003eCME 11.75\u003c\/p\u003e\n\u003cp\u003eCourse Description\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003ch3\u003eUpon completion of this educational activity, learners will be able to:\u003c\/h3\u003e\n\u003cp\u003eDistinguish benign mimickers from neoplastic processes\u003c\/p\u003e\n\u003cp\u003eCorrectly apply current grading and staging criteria for urologic tumors\u003c\/p\u003e\n\u003cp\u003eRecognize emerging urologic tumor entities with important clinical implications\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eKidney – Kiril Trpkov, MD\u003c\/p\u003e\n\u003cp\u003eTestis\/Paratestis – Maria Tretiakova, MD, PhD\u003c\/p\u003e\n\u003cp\u003eBladder and Penis – Priya Rao, MD\u003c\/p\u003e\n\u003cp\u003eProstate – Cristina Magi-Galluzzi, MD, PhD\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405735678148,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/USCAP-Pearls-and-Pitfalls-Plain-or-Splashy-in-Daily-Urologic-Pathology-Practice-2023.png?v=1784215478"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/collections\/Gemini_Generated_Image_18b2tl18b2tl18b2_2.png?v=1784221628","url":"https:\/\/medicalcoursespro.com\/collections\/diagnostic-imaging-radiology.oembed?page=2","provider":"Medicalcoursespro","version":"1.0","type":"link"}